P-value | ln(P) | Term | GO Tree | GO ID | # of Genes in Term | # of Target Genes in Term | # of Total Genes | # of Target Genes | Common Genes |
7.941e-13 | -27.86 | nervous system development | biological process | GO:0007399 | 2185 | 27 | 18204 | 50 |
MSI2,KALRN,NRG3,GPM6A,CAMK2G,DGKG,TNC,RORA,TNIK,PARD3,CTNNA2,CTNND2,DCLK2,NTRK2,ATP1A2,LSAMP,SOX5,NRCAM,NAV2,NRXN1,CNTN1,FAT3,SLC1A2,NAV3,RFX4,PLCB1,NTM |
1.403e-11 | -24.99 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | 764 | 17 | 16828 | 48 |
ATP1A2,NTRK2,NAV2,PARD3,KALRN,RYR3,PLCB1,NRG3,NKAIN3,ADCY2,LSAMP,GPC5,DPP6,LRP1B,HPSE2,SLC1A2,SOX5 |
3.946e-11 | -23.96 | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | 6953 | 42 | 16828 | 48 |
NRG3,FAT3,TNC,RYR3,PLCB1,MACF1,GPC5,ADCY2,NAV3,DGKG,SYNE1,KALRN,RFX4,NTM,FMN2,DTNA,SOX5,DCLK2,NRXN1,CAMK2G,CNTN1,TNIK,LRP1B,DPP6,NEBL,LSAMP,RORA,NRCAM,TRPM3,MGAT4C,ATP1A2,GPM6A,PARD3,NAV2,SLC4A4,SLC1A2,ABLIM1,SORBS1,PITPNC1,NHSL1,CTNND2,SFXN5 |
1.037e-10 | -22.99 | acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_B_cell_leukaemia | 3828 | 32 | 16828 | 48 |
NAV3,NKAIN3,ADCY2,GPC5,RYR3,PLCB1,TNC,NRG3,FAT3,FMN2,NTM,SYNE1,KALRN,NRXN1,SOX5,HPSE2,DPP6,LRP1B,TNIK,CNTN1,NRCAM,LSAMP,RORA,NEBL,NAV2,PARD3,GPM6A,NTRK2,MGAT4C,SLC1A2,SLC4A4,CTNND2 |
1.037e-10 | -22.99 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | 3828 | 32 | 16828 | 48 |
CTNND2,SLC4A4,SLC1A2,NAV2,GPM6A,PARD3,MGAT4C,NTRK2,NRCAM,LSAMP,RORA,NEBL,LRP1B,DPP6,CNTN1,TNIK,NRXN1,SOX5,HPSE2,NTM,FMN2,KALRN,SYNE1,NKAIN3,NAV3,GPC5,ADCY2,TNC,RYR3,PLCB1,NRG3,FAT3 |
7.413e-10 | -21.02 | mantle_cell_lymphoma | COSMIC cancer mutations | mantle_cell_lymphoma | 2849 | 27 | 16828 | 48 |
LRP1B,DPP6,CNTN1,SOX5,HPSE2,SYNE1,KALRN,RFX4,FMN2,GPC5,ADCY2,NKAIN3,NAV3,NRG3,TNC,RYR3,PLCB1,CTNND2,SFXN5,SLC1A2,GPM6A,PARD3,NAV2,TRPM3,NTRK2,LSAMP,NEBL |
8.126e-10 | -20.93 | neurogenesis | biological process | GO:0022008 | 1334 | 19 | 18204 | 50 |
TNC,RORA,TNIK,NAV2,NRXN1,KALRN,DGKG,GPM6A,NRCAM,NAV3,DCLK2,CTNND2,NTRK2,SOX5,NTM,PARD3,CTNNA2,FAT3,CNTN1 |
1.832e-09 | -20.12 | system development | biological process | GO:0048731 | 3533 | 29 | 18204 | 50 |
NTM,RFX4,SYNE1,NAV3,PLCB1,FAT3,CNTN1,SLC1A2,NEBL,NAV2,NRXN1,NRCAM,NTRK2,CTNND2,DCLK2,SOX5,LSAMP,ATP1A2,CTNNA2,PARD3,RORA,TNIK,TNC,DGKG,GPM6A,CAMK2G,MSI2,KALRN,NRG3 |
1.893e-09 | -20.09 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | 2737 | 26 | 16828 | 48 |
SLC1A2,SFXN5,CTNND2,LSAMP,NEBL,NAV2,GPM6A,PARD3,NTRK2,SOX5,HPSE2,DPP6,LRP1B,CNTN1,NAV3,NKAIN3,ADCY2,GPC5,PLCB1,RYR3,TNC,NRG3,FMN2,RFX4,KALRN,SYNE1 |
1.996e-09 | -20.03 | chondroblastoma | COSMIC cancer mutations | chondroblastoma | 534 | 13 | 16828 | 48 |
GPC5,ADCY2,LSAMP,NKAIN3,NRG3,PLCB1,RYR3,GPM6A,FMN2,SOX5,CTNND2,LRP1B,SFXN5 |
2.339e-09 | -19.87 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | 2119 | 23 | 16828 | 48 |
CNTN1,LRP1B,DPP6,HPSE2,SOX5,DGKG,KALRN,RFX4,FMN2,NRG3,RYR3,PLCB1,GPC5,ADCY2,NKAIN3,NHSL1,CTNND2,SLC1A2,NTRK2,PARD3,GPM6A,NAV2,LSAMP |
2.339e-09 | -19.87 | Burkitt_lymphoma | COSMIC cancer mutations | Burkitt_lymphoma | 2119 | 23 | 16828 | 48 |
LSAMP,NTRK2,NAV2,PARD3,GPM6A,SLC1A2,NHSL1,CTNND2,RYR3,PLCB1,NRG3,NKAIN3,ADCY2,GPC5,DGKG,FMN2,RFX4,KALRN,HPSE2,SOX5,CNTN1,DPP6,LRP1B |
5.400e-09 | -19.04 | generation of neurons | biological process | GO:0048699 | 1158 | 17 | 18204 | 50 |
SOX5,NTM,NTRK2,DCLK2,CTNND2,FAT3,CTNNA2,CNTN1,PARD3,TNIK,NRXN1,RORA,TNC,NRCAM,DGKG,GPM6A,KALRN |
5.425e-09 | -19.03 | neuron development | biological process | GO:0048666 | 859 | 15 | 18204 | 50 |
NRXN1,TNIK,TNC,GPM6A,DGKG,NRCAM,KALRN,NTRK2,DCLK2,CTNND2,NTM,CNTN1,CTNNA2,FAT3,PARD3 |
6.314e-09 | -18.88 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | 476 | 12 | 16828 | 48 |
NRG3,RYR3,PLCB1,LSAMP,GPC5,TRPM3,GPM6A,SYNE1,NAV2,SFXN5,CTNND2,LRP1B |
1.048e-08 | -18.37 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | 1174 | 17 | 16828 | 48 |
TNIK,LRP1B,SLC1A2,HPSE2,SOX5,DCLK2,CAMK2G,NTRK2,ATP1A2,KALRN,PARD3,NAV2,NRG3,RYR3,ADCY2,LSAMP,NKAIN3 |
1.048e-08 | -18.37 | myelodysplastic_syndrome | COSMIC cancer mutations | myelodysplastic_syndrome | 1174 | 17 | 16828 | 48 |
SOX5,CAMK2G,DCLK2,SLC1A2,HPSE2,LRP1B,TNIK,LSAMP,ADCY2,NKAIN3,NRG3,RYR3,KALRN,PARD3,NAV2,ATP1A2,NTRK2 |
1.069e-08 | -18.35 | prostate-carcinoma | COSMIC cancer mutations | prostate-carcinoma | 9000 | 44 | 16828 | 48 |
NTRK2,TRPM3,PARD3,SLC4A4,SLC1A2,SORBS1,CTNND2,SFXN5,RYR3,NRG3,NKAIN3,NTM,FMN2,DTNA,HPSE2,DCLK2,NRXN1,CNTN1,DPP6,NEBL,NRCAM,RORA,LSAMP,NAV2,GPM6A,ABLIM1,NHSL1,SLC14A1,PITPNC1,TNC,PLCB1,FAT3,NAV3,GPC5,MACF1,ADCY2,DGKG,MSI2,KALRN,SYNE1,RFX4,SOX5,TNIK,LRP1B |
1.088e-08 | -18.34 | mouth | COSMIC cancer mutations | mouth | 9004 | 44 | 16828 | 48 |
CTNND2,SFXN5,SLC4A4,SLC1A2,SORBS1,NTRK2,ATP1A2,TRPM3,PARD3,CNTN1,DPP6,HPSE2,DCLK2,NRXN1,NTM,DTNA,FMN2,RYR3,NRG3,NHSL1,PITPNC1,ABLIM1,MGAT4C,NAV2,GPM6A,NEBL,NRCAM,RORA,LSAMP,TNIK,LRP1B,CAMK2G,SOX5,DGKG,SYNE1,KALRN,RFX4,TNC,PLCB1,FAT3,NAV3,GPC5,MACF1,ADCY2 |
1.170e-08 | -18.26 | lymph_node | COSMIC cancer mutations | lymph_node | 1703 | 20 | 16828 | 48 |
TRPM3,NTRK2,PARD3,SYNE1,GPM6A,NAV2,DTNA,NEBL,NRG3,RYR3,PLCB1,GPC5,LSAMP,NAV3,TNIK,CTNND2,LRP1B,SFXN5,SOX5,CAMK2G |
1.199e-08 | -18.24 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | 1523 | 19 | 16828 | 48 |
LRP1B,CTNND2,HPSE2,SOX5,DGKG,NTRK2,PARD3,KALRN,FMN2,NAV2,NRG3,NEBL,PLCB1,RYR3,RORA,LSAMP,ADCY2,GPC5,NKAIN3 |
1.199e-08 | -18.24 | acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | acute_myeloid_leukaemia_therapy_related | 1523 | 19 | 16828 | 48 |
NEBL,NRG3,RYR3,PLCB1,GPC5,RORA,ADCY2,LSAMP,NKAIN3,NTRK2,DGKG,KALRN,PARD3,NAV2,FMN2,HPSE2,SOX5,LRP1B,CTNND2 |
1.551e-08 | -17.98 | neuron differentiation | biological process | GO:0030182 | 1081 | 16 | 18204 | 50 |
PARD3,CTNNA2,FAT3,CNTN1,NTM,NTRK2,DCLK2,CTNND2,KALRN,NRCAM,DGKG,GPM6A,TNC,TNIK,NRXN1,RORA |
1.746e-08 | -17.86 | cerebellum | COSMIC cancer mutations | cerebellum | 769 | 14 | 16828 | 48 |
NRXN1,ABLIM1,HPSE2,DPP6,LRP1B,CTNND2,GPC5,NRCAM,NRG3,NEBL,RYR3,PLCB1,PARD3,NTRK2 |
2.213e-08 | -17.63 | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | COSMIC cancer mutations | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | 653 | 13 | 16828 | 48 |
HPSE2,ABLIM1,NRXN1,CTNND2,LRP1B,DPP6,RYR3,PLCB1,NEBL,NRG3,NRCAM,NTRK2,PARD3 |
2.254e-08 | -17.61 | SHH_subtype | COSMIC cancer mutations | SHH_subtype | 654 | 13 | 16828 | 48 |
NRCAM,NRG3,NEBL,PLCB1,RYR3,PARD3,NTRK2,NRXN1,ABLIM1,HPSE2,DPP6,LRP1B,CTNND2 |
2.762e-08 | -17.40 | multicellular organism development | biological process | GO:0007275 | 3957 | 29 | 18204 | 50 |
DGKG,GPM6A,CAMK2G,NRG3,KALRN,MSI2,TNIK,RORA,TNC,CTNNA2,PARD3,SOX5,LSAMP,ATP1A2,NTRK2,CTNND2,DCLK2,NRCAM,NAV2,NRXN1,NEBL,SLC1A2,FAT3,CNTN1,NTM,PLCB1,RFX4,SYNE1,NAV3 |
2.935e-08 | -17.34 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 3608 | 28 | 16828 | 48 |
SLC1A2,CTNND2,NEBL,RORA,LSAMP,ATP1A2,GPM6A,PARD3,NAV2,HPSE2,SOX5,CNTN1,TNIK,DPP6,LRP1B,NRG3,PLCB1,RYR3,TNC,ADCY2,MACF1,GPC5,NAV3,NKAIN3,DGKG,KALRN,SYNE1,FMN2 |
3.024e-08 | -17.31 | diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | diffuse_large_B_cell_lymphoma | 4151 | 30 | 16828 | 48 |
GPC5,MACF1,ADCY2,NKAIN3,NAV3,NRG3,TNC,PLCB1,RYR3,KALRN,SYNE1,DTNA,FMN2,DGKG,SOX5,HPSE2,LRP1B,DPP6,CNTN1,TNIK,LSAMP,RORA,NEBL,GPM6A,PARD3,NAV2,NTRK2,ATP1A2,SLC1A2,CTNND2 |
3.102e-08 | -17.29 | plasma_cell_myeloma | COSMIC cancer mutations | plasma_cell_myeloma | 1263 | 17 | 16828 | 48 |
NTRK2,SYNE1,GPM6A,NTM,FMN2,NEBL,NRG3,TNC,RYR3,MACF1,ADCY2,NAV3,TNIK,CTNND2,LRP1B,HPSE2,ABLIM1 |
3.102e-08 | -17.29 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma | 1263 | 17 | 16828 | 48 |
NEBL,NRG3,TNC,RYR3,MACF1,ADCY2,NAV3,NTRK2,GPM6A,SYNE1,NTM,FMN2,HPSE2,ABLIM1,TNIK,LRP1B,CTNND2 |
3.501e-08 | -17.17 | right_lower_lobe | COSMIC cancer mutations | right_lower_lobe | 5692 | 35 | 16828 | 48 |
DGKG,KALRN,SYNE1,DTNA,FMN2,NTM,NRG3,FAT3,RYR3,PLCB1,TNC,ADCY2,GPC5,MACF1,NAV3,NKAIN3,CNTN1,DPP6,LRP1B,HPSE2,SOX5,TRPM3,ATP1A2,MGAT4C,NTRK2,GPM6A,PARD3,NAV2,NEBL,LSAMP,NRCAM,SLC14A1,CTNND2,SLC4A4,SORBS1 |
3.501e-08 | -17.17 | lung-right_lower_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_lower_lobe-carcinoma-adenocarcinoma | 5692 | 35 | 16828 | 48 |
DGKG,SYNE1,KALRN,DTNA,FMN2,NTM,NRG3,FAT3,PLCB1,RYR3,TNC,ADCY2,MACF1,GPC5,NAV3,NKAIN3,CNTN1,DPP6,LRP1B,HPSE2,SOX5,TRPM3,ATP1A2,MGAT4C,NTRK2,PARD3,GPM6A,NAV2,NEBL,LSAMP,NRCAM,SLC14A1,CTNND2,SLC4A4,SORBS1 |
5.405e-08 | -16.73 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | 7205 | 39 | 16828 | 48 |
CNTN1,TNIK,LRP1B,DPP6,HPSE2,DCLK2,NRXN1,SOX5,DGKG,NTM,FMN2,KALRN,SYNE1,RFX4,RYR3,PLCB1,FAT3,NRG3,NKAIN3,NAV3,GPC5,MACF1,ADCY2,NHSL1,PITPNC1,CTNND2,SFXN5,SLC4A4,SLC1A2,ABLIM1,SORBS1,NTRK2,TRPM3,NAV2,PARD3,GPM6A,NEBL,RORA,LSAMP |
7.535e-08 | -16.40 | PRNP (prion protein (Kanno blood group)) | protein interactions | 5621 | 1118 | 15 | 19454 | 50 |
SLC4A4,TRPM3,GPM6A,NHSL1,SORBS1,MSI2,TNC,PLCB1,MACF1,DPP6,CNTN1,ABLIM1,CAMK2G,ATP1A2,LSAMP |
1.117e-07 | -16.01 | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | 1946 | 20 | 16828 | 48 |
HPSE2,SLC4A4,NRXN1,RBMS3,SOX5,TNIK,CNTN1,DPP6,LRP1B,RYR3,PLCB1,FAT3,NEBL,NAV3,RORA,MACF1,MGAT4C,FMN2,GPM6A,SYNE1 |
1.136e-07 | -15.99 | larynx | COSMIC cancer mutations | larynx | 1948 | 20 | 16828 | 48 |
RBMS3,NRXN1,SOX5,SLC4A4,HPSE2,LRP1B,DPP6,CNTN1,TNIK,NAV3,MACF1,RORA,PLCB1,RYR3,NEBL,FAT3,FMN2,SYNE1,GPM6A,MGAT4C |
1.245e-07 | -15.90 | CTNNA1 (catenin alpha 1) | protein interactions | 1495 | 325 | 9 | 19454 | 50 |
TNIK,MACF1,SORBS1,PARD3,NEBL,DTNA,ABLIM1,CTNNA2,NHSL1 |
2.374e-07 | -15.25 | pharynx | COSMIC cancer mutations | pharynx | 2696 | 23 | 16828 | 48 |
LRP1B,DPP6,SYNE1,RFX4,DTNA,FMN2,DGKG,GPC5,MACF1,FAT3,NRG3,RYR3,CTNND2,SFXN5,PITPNC1,NHSL1,SLC14A1,SORBS1,SLC4A4,SLC1A2,NTRK2,ATP1A2,NRCAM |
2.662e-07 | -15.14 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 1117 | 15 | 16828 | 48 |
NRG3,RYR3,PLCB1,ADCY2,GPC5,DGKG,SYNE1,KALRN,PARD3,FMN2,NAV2,SLC1A2,SOX5,DPP6,LRP1B |
2.687e-07 | -15.13 | cell periphery | cellular component | GO:0071944 | 6020 | 33 | 19108 | 49 |
NRXN1,TRPM3,CNTN1,HPSE2,NAV2,NRG3,SLC14A1,SLC4A4,TNC,DGKG,NRCAM,PARD3,MACF1,NKAIN3,FMN2,DTNA,ADCY2,DPP6,LSAMP,SORBS1,RYR3,ATP1A2,SLC1A2,CTNND2,CTNNA2,GPC5,NTRK2,LRP1B,MAPK10,TNIK,GPM6A,SYNE1,NTM |
2.830e-07 | -15.08 | regulation of neuron projection development | biological process | GO:0010975 | 443 | 10 | 18204 | 50 |
CNTN1,CAMK2G,DGKG,CTNNA2,FAT3,NRCAM,SYNE1,NTRK2,MACF1,TNIK |
3.366e-07 | -14.90 | bone-tibia-other-chondroblastoma | COSMIC cancer mutations | bone-tibia-other-chondroblastoma | 98 | 6 | 16828 | 48 |
NKAIN3,LSAMP,PLCB1,CTNND2,GPM6A,LRP1B |
3.720e-07 | -14.80 | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | 2531 | 22 | 16828 | 48 |
TNIK,DPP6,LRP1B,HPSE2,SOX5,FMN2,KALRN,SYNE1,RYR3,PLCB1,NRG3,NKAIN3,ADCY2,GPC5,SLC14A1,SFXN5,CTNND2,NAV2,PARD3,GPM6A,RORA,LSAMP |
3.885e-07 | -14.76 | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 26 | 16828 | 48 |
CTNND2,PITPNC1,SLC4A4,NAV2,PARD3,NTRK2,MGAT4C,TRPM3,NRCAM,LSAMP,LRP1B,DPP6,TNIK,HPSE2,DTNA,FMN2,MSI2,SYNE1,KALRN,GPC5,MACF1,ADCY2,PLCB1,RYR3,NRG3,FAT3 |
3.885e-07 | -14.76 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 26 | 16828 | 48 |
DTNA,FMN2,MSI2,KALRN,SYNE1,MACF1,GPC5,ADCY2,PLCB1,RYR3,FAT3,NRG3,LRP1B,DPP6,TNIK,HPSE2,NAV2,PARD3,NTRK2,MGAT4C,TRPM3,NRCAM,LSAMP,CTNND2,PITPNC1,SLC4A4 |
4.244e-07 | -14.67 | scalp | COSMIC cancer mutations | scalp | 2110 | 20 | 16828 | 48 |
FMN2,NTM,SYNE1,ATP1A2,NAV3,NRCAM,LSAMP,RORA,MACF1,GPC5,PLCB1,TNC,NEBL,CNTN1,NRXN1,CAMK2G,RBMS3,SOX5,SORBS1,SLC4A4 |
4.831e-07 | -14.54 | cell differentiation | biological process | GO:0030154 | 3645 | 26 | 18204 | 50 |
PARD3,CTNNA2,NHSL1,SOX5,CTNND2,NTRK2,DCLK2,MSI2,KALRN,DGKG,CAMK2G,GPM6A,TNC,TNIK,RORA,NEBL,FAT3,CNTN1,PLCB1,SYNE1,FMN2,NAV3,NTM,NRCAM,NAV2,NRXN1 |
4.913e-07 | -14.53 | cellular developmental process | biological process | GO:0048869 | 3648 | 26 | 18204 | 50 |
TNC,RORA,TNIK,MSI2,KALRN,DGKG,GPM6A,CAMK2G,NHSL1,CTNND2,NTRK2,DCLK2,SOX5,PARD3,CTNNA2,NAV2,NRXN1,NRCAM,SYNE1,NAV3,FMN2,PLCB1,NTM,FAT3,CNTN1,NEBL |
6.436e-07 | -14.26 | plasma membrane | cellular component | GO:0005886 | 5538 | 31 | 19108 | 49 |
TRPM3,NRXN1,HPSE2,CNTN1,SLC14A1,NRG3,NRCAM,SLC4A4,DGKG,PARD3,NKAIN3,MACF1,LSAMP,SORBS1,FMN2,DTNA,DPP6,ADCY2,ATP1A2,RYR3,CTNND2,SLC1A2,CTNNA2,NTRK2,GPC5,LRP1B,SYNE1,NTM,MAPK10,TNIK,GPM6A |
6.984e-07 | -14.17 | brainstem | COSMIC cancer mutations | brainstem | 3102 | 24 | 16828 | 48 |
GPM6A,PARD3,NAV2,RORA,LSAMP,SFXN5,CTNND2,SLC14A1,SLC1A2,SYNE1,KALRN,FMN2,ADCY2,GPC5,NKAIN3,NRG3,RYR3,PLCB1,TNC,DPP6,LRP1B,TNIK,SOX5,HPSE2 |
7.886e-07 | -14.05 | soft_tissue-blood_vessel-angiosarcoma | COSMIC cancer mutations | soft_tissue-blood_vessel-angiosarcoma | 2192 | 20 | 16828 | 48 |
DPP6,LRP1B,CTNND2,SLC1A2,HPSE2,SOX5,NTRK2,FMN2,NAV2,SYNE1,PARD3,GPM6A,PLCB1,RYR3,NRG3,NEBL,NKAIN3,LSAMP,ADCY2,GPC5 |
7.886e-07 | -14.05 | angiosarcoma | COSMIC cancer mutations | angiosarcoma | 2192 | 20 | 16828 | 48 |
PARD3,GPM6A,SYNE1,FMN2,NAV2,NTRK2,ADCY2,LSAMP,GPC5,NKAIN3,NRG3,NEBL,RYR3,PLCB1,DPP6,CTNND2,LRP1B,SOX5,SLC1A2,HPSE2 |
8.927e-07 | -13.93 | anatomical structure development | biological process | GO:0048856 | 5207 | 31 | 18204 | 50 |
PLCB1,SYNE1,RFX4,FMN2,NAV3,NTM,NEBL,SLC1A2,FAT3,CNTN1,NRXN1,NAV2,NRCAM,ABLIM1,ATP1A2,SOX5,LSAMP,CTNND2,NTRK2,DCLK2,PARD3,CTNNA2,TNC,TNIK,RORA,NRG3,MSI2,KALRN,DGKG,CAMK2G,GPM6A |
9.065e-07 | -13.91 | blood_vessel | COSMIC cancer mutations | blood_vessel | 2211 | 20 | 16828 | 48 |
RYR3,PLCB1,NEBL,NRG3,NKAIN3,GPC5,LSAMP,ADCY2,NTRK2,NAV2,FMN2,GPM6A,SYNE1,PARD3,SLC1A2,HPSE2,SOX5,LRP1B,CTNND2,DPP6 |
1.066e-06 | -13.75 | upper_aerodigestive_tract-mouth-carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma | 6426 | 35 | 16828 | 48 |
RFX4,SYNE1,KALRN,FMN2,NTM,DGKG,ADCY2,GPC5,MACF1,NAV3,NRG3,FAT3,RYR3,PLCB1,TNC,DPP6,LRP1B,CNTN1,SOX5,HPSE2,GPM6A,PARD3,NAV2,TRPM3,MGAT4C,RORA,NRCAM,SFXN5,CTNND2,PITPNC1,NHSL1,SORBS1,SLC1A2,ABLIM1,SLC4A4 |
1.247e-06 | -13.60 | endometrium-carcinoma-serous_carcinoma | COSMIC cancer mutations | endometrium-carcinoma-serous_carcinoma | 1442 | 16 | 16828 | 48 |
TRPM3,FMN2,SYNE1,PARD3,RYR3,FAT3,LSAMP,GPC5,TNIK,CNTN1,DPP6,CTNND2,LRP1B,SLC4A4,NRXN1,SORBS1 |
1.436e-06 | -13.45 | Ig_I-set | interpro domains | IPR013098 | 132 | 6 | 18521 | 50 |
NTRK2,NRCAM,CNTN1,KALRN,NTM,LSAMP |
1.472e-06 | -13.43 | regulation of plasma membrane bounded cell projection organization | biological process | GO:0120035 | 666 | 11 | 18204 | 50 |
CAMK2G,GPM6A,DGKG,NRCAM,MACF1,TNIK,CNTN1,CTNNA2,FAT3,SYNE1,NTRK2 |
1.600e-06 | -13.35 | I-set | pfam domains | PF07679 | 132 | 6 | 17795 | 49 |
NRCAM,NTRK2,LSAMP,CNTN1,KALRN,NTM |
1.880e-06 | -13.18 | regulation of cell projection organization | biological process | GO:0031344 | 683 | 11 | 18204 | 50 |
FAT3,CTNNA2,CNTN1,SYNE1,NTRK2,NRCAM,DGKG,CAMK2G,GPM6A,TNIK,MACF1 |
1.912e-06 | -13.17 | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | 3531 | 25 | 16828 | 48 |
SOX5,HPSE2,LRP1B,TNIK,MACF1,GPC5,ADCY2,NAV3,NRG3,FAT3,TNC,RYR3,SYNE1,FMN2,DGKG,SLC4A4,ABLIM1,CTNND2,NHSL1,NEBL,PARD3,GPM6A,NAV2,TRPM3,ATP1A2 |
1.926e-06 | -13.16 | central nervous system development | biological process | GO:0007417 | 995 | 13 | 18204 | 50 |
RFX4,PLCB1,RORA,DCLK2,NTRK2,ATP1A2,NAV2,MSI2,NRG3,CTNNA2,CNTN1,NRCAM,SLC1A2 |
1.933e-06 | -13.16 | middle_third | COSMIC cancer mutations | middle_third | 3533 | 25 | 16828 | 48 |
HPSE2,SOX5,TNIK,LRP1B,TNC,RYR3,NRG3,FAT3,NAV3,GPC5,MACF1,ADCY2,DGKG,FMN2,SYNE1,SLC4A4,ABLIM1,NHSL1,CTNND2,NEBL,ATP1A2,TRPM3,NAV2,GPM6A,PARD3 |
1.935e-06 | -13.16 | bone-humerus-other-chondroblastoma | COSMIC cancer mutations | bone-humerus-other-chondroblastoma | 301 | 8 | 16828 | 48 |
LRP1B,GPM6A,SFXN5,FMN2,GPC5,SOX5,ADCY2,NKAIN3 |
2.083e-06 | -13.08 | developmental process | biological process | GO:0032502 | 5716 | 32 | 18204 | 50 |
PARD3,CTNNA2,NHSL1,NTRK2,DCLK2,CTNND2,LSAMP,SOX5,ATP1A2,MSI2,KALRN,NRG3,DGKG,CAMK2G,GPM6A,TNC,RORA,TNIK,FAT3,CNTN1,NEBL,SLC1A2,SYNE1,RFX4,NAV3,FMN2,PLCB1,NTM,NRCAM,ABLIM1,NRXN1,NAV2 |
2.165e-06 | -13.04 | neuron projection development | biological process | GO:0031175 | 693 | 11 | 18204 | 50 |
NRCAM,CTNNA2,FAT3,CNTN1,GPM6A,PARD3,KALRN,TNIK,NRXN1,CTNND2,TNC |
2.308e-06 | -12.98 | action potential propagation | biological process | GO:0098870 | 10 | 3 | 18204 | 50 |
NRCAM,ATP1A2,NTRK2 |
2.308e-06 | -12.98 | neuronal action potential propagation | biological process | GO:0019227 | 10 | 3 | 18204 | 50 |
NRCAM,ATP1A2,NTRK2 |
2.565e-06 | -12.87 | humerus | COSMIC cancer mutations | humerus | 546 | 10 | 16828 | 48 |
GPC5,SOX5,ADCY2,NKAIN3,NEBL,LRP1B,KALRN,GPM6A,SFXN5,FMN2 |
2.846e-06 | -12.77 | bone | COSMIC cancer mutations | bone | 8157 | 39 | 16828 | 48 |
SORBS1,SLC4A4,ABLIM1,CTNND2,SFXN5,NRCAM,LSAMP,RORA,NEBL,NAV2,PARD3,GPM6A,NTRK2,ATP1A2,TRPM3,DCLK2,NRXN1,CAMK2G,SOX5,HPSE2,LRP1B,DPP6,CNTN1,TNIK,NKAIN3,NAV3,GPC5,MACF1,ADCY2,TNC,RYR3,PLCB1,NRG3,FAT3,FMN2,DTNA,KALRN,SYNE1,DGKG |
3.016e-06 | -12.71 | lung-left_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-left_upper_lobe-carcinoma-adenocarcinoma | 556 | 10 | 16828 | 48 |
ADCY2,NAV3,SLC4A4,FAT3,RYR3,PLCB1,SYNE1,LRP1B,CTNND2,NTRK2 |
3.114e-06 | -12.68 | left_upper_lobe | COSMIC cancer mutations | left_upper_lobe | 558 | 10 | 16828 | 48 |
NAV3,ADCY2,RYR3,PLCB1,FAT3,SLC4A4,SYNE1,CTNND2,LRP1B,NTRK2 |
3.175e-06 | -12.66 | cell development | biological process | GO:0048468 | 2236 | 19 | 18204 | 50 |
NTM,NTRK2,CTNND2,DCLK2,FMN2,NEBL,CNTN1,CTNNA2,FAT3,PARD3,NRXN1,TNIK,RORA,TNC,NRCAM,GPM6A,DGKG,KALRN,MSI2 |
3.302e-06 | -12.62 | brain development | biological process | GO:0007420 | 724 | 11 | 18204 | 50 |
NRCAM,SLC1A2,CTNNA2,CNTN1,NRG3,ATP1A2,RORA,DCLK2,NTRK2,PLCB1,RFX4 |
3.587e-06 | -12.54 | multicellular organismal process | biological process | GO:0032501 | 6177 | 33 | 18204 | 50 |
GPM6A,CAMK2G,DGKG,NRG3,KALRN,MSI2,TNIK,SLC4A4,RORA,TNC,CTNNA2,PARD3,LSAMP,ATP1A2,SOX5,CTNND2,DCLK2,NTRK2,ABLIM1,NRCAM,DTNA,NAV2,NRXN1,NEBL,SLC1A2,CNTN1,FAT3,RYR3,NTM,PLCB1,NAV3,SYNE1,RFX4 |
3.650e-06 | -12.52 | MAPT (microtubule associated protein tau) | protein interactions | 4137 | 948 | 12 | 19454 | 50 |
ABLIM1,CTNNA2,CTNND2,NTM,SORBS1,ATP1A2,SLC1A2,LSAMP,NEBL,TNIK,GPM6A,MAPK10 |
3.952e-06 | -12.44 | neuron projection | cellular component | GO:0043005 | 1331 | 14 | 19108 | 49 |
GPM6A,PARD3,SYNE1,NRCAM,NTRK2,CNTN1,CTNNA2,CAMK2G,SLC1A2,CTNND2,ATP1A2,FAT3,ADCY2,DTNA |
4.541e-06 | -12.30 | postsynapse | cellular component | GO:0098794 | 646 | 10 | 19108 | 49 |
CTNND2,KALRN,NRCAM,SYNE1,GPM6A,CNTN1,TNIK,NTRK2,ATP1A2,PLCB1 |
4.679e-06 | -12.27 | cell junction | cellular component | GO:0030054 | 2224 | 18 | 19108 | 49 |
CNTN1,CTNNA2,NRXN1,SLC1A2,KALRN,CTNND2,PLCB1,ATP1A2,DTNA,SORBS1,GPM6A,TNIK,PARD3,SYNE1,TNC,NRCAM,NRG3,NTRK2 |
5.753e-06 | -12.07 | skin-face-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-face-carcinoma-squamous_cell_carcinoma | 2036 | 18 | 16828 | 48 |
SYNE1,PARD3,GPM6A,FMN2,MSI2,NAV2,TRPM3,RORA,LSAMP,MACF1,GPC5,NAV3,NRG3,NEBL,PLCB1,LRP1B,RBMS3,ABLIM1 |
6.057e-06 | -12.01 | neuron projection morphogenesis | biological process | GO:0048812 | 486 | 9 | 18204 | 50 |
CTNND2,TNIK,NRXN1,CTNNA2,GPM6A,CNTN1,NRCAM,PARD3,KALRN |
6.254e-06 | -11.98 | head development | biological process | GO:0060322 | 774 | 11 | 18204 | 50 |
CTNNA2,CNTN1,NRCAM,SLC1A2,NRG3,RORA,NTRK2,DCLK2,ATP1A2,RFX4,PLCB1 |
6.387e-06 | -11.96 | intestinal_adenocarcinoma | COSMIC cancer mutations | intestinal_adenocarcinoma | 7225 | 36 | 16828 | 48 |
HPSE2,SOX5,NRXN1,DCLK2,CNTN1,LRP1B,NRG3,FAT3,RYR3,PLCB1,TNC,ADCY2,MACF1,NAV3,DGKG,RFX4,SYNE1,KALRN,FMN2,NTM,SLC1A2,SLC4A4,PITPNC1,SLC14A1,NHSL1,SFXN5,CTNND2,NEBL,LSAMP,RORA,NRCAM,TRPM3,ATP1A2,NTRK2,PARD3,NAV2 |
6.387e-06 | -11.96 | stomach-carcinoma-intestinal_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-intestinal_adenocarcinoma | 7225 | 36 | 16828 | 48 |
SLC1A2,SLC4A4,SFXN5,CTNND2,PITPNC1,SLC14A1,NHSL1,LSAMP,RORA,NRCAM,NEBL,PARD3,NAV2,TRPM3,ATP1A2,NTRK2,SOX5,NRXN1,DCLK2,HPSE2,LRP1B,CNTN1,ADCY2,MACF1,NAV3,NRG3,FAT3,PLCB1,RYR3,TNC,RFX4,SYNE1,KALRN,FMN2,NTM,DGKG |
6.578e-06 | -11.93 | plasma membrane bounded cell projection morphogenesis | biological process | GO:0120039 | 491 | 9 | 18204 | 50 |
NRCAM,CTNNA2,CNTN1,GPM6A,PARD3,KALRN,TNIK,NRXN1,CTNND2 |
7.138e-06 | -11.85 | cell projection morphogenesis | biological process | GO:0048858 | 496 | 9 | 18204 | 50 |
PARD3,KALRN,CTNNA2,GPM6A,CNTN1,NRCAM,CTNND2,TNIK,NRXN1 |
7.941e-06 | -11.74 | upper_aerodigestive_tract | COSMIC cancer mutations | upper_aerodigestive_tract | 13181 | 48 | 16828 | 48 |
MGAT4C,NAV2,GPM6A,NEBL,NRCAM,RORA,LSAMP,NHSL1,SLC14A1,PITPNC1,ABLIM1,DGKG,MSI2,KALRN,SYNE1,RFX4,TNC,PLCB1,FAT3,NAV3,GPC5,MACF1,ADCY2,TNIK,LRP1B,RBMS3,CAMK2G,SOX5,NTRK2,ATP1A2,TRPM3,PARD3,CTNND2,SFXN5,SLC4A4,SLC1A2,SORBS1,NTM,DTNA,FMN2,RYR3,NRG3,NKAIN3,CNTN1,DPP6,HPSE2,DCLK2,NRXN1 |
8.691e-06 | -11.65 | trunk | COSMIC cancer mutations | trunk | 3554 | 24 | 16828 | 48 |
RYR3,PLCB1,TNC,NRG3,FAT3,MACF1,DGKG,KALRN,SYNE1,HPSE2,NRXN1,DCLK2,SOX5,LRP1B,NEBL,NRCAM,LSAMP,ATP1A2,MGAT4C,NTRK2,PARD3,ABLIM1,SLC14A1,CTNND2 |
9.591e-06 | -11.55 | plasma membrane bounded cell projection organization | biological process | GO:0120036 | 1152 | 13 | 18204 | 50 |
KALRN,PARD3,ABLIM1,NRCAM,GPM6A,CNTN1,FAT3,CTNNA2,TNC,RFX4,NRXN1,TNIK,CTNND2 |
9.764e-06 | -11.54 | telencephalon development | biological process | GO:0021537 | 276 | 7 | 18204 | 50 |
NRG3,SLC1A2,PLCB1,RFX4,ATP1A2,NTRK2,DCLK2 |
1.140e-05 | -11.38 | carcinoid-endocrine_tumour | COSMIC cancer mutations | carcinoid-endocrine_tumour | 7752 | 37 | 16828 | 48 |
SLC4A4,SLC1A2,ABLIM1,NHSL1,CTNND2,SFXN5,NEBL,RORA,LSAMP,NRCAM,TRPM3,NTRK2,ATP1A2,GPM6A,PARD3,NAV2,HPSE2,SOX5,DCLK2,CAMK2G,CNTN1,TNIK,LRP1B,DPP6,NRG3,TNC,RYR3,PLCB1,MACF1,GPC5,ADCY2,NKAIN3,DGKG,KALRN,SYNE1,RFX4,FMN2 |
1.156e-05 | -11.37 | face | COSMIC cancer mutations | face | 2139 | 18 | 16828 | 48 |
TRPM3,SYNE1,GPM6A,PARD3,NAV2,MSI2,FMN2,NEBL,NRG3,PLCB1,MACF1,GPC5,RORA,LSAMP,NAV3,LRP1B,ABLIM1,RBMS3 |
1.209e-05 | -11.32 | nodular | COSMIC cancer mutations | nodular | 1515 | 15 | 16828 | 48 |
CNTN1,CTNND2,LRP1B,ABLIM1,SLC4A4,DCLK2,ATP1A2,DGKG,NTRK2,SYNE1,KALRN,FMN2,NEBL,PLCB1,MACF1 |
1.272e-05 | -11.27 | synapse | cellular component | GO:0045202 | 1473 | 14 | 19108 | 49 |
NRXN1,SLC1A2,KALRN,CTNND2,NRCAM,GPM6A,TNIK,CNTN1,SYNE1,DTNA,NTRK2,PLCB1,NRG3,ATP1A2 |
1.338e-05 | -11.22 | kidney-carcinoma-papillary_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-papillary_renal_cell_carcinoma | 6364 | 33 | 16828 | 48 |
TNIK,CNTN1,LRP1B,HPSE2,NRXN1,CAMK2G,DCLK2,SOX5,DGKG,FMN2,NTM,RFX4,KALRN,SYNE1,PLCB1,RYR3,NRG3,FAT3,NAV3,ADCY2,GPC5,MACF1,PITPNC1,CTNND2,ABLIM1,SLC4A4,ATP1A2,NTRK2,TRPM3,NAV2,PARD3,NRCAM,RORA |
1.338e-05 | -11.22 | papillary_renal_cell_carcinoma | COSMIC cancer mutations | papillary_renal_cell_carcinoma | 6364 | 33 | 16828 | 48 |
PITPNC1,CTNND2,SLC4A4,ABLIM1,TRPM3,NTRK2,ATP1A2,PARD3,NAV2,RORA,NRCAM,CNTN1,TNIK,LRP1B,HPSE2,SOX5,DCLK2,NRXN1,CAMK2G,DGKG,SYNE1,KALRN,RFX4,NTM,FMN2,NRG3,FAT3,RYR3,PLCB1,GPC5,MACF1,ADCY2,NAV3 |
1.353e-05 | -11.21 | C11orf52 (chromosome 11 open reading frame 52) | protein interactions | 91894 | 310 | 7 | 19454 | 50 |
DTNA,ABLIM1,PARD3,TNIK,PLCB1,MACF1,FMN2 |
1.354e-05 | -11.21 | cell projection | cellular component | GO:0042995 | 2398 | 18 | 19108 | 49 |
NTRK2,GPM6A,PARD3,SYNE1,MACF1,NRCAM,ATP1A2,DTNA,FMN2,FAT3,ADCY2,CNTN1,ABLIM1,CTNNA2,NRXN1,SLC1A2,CAMK2G,CTNND2 |
1.370e-05 | -11.20 | plasma membrane region | cellular component | GO:0098590 | 1278 | 13 | 19108 | 49 |
CNTN1,SLC1A2,NRXN1,ATP1A2,SORBS1,MACF1,PARD3,SYNE1,GPM6A,TNIK,NRCAM,SLC4A4,SLC14A1 |
1.437e-05 | -11.15 | cell morphogenesis | biological process | GO:0000902 | 687 | 10 | 18204 | 50 |
CTNNA2,FAT3,CNTN1,GPM6A,NRCAM,PARD3,KALRN,CTNND2,TNIK,NRXN1 |
1.487e-05 | -11.12 | cell projection organization | biological process | GO:0030030 | 1200 | 13 | 18204 | 50 |
NRCAM,ABLIM1,GPM6A,KALRN,TNIK,NRXN1,TNC,FAT3,CTNNA2,CNTN1,PARD3,CTNND2,RFX4 |
1.562e-05 | -11.07 | lung-carcinoma-small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-small_cell_carcinoma | 9908 | 42 | 16828 | 48 |
NAV3,NKAIN3,GPC5,MACF1,RYR3,PLCB1,TNC,FAT3,NRG3,DTNA,FMN2,MSI2,NTM,RFX4,KALRN,SYNE1,DGKG,CAMK2G,NRXN1,DCLK2,SOX5,HPSE2,DPP6,LRP1B,TNIK,CNTN1,NRCAM,RORA,NEBL,NAV2,GPM6A,PARD3,ATP1A2,MGAT4C,NTRK2,TRPM3,SORBS1,ABLIM1,SLC4A4,CTNND2,SLC14A1,PITPNC1 |
1.569e-05 | -11.06 | right_upper_lobe | COSMIC cancer mutations | right_upper_lobe | 10376 | 43 | 16828 | 48 |
DPP6,LRP1B,TNIK,CNTN1,NRXN1,DCLK2,SOX5,HPSE2,DTNA,FMN2,NTM,RFX4,SYNE1,KALRN,DGKG,NAV3,NKAIN3,ADCY2,MACF1,GPC5,RYR3,PLCB1,TNC,FAT3,NRG3,SFXN5,CTNND2,PITPNC1,SORBS1,SLC1A2,ABLIM1,SLC4A4,NAV2,GPM6A,PARD3,ATP1A2,MGAT4C,NTRK2,TRPM3,NRCAM,RORA,LSAMP,NEBL |
1.569e-05 | -11.06 | lung-right_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_upper_lobe-carcinoma-adenocarcinoma | 10376 | 43 | 16828 | 48 |
NRCAM,LSAMP,RORA,NEBL,NAV2,GPM6A,MGAT4C,ABLIM1,PITPNC1,NAV3,MACF1,GPC5,ADCY2,TNC,PLCB1,FAT3,SYNE1,KALRN,RFX4,DGKG,SOX5,LRP1B,TNIK,PARD3,NTRK2,ATP1A2,TRPM3,SORBS1,SLC4A4,SLC1A2,CTNND2,SFXN5,NKAIN3,RYR3,NRG3,NTM,DTNA,FMN2,DCLK2,NRXN1,HPSE2,DPP6,CNTN1 |
1.589e-05 | -11.05 | small_cell_carcinoma | COSMIC cancer mutations | small_cell_carcinoma | 9913 | 42 | 16828 | 48 |
DCLK2,NRXN1,CAMK2G,SOX5,HPSE2,LRP1B,DPP6,CNTN1,TNIK,NKAIN3,NAV3,MACF1,GPC5,TNC,RYR3,PLCB1,NRG3,FAT3,NTM,FMN2,MSI2,DTNA,KALRN,SYNE1,RFX4,DGKG,SORBS1,SLC4A4,ABLIM1,CTNND2,SLC14A1,PITPNC1,NRCAM,RORA,NEBL,NAV2,PARD3,GPM6A,NTRK2,MGAT4C,ATP1A2,TRPM3 |
1.776e-05 | -10.94 | tibia | COSMIC cancer mutations | tibia | 836 | 11 | 16828 | 48 |
TRPM3,TNIK,LRP1B,CTNND2,GPM6A,ABLIM1,FAT3,PLCB1,MACF1,LSAMP,NKAIN3 |
1.850e-05 | -10.90 | FLOT1 (flotillin 1) | protein interactions | 10211 | 453 | 8 | 19454 | 50 |
ABLIM1,DTNA,PARD3,SOX5,SORBS1,MACF1,SLC14A1,FMN2 |
1.892e-05 | -10.88 | oesophagus-carcinoma | COSMIC cancer mutations | oesophagus-carcinoma | 4269 | 26 | 16828 | 48 |
CTNND2,NHSL1,SORBS1,SLC4A4,GPM6A,PARD3,TRPM3,NTRK2,NRCAM,DPP6,LRP1B,TNIK,CNTN1,SOX5,HPSE2,RFX4,KALRN,SYNE1,FMN2,NTM,ADCY2,MACF1,NAV3,NRG3,RYR3,PLCB1 |
2.057e-05 | -10.79 | autonomic_ganglia | COSMIC cancer mutations | autonomic_ganglia | 4005 | 25 | 16828 | 48 |
ADCY2,MACF1,NAV3,NEBL,PLCB1,RYR3,TNC,RFX4,PARD3,KALRN,GPM6A,SYNE1,FMN2,NAV2,ATP1A2,NTRK2,DGKG,CAMK2G,SLC1A2,SLC4A4,LRP1B,CTNND2,PITPNC1,TNIK,NHSL1 |
2.126e-05 | -10.76 | oesophagus-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-carcinoma-squamous_cell_carcinoma | 6486 | 33 | 16828 | 48 |
NAV2,GPM6A,PARD3,ATP1A2,MGAT4C,TRPM3,NEBL,SFXN5,CTNND2,PITPNC1,SORBS1,ABLIM1,SLC4A4,FMN2,SYNE1,KALRN,NAV3,ADCY2,GPC5,MACF1,PLCB1,RYR3,TNC,FAT3,NRG3,DPP6,LRP1B,TNIK,CNTN1,NRXN1,DCLK2,SOX5,HPSE2 |
2.139e-05 | -10.75 | Nav/unc-53 | interpro domains | IPR039041 | 3 | 2 | 18521 | 50 |
NAV3,NAV2 |
2.529e-05 | -10.59 | cell morphogenesis involved in neuron differentiation | biological process | GO:0048667 | 443 | 8 | 18204 | 50 |
KALRN,PARD3,NRCAM,CNTN1,FAT3,CTNNA2,NRXN1,CTNND2 |
2.562e-05 | -10.57 | membrane | cellular component | GO:0016020 | 9220 | 38 | 19108 | 49 |
NKAIN3,MACF1,PARD3,DGKG,TNC,SLC4A4,NRCAM,NRG3,NAV3,SLC14A1,CNTN1,HPSE2,NRXN1,CAMK2G,TRPM3,GPM6A,TNIK,MAPK10,NTM,SYNE1,LRP1B,GPC5,NTRK2,SFXN5,CTNNA2,SLC1A2,CTNND2,KALRN,RYR3,PLCB1,ATP1A2,DPP6,ADCY2,FMN2,DTNA,MGAT4C,SORBS1,LSAMP |
2.673e-05 | -10.53 | breast-carcinoma-ductolobular_carcinoma | COSMIC cancer mutations | breast-carcinoma-ductolobular_carcinoma | 1619 | 15 | 16828 | 48 |
NAV3,NRCAM,RORA,MACF1,PLCB1,DTNA,FMN2,SYNE1,KALRN,DGKG,SORBS1,ABLIM1,DPP6,CTNND2,CNTN1 |
2.673e-05 | -10.53 | ductolobular_carcinoma | COSMIC cancer mutations | ductolobular_carcinoma | 1619 | 15 | 16828 | 48 |
SORBS1,ABLIM1,CTNND2,DPP6,CNTN1,NRCAM,NAV3,MACF1,RORA,PLCB1,FMN2,DTNA,SYNE1,KALRN,DGKG |
2.933e-05 | -10.44 | plasma membrane bounded cell projection | cellular component | GO:0120025 | 2285 | 17 | 19108 | 49 |
CTNND2,CAMK2G,SLC1A2,CTNNA2,ABLIM1,CNTN1,FAT3,ADCY2,FMN2,DTNA,ATP1A2,NRCAM,MACF1,PARD3,SYNE1,GPM6A,NTRK2 |
3.423e-05 | -10.28 | CH | pfam domains | PF00307 | 67 | 4 | 17795 | 49 |
NAV2,SYNE1,MACF1,NAV3 |
3.600e-05 | -10.23 | Spectrin_repeat | interpro domains | IPR002017 | 24 | 3 | 18521 | 50 |
SYNE1,MACF1,KALRN |
3.813e-05 | -10.17 | Spectrin | pfam domains | PF00435 | 24 | 3 | 17795 | 49 |
SYNE1,KALRN,MACF1 |
3.911e-05 | -10.15 | cell adhesion | biological process | GO:0007155 | 942 | 11 | 18204 | 50 |
CTNND2,LSAMP,NRXN1,NTM,SORBS1,TNC,FAT3,CTNNA2,CNTN1,NRCAM,PARD3 |
3.935e-05 | -10.14 | lymphoid_neoplasm | COSMIC cancer mutations | lymphoid_neoplasm | 12233 | 46 | 16828 | 48 |
MGAT4C,NAV2,GPM6A,NEBL,NRCAM,RORA,LSAMP,NHSL1,PITPNC1,ABLIM1,DGKG,MSI2,KALRN,SYNE1,RFX4,TNC,PLCB1,FAT3,NAV3,GPC5,MACF1,ADCY2,TNIK,LRP1B,CAMK2G,SOX5,NTRK2,ATP1A2,TRPM3,PARD3,CTNND2,SFXN5,SLC4A4,SLC1A2,SORBS1,NTM,FMN2,DTNA,RYR3,NRG3,NKAIN3,CNTN1,DPP6,HPSE2,DCLK2,NRXN1 |
3.994e-05 | -10.13 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 748 | 10 | 16828 | 48 |
NEBL,PLCB1,SOX5,NAV3,NTRK2,CTNND2,PARD3,LRP1B,SYNE1,DTNA |
4.286e-05 | -10.06 | Ig_sub2 | interpro domains | IPR003598 | 239 | 6 | 18521 | 50 |
NRCAM,NTRK2,CNTN1,KALRN,NTM,LSAMP |
4.550e-05 | -10.00 | Htt (huntingtin) | protein interactions | 15194 | 77 | 4 | 19454 | 50 |
LSAMP,GPM6A,CNTN1,NTM |
4.839e-05 | -9.94 | superficial_spreading | COSMIC cancer mutations | superficial_spreading | 1110 | 12 | 16828 | 48 |
TNC,PLCB1,MACF1,ADCY2,MGAT4C,NTM,KALRN,SYNE1,SLC4A4,SORBS1,CTNND2,LRP1B |
5.229e-05 | -9.86 | anatomical structure morphogenesis | biological process | GO:0009653 | 2225 | 17 | 18204 | 50 |
NRCAM,ABLIM1,GPM6A,NRG3,KALRN,TNIK,NRXN1,RORA,TNC,NEBL,CTNNA2,FAT3,CNTN1,PARD3,SOX5,NTRK2,CTNND2 |
5.822e-05 | -9.75 | skin-trunk-malignant_melanoma | COSMIC cancer mutations | skin-trunk-malignant_melanoma | 2647 | 19 | 16828 | 48 |
NEBL,NRG3,FAT3,TNC,PLCB1,RYR3,LSAMP,NRCAM,MGAT4C,ATP1A2,SYNE1,KALRN,PARD3,HPSE2,SOX5,NRXN1,SLC14A1,LRP1B,CTNND2 |
6.014e-05 | -9.72 | NS-malignant_melanoma | COSMIC cancer mutations | NS-malignant_melanoma | 3420 | 22 | 16828 | 48 |
NEBL,PARD3,NAV2,TRPM3,MGAT4C,ATP1A2,CTNND2,PITPNC1,MACF1,GPC5,ADCY2,NRG3,TNC,PLCB1,KALRN,SYNE1,RFX4,FMN2,DGKG,NRXN1,LRP1B,DPP6 |
6.112e-05 | -9.70 | autonomic_ganglia-neuroblastoma | COSMIC cancer mutations | autonomic_ganglia-neuroblastoma | 3970 | 24 | 16828 | 48 |
NAV2,FMN2,KALRN,PARD3,GPM6A,SYNE1,RFX4,DGKG,NTRK2,ATP1A2,NAV3,MACF1,ADCY2,TNC,PLCB1,RYR3,NEBL,LRP1B,CTNND2,TNIK,PITPNC1,CAMK2G,SLC4A4,SLC1A2 |
6.138e-05 | -9.70 | neuroblastoma | COSMIC cancer mutations | neuroblastoma | 3971 | 24 | 16828 | 48 |
PARD3,GPM6A,NAV2,ATP1A2,NTRK2,NEBL,CTNND2,PITPNC1,SLC1A2,SLC4A4,RFX4,SYNE1,KALRN,FMN2,DGKG,ADCY2,MACF1,NAV3,RYR3,PLCB1,TNC,LRP1B,TNIK,CAMK2G |
6.709e-05 | -9.61 | CH_dom | interpro domains | IPR001715 | 81 | 4 | 18521 | 50 |
SYNE1,MACF1,NAV3,NAV2 |
7.039e-05 | -9.56 | CH_dom_sf | interpro domains | IPR036872 | 82 | 4 | 18521 | 50 |
SYNE1,MACF1,NAV3,NAV2 |
7.140e-05 | -9.55 | Spectrin/alpha-actinin | interpro domains | IPR018159 | 30 | 3 | 18521 | 50 |
MACF1,SYNE1,KALRN |
7.693e-05 | -9.47 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | 981 | 11 | 16828 | 48 |
HPSE2,SOX5,LRP1B,CTNND2,NRG3,NKAIN3,GPC5,ADCY2,LSAMP,RORA,PARD3 |
8.255e-05 | -9.40 | NTM (neurotrimin) | protein interactions | 50863 | 33 | 3 | 19454 | 50 |
LSAMP,GPM6A,NTM |
8.676e-05 | -9.35 | CH | smart domains | SM00033 | 66 | 4 | 9717 | 35 |
NAV3,SYNE1,NAV2,MACF1 |
9.194e-05 | -9.29 | cell junction organization | biological process | GO:0034330 | 532 | 8 | 18204 | 50 |
NRXN1,CTNND2,TNC,SORBS1,NRCAM,GPM6A,NRG3,PARD3 |
9.391e-05 | -9.27 | adrenal_cortical_carcinoma | COSMIC cancer mutations | adrenal_cortical_carcinoma | 2256 | 17 | 16828 | 48 |
SLC1A2,HPSE2,SOX5,CNTN1,NHSL1,LRP1B,CTNND2,NRG3,TNC,NRCAM,TRPM3,ATP1A2,DGKG,NTRK2,RFX4,SYNE1,FMN2 |
9.463e-05 | -9.27 | Calponin-like domain | gene3d domains | 1.10.418.10 | 79 | 4 | 14470 | 44 |
SYNE1,NAV2,MACF1,NAV3 |
9.610e-05 | -9.25 | pancreas-carcinoma-adenocarcinoma | COSMIC cancer mutations | pancreas-carcinoma-adenocarcinoma | 517 | 8 | 16828 | 48 |
HPSE2,NEBL,TNC,GPC5,MACF1,DCLK2,LRP1B,SYNE1 |
9.811e-05 | -9.23 | skin-scalp-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-scalp-carcinoma-squamous_cell_carcinoma | 1596 | 14 | 16828 | 48 |
SYNE1,ATP1A2,NRCAM,NAV3,MACF1,GPC5,RORA,LSAMP,PLCB1,CNTN1,RBMS3,NRXN1,SOX5,SLC4A4 |
1.006e-04 | -9.20 | Gastric acid secretion | KEGG pathways | hsa04971 | 75 | 4 | 7161 | 24 |
CAMK2G,ADCY2,ATP1A2,PLCB1 |
1.006e-04 | -9.20 | Gastric acid secretion | KEGG pathways | ko04971 | 75 | 4 | 7161 | 24 |
ATP1A2,ADCY2,CAMK2G,PLCB1 |
1.038e-04 | -9.17 | diffuse_adenocarcinoma | COSMIC cancer mutations | diffuse_adenocarcinoma | 4383 | 25 | 16828 | 48 |
FAT3,NRG3,TNC,RYR3,MACF1,ADCY2,DGKG,SYNE1,KALRN,RFX4,FMN2,DTNA,SOX5,CNTN1,LRP1B,DPP6,TRPM3,MGAT4C,ATP1A2,GPM6A,PARD3,NAV2,ABLIM1,NHSL1,CTNND2 |
1.038e-04 | -9.17 | stomach-carcinoma-diffuse_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-diffuse_adenocarcinoma | 4383 | 25 | 16828 | 48 |
PARD3,GPM6A,NAV2,TRPM3,MGAT4C,ATP1A2,ABLIM1,CTNND2,NHSL1,MACF1,ADCY2,NRG3,FAT3,TNC,RYR3,KALRN,SYNE1,RFX4,FMN2,DTNA,DGKG,SOX5,LRP1B,DPP6,CNTN1 |
1.074e-04 | -9.14 | PTPRB (protein tyrosine phosphatase receptor type B) | protein interactions | 5787 | 36 | 3 | 19454 | 50 |
CNTN1,NRCAM,TNC |
1.104e-04 | -9.11 | follicular_lymphoma | COSMIC cancer mutations | follicular_lymphoma | 1209 | 12 | 16828 | 48 |
CTNND2,LRP1B,TNIK,SOX5,HPSE2,PARD3,NKAIN3,GPC5,LSAMP,ADCY2,RORA,NRG3 |
1.166e-04 | -9.06 | CDH1 (cadherin 1) | protein interactions | 999 | 757 | 9 | 19454 | 50 |
MACF1,CTNND2,SORBS1,PARD3,NEBL,ABLIM1,NHSL1,CTNNA2,NAV2 |
1.167e-04 | -9.06 | DNAAF2 (dynein axonemal assembly factor 2) | protein interactions | 55172 | 98 | 4 | 19454 | 50 |
DPP6,GPM6A,LSAMP,CNTN1 |
1.174e-04 | -9.05 | forebrain development | biological process | GO:0030900 | 408 | 7 | 18204 | 50 |
ATP1A2,SLC1A2,DCLK2,NTRK2,NRG3,PLCB1,RFX4 |
1.245e-04 | -8.99 | cell junction assembly | biological process | GO:0034329 | 285 | 6 | 18204 | 50 |
GPM6A,NRCAM,NRXN1,PARD3,SORBS1,NRG3 |
1.370e-04 | -8.90 | actin binding | molecular function | GO:0003779 | 434 | 7 | 18094 | 48 |
SORBS1,ABLIM1,SYNE1,FMN2,MACF1,NEBL,CTNNA2 |
1.380e-04 | -8.89 | CH | prosite domains | PS50021 | 81 | 4 | 12186 | 40 |
NAV2,NAV3,MACF1,SYNE1 |
1.404e-04 | -8.87 | axon development | biological process | GO:0061564 | 420 | 7 | 18204 | 50 |
NRCAM,NRXN1,CTNNA2,CNTN1,TNC,PARD3,KALRN |
1.461e-04 | -8.83 | skin-extremity-malignant_melanoma | COSMIC cancer mutations | skin-extremity-malignant_melanoma | 1875 | 15 | 16828 | 48 |
PITPNC1,DPP6,LRP1B,HPSE2,DGKG,NTRK2,PARD3,SYNE1,FMN2,NEBL,RYR3,PLCB1,TNC,ADCY2,NAV3 |
1.467e-04 | -8.83 | SPEC | smart domains | SM00150 | 29 | 3 | 9717 | 35 |
KALRN,MACF1,SYNE1 |
1.470e-04 | -8.83 | extremity | COSMIC cancer mutations | extremity | 1876 | 15 | 16828 | 48 |
PLCB1,RYR3,TNC,NEBL,NAV3,ADCY2,NTRK2,DGKG,FMN2,SYNE1,PARD3,HPSE2,PITPNC1,DPP6,LRP1B |
1.476e-04 | -8.82 | DZIP1 (DAZ interacting zinc finger protein 1) | protein interactions | 22873 | 40 | 3 | 19454 | 50 |
PARD3,CAMK2G,NTRK2 |
1.531e-04 | -8.78 | LCK (LCK proto-oncogene, Src family tyrosine kinase) | protein interactions | 3932 | 455 | 7 | 19454 | 50 |
MACF1,KALRN,FMN2,CAMK2G,DTNA,PARD3,CTNND2 |
1.558e-04 | -8.77 | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | 6040 | 30 | 16828 | 48 |
FMN2,DTNA,KALRN,SYNE1,RFX4,DGKG,NAV3,GPC5,MACF1,ADCY2,TNC,PLCB1,NRG3,LRP1B,NRXN1,CAMK2G,HPSE2,NAV2,PARD3,GPM6A,MGAT4C,NTRK2,ATP1A2,TRPM3,NRCAM,NEBL,SFXN5,SORBS1,SLC4A4,ABLIM1 |
1.560e-04 | -8.77 | haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_neoplasm | 11082 | 43 | 16828 | 48 |
TNIK,CNTN1,LRP1B,DPP6,HPSE2,DCLK2,RBMS3,CAMK2G,NRXN1,SOX5,DGKG,NTM,MSI2,FMN2,DTNA,KALRN,SYNE1,RFX4,TNC,PLCB1,RYR3,NRG3,FAT3,NKAIN3,NAV3,GPC5,MACF1,ADCY2,SLC14A1,NHSL1,CTNND2,SFXN5,SLC4A4,ABLIM1,SLC1A2,NTRK2,ATP1A2,TRPM3,NAV2,PARD3,NEBL,RORA,LSAMP |
1.569e-04 | -8.76 | transitional_cell_carcinoma | COSMIC cancer mutations | transitional_cell_carcinoma | 6042 | 30 | 16828 | 48 |
HPSE2,NRXN1,CAMK2G,LRP1B,PLCB1,TNC,NRG3,NAV3,ADCY2,MACF1,GPC5,DGKG,FMN2,DTNA,RFX4,KALRN,SYNE1,ABLIM1,SLC4A4,SORBS1,SFXN5,NEBL,NRCAM,ATP1A2,MGAT4C,NTRK2,TRPM3,NAV2,GPM6A,PARD3 |
1.604e-04 | -8.74 | - | gene3d domains | 1.20.58.60 | 35 | 3 | 14470 | 44 |
MACF1,KALRN,SYNE1 |
1.626e-04 | -8.72 | regulation of dendrite development | biological process | GO:0050773 | 100 | 4 | 18204 | 50 |
TNIK,FAT3,DGKG,SYNE1 |
1.627e-04 | -8.72 | TIAM1 (TIAM Rac1 associated GEF 1) | protein interactions | 7074 | 201 | 5 | 19454 | 50 |
CAMK2G,DTNA,ATP1A2,PARD3,RYR3 |
1.639e-04 | -8.72 | Insulin secretion | KEGG pathways | hsa04911 | 85 | 4 | 7161 | 24 |
CAMK2G,ATP1A2,ADCY2,PLCB1 |
1.829e-04 | -8.61 | Neurofascin interactions | REACTOME pathways | R-HSA-447043 | 7 | 2 | 10285 | 31 |
NRCAM,CNTN1 |
1.834e-04 | -8.60 | C2CD4B (C2 calcium dependent domain containing 4B) | protein interactions | 388125 | 43 | 3 | 19454 | 50 |
LRP1B,FAT3,MACF1 |
1.855e-04 | -8.59 | IGc2 | smart domains | SM00408 | 239 | 6 | 9717 | 35 |
KALRN,NTRK2,NRCAM,NTM,LSAMP,CNTN1 |
1.865e-04 | -8.59 | adrenal_gland | COSMIC cancer mutations | adrenal_gland | 2628 | 18 | 16828 | 48 |
SYNE1,RFX4,FMN2,TRPM3,DGKG,NTRK2,ATP1A2,ADCY2,NRCAM,NRG3,TNC,CTNND2,LRP1B,NHSL1,CNTN1,SOX5,HPSE2,SLC1A2 |
1.907e-04 | -8.56 | upper_aerodigestive_tract-pharynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-squamous_cell_carcinoma | 1485 | 13 | 16828 | 48 |
SLC14A1,LRP1B,DPP6,SORBS1,DGKG,SYNE1,FMN2,DTNA,NRG3,RYR3,MACF1,GPC5,NRCAM |
2.046e-04 | -8.49 | Salivary secretion | KEGG pathways | ko04970 | 90 | 4 | 7161 | 24 |
PLCB1,RYR3,ADCY2,ATP1A2 |
2.046e-04 | -8.49 | Salivary secretion | KEGG pathways | hsa04970 | 90 | 4 | 7161 | 24 |
PLCB1,ATP1A2,ADCY2,RYR3 |
2.053e-04 | -8.49 | skin-trunk-malignant_melanoma-nodular | COSMIC cancer mutations | skin-trunk-malignant_melanoma-nodular | 1291 | 12 | 16828 | 48 |
DCLK2,ABLIM1,LRP1B,CTNND2,MACF1,NEBL,PLCB1,KALRN,SYNE1,DGKG,NTRK2,ATP1A2 |
2.209e-04 | -8.42 | acral_lentiginous | COSMIC cancer mutations | acral_lentiginous | 745 | 9 | 16828 | 48 |
PARD3,LRP1B,KALRN,SYNE1,NAV3,MACF1,PLCB1,TNC,NRG3 |
2.225e-04 | -8.41 | cytoskeletal protein binding | molecular function | GO:0008092 | 989 | 10 | 18094 | 48 |
FMN2,MACF1,NRCAM,NAV3,NEBL,CTNNA2,SORBS1,ABLIM1,SYNE1,DCLK2 |
2.227e-04 | -8.41 | GnRH signaling pathway | KEGG pathways | ko04912 | 92 | 4 | 7161 | 24 |
PLCB1,CAMK2G,MAPK10,ADCY2 |
2.227e-04 | -8.41 | GnRH signaling pathway | KEGG pathways | hsa04912 | 92 | 4 | 7161 | 24 |
PLCB1,MAPK10,CAMK2G,ADCY2 |
2.255e-04 | -8.40 | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | 105 | 4 | 16828 | 48 |
PARD3,LRP1B,GPC5,NRG3 |
2.257e-04 | -8.40 | axon | cellular component | GO:0030424 | 650 | 8 | 19108 | 49 |
GPM6A,CNTN1,CTNNA2,PARD3,SLC1A2,DTNA,NTRK2,NRCAM |
2.284e-04 | -8.38 | skin-head_neck-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-head_neck-malignant_melanoma-superficial_spreading | 923 | 10 | 16828 | 48 |
MGAT4C,KALRN,CTNND2,SYNE1,LRP1B,TNC,PLCB1,SORBS1,MACF1,ADCY2 |
2.304e-04 | -8.38 | NEGR1 (neuronal growth regulator 1) | protein interactions | 257194 | 9 | 2 | 19454 | 50 |
LSAMP,NTM |
2.304e-04 | -8.38 | LSAMP (limbic system associated membrane protein) | protein interactions | 4045 | 9 | 2 | 19454 | 50 |
NTM,LSAMP |
2.342e-04 | -8.36 | actin filament binding | molecular function | GO:0051015 | 211 | 5 | 18094 | 48 |
MACF1,ABLIM1,NEBL,SYNE1,CTNNA2 |
2.392e-04 | -8.34 | CNTN1 (contactin 1) | protein interactions | 1272 | 47 | 3 | 19454 | 50 |
TNC,GPM6A,CNTN1 |
2.520e-04 | -8.29 | Pancreatic secretion | KEGG pathways | ko04972 | 95 | 4 | 7161 | 24 |
ATP1A2,ADCY2,SLC4A4,PLCB1 |
2.520e-04 | -8.29 | Pancreatic secretion | KEGG pathways | hsa04972 | 95 | 4 | 7161 | 24 |
ATP1A2,ADCY2,SLC4A4,PLCB1 |
2.544e-04 | -8.28 | adenoid_cystic_carcinoma | COSMIC cancer mutations | adenoid_cystic_carcinoma | 1123 | 11 | 16828 | 48 |
CAMK2G,NRCAM,RORA,RYR3,NAV2,SYNE1,LRP1B,CTNND2,TNIK,NTRK2,MGAT4C |
2.564e-04 | -8.27 | OCLN (occludin) | protein interactions | 100506658 | 495 | 7 | 19454 | 50 |
PARD3,FMN2,MACF1,NTRK2,TNIK,DTNA,ABLIM1 |
2.586e-04 | -8.26 | cellular response to organic cyclic compound | biological process | GO:0071407 | 464 | 7 | 18204 | 50 |
PLCB1,TNC,RORA,ATP1A2,RYR3,SLC1A2,ADCY2 |
2.624e-04 | -8.25 | Circadian entrainment | KEGG pathways | hsa04713 | 96 | 4 | 7161 | 24 |
CAMK2G,RYR3,ADCY2,PLCB1 |
2.624e-04 | -8.25 | Circadian entrainment | KEGG pathways | ko04713 | 96 | 4 | 7161 | 24 |
PLCB1,RYR3,CAMK2G,ADCY2 |
2.731e-04 | -8.21 | Inflammatory mediator regulation of TRP channels | KEGG pathways | hsa04750 | 97 | 4 | 7161 | 24 |
CAMK2G,MAPK10,ADCY2,PLCB1 |
2.731e-04 | -8.21 | Inflammatory mediator regulation of TRP channels | KEGG pathways | ko04750 | 97 | 4 | 7161 | 24 |
CAMK2G,MAPK10,ADCY2,PLCB1 |
2.876e-04 | -8.15 | salivary_gland | COSMIC cancer mutations | salivary_gland | 1139 | 11 | 16828 | 48 |
TNIK,CTNND2,LRP1B,CAMK2G,MGAT4C,NTRK2,NAV2,SYNE1,RYR3,NRCAM,RORA |
2.879e-04 | -8.15 | pancreas-carcinoid-endocrine_tumour | COSMIC cancer mutations | pancreas-carcinoid-endocrine_tumour | 7250 | 33 | 16828 | 48 |
GPM6A,PARD3,NAV2,ATP1A2,NTRK2,RORA,LSAMP,NRCAM,NEBL,SFXN5,CTNND2,NHSL1,SLC1A2,ABLIM1,SLC4A4,RFX4,KALRN,SYNE1,FMN2,DGKG,ADCY2,MACF1,GPC5,NKAIN3,NRG3,PLCB1,RYR3,TNC,DPP6,LRP1B,CNTN1,SOX5,HPSE2 |
2.889e-04 | -8.15 | synapse organization | biological process | GO:0050808 | 333 | 6 | 18204 | 50 |
GPM6A,NRCAM,NRG3,CTNND2,NRXN1,TNC |
2.906e-04 | -8.14 | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 10 | 16828 | 48 |
SLC1A2,TNC,GPC5,MACF1,TRPM3,CNTN1,SYNE1,LRP1B,PARD3,FMN2 |
2.906e-04 | -8.14 | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 10 | 16828 | 48 |
SLC1A2,TNC,GPC5,MACF1,TRPM3,CNTN1,PARD3,SYNE1,LRP1B,FMN2 |
3.069e-04 | -8.09 | synapse assembly | biological process | GO:0007416 | 118 | 4 | 18204 | 50 |
NRXN1,NRCAM,GPM6A,NRG3 |
3.150e-04 | -8.06 | skin-mucosal-malignant_melanoma | COSMIC cancer mutations | skin-mucosal-malignant_melanoma | 2009 | 15 | 16828 | 48 |
ABLIM1,SORBS1,LRP1B,CTNND2,TNC,PLCB1,NEBL,NRG3,RORA,MGAT4C,ATP1A2,NAV2,FMN2,PARD3,SYNE1 |
3.150e-04 | -8.06 | mucosal | COSMIC cancer mutations | mucosal | 2009 | 15 | 16828 | 48 |
SORBS1,ABLIM1,CTNND2,LRP1B,RORA,PLCB1,TNC,NRG3,NEBL,FMN2,NAV2,PARD3,SYNE1,ATP1A2,MGAT4C |
3.162e-04 | -8.06 | EPB41L4A (erythrocyte membrane protein band 4.1 like 4A) | protein interactions | 64097 | 127 | 4 | 19454 | 50 |
DTNA,ABLIM1,MACF1,PARD3 |
3.285e-04 | -8.02 | acute_myeloid_leukaemia | COSMIC cancer mutations | acute_myeloid_leukaemia | 10418 | 41 | 16828 | 48 |
SLC14A1,NHSL1,SFXN5,CTNND2,SLC1A2,ABLIM1,SLC4A4,ATP1A2,NTRK2,TRPM3,NAV2,PARD3,NEBL,LSAMP,RORA,CNTN1,TNIK,DPP6,LRP1B,HPSE2,CAMK2G,NRXN1,RBMS3,SOX5,DGKG,MSI2,FMN2,NTM,RFX4,SYNE1,KALRN,PLCB1,RYR3,TNC,FAT3,NRG3,NAV3,NKAIN3,ADCY2,GPC5,MACF1 |
3.285e-04 | -8.02 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | 10418 | 41 | 16828 | 48 |
PARD3,NAV2,TRPM3,NTRK2,ATP1A2,RORA,LSAMP,NEBL,CTNND2,SFXN5,NHSL1,SLC14A1,SLC4A4,SLC1A2,ABLIM1,KALRN,SYNE1,RFX4,NTM,FMN2,MSI2,DGKG,MACF1,GPC5,ADCY2,NKAIN3,NAV3,FAT3,NRG3,TNC,PLCB1,RYR3,LRP1B,DPP6,TNIK,CNTN1,SOX5,RBMS3,CAMK2G,NRXN1,HPSE2 |
3.290e-04 | -8.02 | stomach-adenocarcinoma | COSMIC cancer mutations | stomach-adenocarcinoma | 4101 | 23 | 16828 | 48 |
NEBL,NRG3,TNC,PLCB1,GPC5,MACF1,RORA,NRCAM,NAV3,MGAT4C,ATP1A2,SYNE1,KALRN,PARD3,RFX4,NAV2,FMN2,SLC4A4,SLC1A2,ABLIM1,CNTN1,LRP1B,CTNND2 |
3.387e-04 | -7.99 | actin cytoskeleton | cellular component | GO:0015629 | 520 | 7 | 19108 | 49 |
SORBS1,FMN2,CTNNA2,MACF1,ABLIM1,KALRN,NEBL |
3.423e-04 | -7.98 | animal organ development | biological process | GO:0048513 | 2846 | 18 | 18204 | 50 |
ATP1A2,SOX5,DCLK2,NTRK2,PLCB1,SYNE1,RFX4,SLC1A2,NEBL,CTNNA2,FAT3,CNTN1,RORA,TNC,NRCAM,ABLIM1,GPM6A,NRG3 |
3.432e-04 | -7.98 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | 7307 | 33 | 16828 | 48 |
MGAT4C,NTRK2,GPM6A,PARD3,NAV2,NEBL,RORA,LSAMP,NHSL1,SFXN5,CTNND2,ABLIM1,SLC1A2,DGKG,RFX4,KALRN,SYNE1,FMN2,NRG3,RYR3,PLCB1,TNC,ADCY2,GPC5,MACF1,NAV3,NKAIN3,TNIK,CNTN1,DPP6,LRP1B,HPSE2,SOX5 |
3.491e-04 | -7.96 | interstitial matrix | cellular component | GO:0005614 | 11 | 2 | 19108 | 49 |
NAV2,TNC |
3.669e-04 | -7.91 | YWHAH (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta) | protein interactions | 7533 | 1083 | 10 | 19454 | 50 |
PITPNC1,DCLK2,MACF1,FMN2,ABLIM1,NAV2,NHSL1,CAMK2G,SORBS1,PARD3 |
3.702e-04 | -7.90 | EZR (ezrin) | protein interactions | 7430 | 526 | 7 | 19454 | 50 |
MAPK10,NEBL,SORBS1,MACF1,DTNA,ABLIM1,TNIK |
3.713e-04 | -7.90 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-NK-T_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-NK-T_cell_lymphoma | 217 | 5 | 16828 | 48 |
RFX4,NAV2,DTNA,MGAT4C,PLCB1 |
3.863e-04 | -7.86 | skin-scalp-malignant_melanoma | COSMIC cancer mutations | skin-scalp-malignant_melanoma | 634 | 8 | 16828 | 48 |
SORBS1,CAMK2G,NEBL,TNC,PLCB1,SYNE1,NTM,FMN2 |
3.954e-04 | -7.84 | EGF-like_dom | interpro domains | IPR000742 | 232 | 5 | 18521 | 50 |
FAT3,TNC,NRXN1,LRP1B,NRG3 |
3.988e-04 | -7.83 | NTRK2 (neurotrophic receptor tyrosine kinase 2) | protein interactions | 4915 | 135 | 4 | 19454 | 50 |
PARD3,ABLIM1,DTNA,NTRK2 |
4.260e-04 | -7.76 | EGF_3 | prosite domains | PS50026 | 196 | 5 | 12186 | 40 |
NRXN1,NRG3,TNC,FAT3,LRP1B |
4.301e-04 | -7.75 | LYN (LYN proto-oncogene, Src family tyrosine kinase) | protein interactions | 4067 | 713 | 8 | 19454 | 50 |
TNIK,PLCB1,MACF1,FMN2,DTNA,ABLIM1,MSI2,PARD3 |
4.382e-04 | -7.73 | NK-T_cell_lymphoma | COSMIC cancer mutations | NK-T_cell_lymphoma | 225 | 5 | 16828 | 48 |
PLCB1,MGAT4C,RFX4,DTNA,NAV2 |
4.599e-04 | -7.68 | gallbladder | COSMIC cancer mutations | gallbladder | 2821 | 18 | 16828 | 48 |
TRPM3,FMN2,SYNE1,PARD3,RYR3,TNC,FAT3,NRG3,NKAIN3,NRCAM,MACF1,TNIK,NHSL1,PITPNC1,DPP6,CTNND2,LRP1B,SLC4A4 |
4.599e-04 | -7.68 | biliary_tract-gallbladder-carcinoma-adenocarcinoma | COSMIC cancer mutations | biliary_tract-gallbladder-carcinoma-adenocarcinoma | 2821 | 18 | 16828 | 48 |
FMN2,PARD3,SYNE1,TRPM3,NKAIN3,NRCAM,MACF1,RYR3,TNC,NRG3,FAT3,DPP6,LRP1B,CTNND2,TNIK,NHSL1,PITPNC1,SLC4A4 |
4.776e-04 | -7.65 | axonogenesis | biological process | GO:0007409 | 366 | 6 | 18204 | 50 |
KALRN,PARD3,CNTN1,CTNNA2,NRXN1,NRCAM |
5.017e-04 | -7.60 | haematopoietic_and_lymphoid_tissue | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue | 14368 | 48 | 16828 | 48 |
NKAIN3,RYR3,NRG3,FMN2,DTNA,NTM,NRXN1,DCLK2,HPSE2,DPP6,CNTN1,PARD3,ATP1A2,NTRK2,TRPM3,SORBS1,SLC1A2,SLC4A4,SFXN5,CTNND2,NAV3,ADCY2,GPC5,MACF1,PLCB1,TNC,FAT3,MSI2,RFX4,KALRN,SYNE1,DGKG,CAMK2G,RBMS3,SOX5,LRP1B,TNIK,NRCAM,LSAMP,RORA,NEBL,NAV2,GPM6A,MGAT4C,ABLIM1,SLC14A1,NHSL1,PITPNC1 |
5.099e-04 | -7.58 | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | 1425 | 12 | 16828 | 48 |
FAT3,FMN2,SYNE1,RFX4,NTRK2,ATP1A2,SLC4A4,SLC1A2,CTNND2,SFXN5,NHSL1,PITPNC1 |
5.099e-04 | -7.58 | nasopharyngeal_carcinoma | COSMIC cancer mutations | nasopharyngeal_carcinoma | 1425 | 12 | 16828 | 48 |
FAT3,NTRK2,ATP1A2,SYNE1,RFX4,FMN2,SLC4A4,SLC1A2,PITPNC1,NHSL1,CTNND2,SFXN5 |
5.297e-04 | -7.54 | synaptic membrane | cellular component | GO:0097060 | 400 | 6 | 19108 | 49 |
NRCAM,SLC1A2,NRXN1,SYNE1,GPM6A,CNTN1 |
5.297e-04 | -7.54 | fn3 | pfam domains | PF00041 | 136 | 4 | 17795 | 49 |
CNTN1,KALRN,NRCAM,TNC |
5.583e-04 | -7.49 | regulation of synapse organization | biological process | GO:0050807 | 246 | 5 | 18204 | 50 |
CTNNA2,GPM6A,NTRK2,NRCAM,NRXN1 |
5.605e-04 | -7.49 | hairy_cell_leukaemia | COSMIC cancer mutations | hairy_cell_leukaemia | 1440 | 12 | 16828 | 48 |
NRXN1,CTNND2,LRP1B,CNTN1,NAV3,MACF1,RYR3,NEBL,NAV2,FMN2,SYNE1,RFX4 |
5.605e-04 | -7.49 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-hairy_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-hairy_cell_leukaemia | 1440 | 12 | 16828 | 48 |
SYNE1,RFX4,NAV2,FMN2,MACF1,NAV3,NEBL,RYR3,CTNND2,LRP1B,CNTN1,NRXN1 |
5.774e-04 | -7.46 | adenoma | COSMIC cancer mutations | adenoma | 2873 | 18 | 16828 | 48 |
ADCY2,MACF1,GPC5,NAV3,NEBL,RYR3,TNC,GPM6A,SYNE1,KALRN,PARD3,TRPM3,NTRK2,SOX5,DCLK2,HPSE2,LRP1B,CTNND2 |
5.879e-04 | -7.44 | Laminin | gene3d domains | 2.10.25.10 | 226 | 5 | 14470 | 44 |
NRXN1,FAT3,NRG3,LRP1B,TNC |
5.976e-04 | -7.42 | transmission of nerve impulse | biological process | GO:0019226 | 60 | 3 | 18204 | 50 |
NRCAM,ATP1A2,NTRK2 |
6.009e-04 | -7.42 | regulation of cellular component organization | biological process | GO:0051128 | 2455 | 16 | 18204 | 50 |
CTNNA2,FAT3,CNTN1,SYNE1,NAV3,PLCB1,NTRK2,NRG3,DGKG,CAMK2G,GPM6A,NRCAM,TNC,MACF1,TNIK,NRXN1 |
6.017e-04 | -7.42 | cell communication | biological process | GO:0007154 | 5010 | 25 | 18204 | 50 |
RYR3,ADCY2,MAPK10,SLC1A2,CNTN1,PLCB1,FMN2,NRCAM,DTNA,NRXN1,PARD3,PITPNC1,SORBS1,ATP1A2,DCLK2,CTNND2,NTRK2,NRG3,KALRN,DGKG,CAMK2G,TNC,TNIK,RORA,MACF1 |
6.069e-04 | -7.41 | Ig_3 | pfam domains | PF13927 | 141 | 4 | 17795 | 49 |
NRCAM,LSAMP,NTM,CNTN1 |
6.169e-04 | -7.39 | Ion homeostasis | REACTOME pathways | R-HSA-5578775 | 56 | 3 | 10285 | 31 |
CAMK2G,RYR3,ATP1A2 |
6.187e-04 | -7.39 | glutamatergic synapse | cellular component | GO:0098978 | 412 | 6 | 19108 | 49 |
SLC1A2,NRCAM,TNIK,GPM6A,NRG3,PLCB1 |
6.187e-04 | -7.39 | neuron migration | biological process | GO:0001764 | 142 | 4 | 18204 | 50 |
NRCAM,NTRK2,GPM6A,FAT3 |
6.227e-04 | -7.38 | regulation of synapse structure or activity | biological process | GO:0050803 | 252 | 5 | 18204 | 50 |
CTNNA2,GPM6A,NTRK2,NRCAM,NRXN1 |
6.409e-04 | -7.35 | EF-hand-dom_pair | interpro domains | IPR011992 | 258 | 5 | 18521 | 50 |
DGKG,PLCB1,RYR3,DTNA,MACF1 |
6.412e-04 | -7.35 | cell adhesion molecule binding | molecular function | GO:0050839 | 560 | 7 | 18094 | 48 |
CNTN1,NRXN1,TNC,CTNNA2,NRCAM,MACF1,CTNND2 |
6.429e-04 | -7.35 | Ig_sub | interpro domains | IPR003599 | 394 | 6 | 18521 | 50 |
CNTN1,NRCAM,NTRK2,LSAMP,NTM,KALRN |
6.451e-04 | -7.35 | kidney-other-neoplasm | COSMIC cancer mutations | kidney-other-neoplasm | 10653 | 41 | 16828 | 48 |
TNC,RYR3,PLCB1,FAT3,NRG3,NKAIN3,NAV3,GPC5,MACF1,ADCY2,DGKG,DTNA,FMN2,SYNE1,KALRN,RFX4,HPSE2,CAMK2G,NRXN1,SOX5,TNIK,CNTN1,LRP1B,DPP6,NEBL,NRCAM,LSAMP,RORA,NTRK2,MGAT4C,ATP1A2,TRPM3,NAV2,PARD3,GPM6A,SLC1A2,ABLIM1,SORBS1,NHSL1,CTNND2,SFXN5 |
6.513e-04 | -7.34 | Cell-type Dependent Selectivity of CCK2R Signaling | WikiPathways | WP3679 | 13 | 2 | 5310 | 16 |
PLCB1,RYR3 |
6.544e-04 | -7.33 | astrocytoma_Grade_I | COSMIC cancer mutations | astrocytoma_Grade_I | 139 | 4 | 16828 | 48 |
NRG3,PARD3,GPC5,LRP1B |
6.557e-04 | -7.33 | soft_tissue | COSMIC cancer mutations | soft_tissue | 5828 | 28 | 16828 | 48 |
MACF1,GPC5,ADCY2,NKAIN3,FAT3,NRG3,TNC,RYR3,PLCB1,SYNE1,FMN2,SOX5,CAMK2G,HPSE2,LRP1B,DPP6,RORA,LSAMP,NEBL,GPM6A,PARD3,NAV2,TRPM3,NTRK2,SORBS1,SLC1A2,CTNND2,NHSL1 |
6.588e-04 | -7.33 | sodium ion export across plasma membrane | biological process | GO:0036376 | 14 | 2 | 18204 | 50 |
ATP1A2,SLC4A4 |
6.654e-04 | -7.32 | TIAM2 (TIAM Rac1 associated GEF 2) | protein interactions | 26230 | 15 | 2 | 19454 | 50 |
PARD3,TNIK |
6.868e-04 | -7.28 | Transmembrane transport of small molecules | REACTOME pathways | R-HSA-382551 | 677 | 8 | 10285 | 31 |
RYR3,ADCY2,SLC4A4,ATP1A2,CAMK2G,SLC1A2,TRPM3,SLC14A1 |
6.979e-04 | -7.27 | central_nervous_system-cerebrum-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-cerebrum-glioma-astrocytoma_Grade_IV | 61 | 3 | 16828 | 48 |
CNTN1,SYNE1,LRP1B |
6.998e-04 | -7.26 | YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta) | protein interactions | 7529 | 965 | 9 | 19454 | 50 |
PARD3,SORBS1,NHSL1,CAMK2G,NAV2,ABLIM1,MACF1,DCLK2,PITPNC1 |
7.064e-04 | -7.26 | main axon | cellular component | GO:0044304 | 68 | 3 | 19108 | 49 |
SLC1A2,NRCAM,PARD3 |
7.385e-04 | -7.21 | DTNBP1 (dystrobrevin binding protein 1) | protein interactions | 84062 | 159 | 4 | 19454 | 50 |
DTNA,SYNE1,MACF1,KALRN |
7.470e-04 | -7.20 | skin-subungual-malignant_melanoma-acral_lentiginous | COSMIC cancer mutations | skin-subungual-malignant_melanoma-acral_lentiginous | 144 | 4 | 16828 | 48 |
NAV3,SYNE1,LRP1B,MACF1 |
7.565e-04 | -7.19 | ovary-carcinoma-serous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-serous_carcinoma | 10710 | 41 | 16828 | 48 |
TNIK,CNTN1,DPP6,LRP1B,HPSE2,SOX5,NRXN1,CAMK2G,DCLK2,DGKG,KALRN,SYNE1,DTNA,FMN2,MSI2,NTM,FAT3,NRG3,PLCB1,RYR3,TNC,ADCY2,GPC5,MACF1,NAV3,NHSL1,SFXN5,CTNND2,SLC1A2,SLC4A4,SORBS1,TRPM3,ATP1A2,MGAT4C,NTRK2,PARD3,NAV2,NEBL,LSAMP,RORA,NRCAM |
7.764e-04 | -7.16 | localization | biological process | GO:0051179 | 4474 | 23 | 18204 | 50 |
RYR3,PARD3,SFXN5,SLC1A2,PITPNC1,PLCB1,SYNE1,FMN2,ATP1A2,TRPM3,NTRK2,DCLK2,KALRN,NRCAM,SLC14A1,GPM6A,CAMK2G,DPP6,TNIK,LRP1B,NRXN1,SLC4A4,MACF1 |
7.948e-04 | -7.14 | EGF | pfam domains | PF00008 | 66 | 3 | 17795 | 49 |
NRXN1,LRP1B,FAT3 |
8.069e-04 | -7.12 | subungual | COSMIC cancer mutations | subungual | 147 | 4 | 16828 | 48 |
MACF1,SYNE1,LRP1B,NAV3 |
8.074e-04 | -7.12 | ANK2 (ankyrin 2) | protein interactions | 287 | 71 | 3 | 19454 | 50 |
NRCAM,TNIK,GPM6A |
8.076e-04 | -7.12 | lamin binding | molecular function | GO:0005521 | 16 | 2 | 18094 | 48 |
SYNE1,PLCB1 |
8.309e-04 | -7.09 | PARD3 (par-3 family cell polarity regulator) | protein interactions | 56288 | 287 | 5 | 19454 | 50 |
PARD3,SORBS1,PLCB1,NTRK2,DTNA |
8.382e-04 | -7.08 | learning | biological process | GO:0007612 | 154 | 4 | 18204 | 50 |
PLCB1,NTRK2,NRXN1,ATP1A2 |
8.440e-04 | -7.08 | VASP (vasodilator stimulated phosphoprotein) | protein interactions | 7408 | 288 | 5 | 19454 | 50 |
NHSL1,PARD3,NEBL,FMN2,SORBS1 |
8.590e-04 | -7.06 | CNTN2 (contactin 2) | protein interactions | 6900 | 17 | 2 | 19454 | 50 |
NRCAM,CNTN1 |
8.657e-04 | -7.05 | asymmetric cell division | biological process | GO:0008356 | 16 | 2 | 18204 | 50 |
SOX5,PARD3 |
8.793e-04 | -7.04 | YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma) | protein interactions | 7532 | 1211 | 10 | 19454 | 50 |
PARD3,SORBS1,NAV2,CAMK2G,NHSL1,ABLIM1,FMN2,PITPNC1,MACF1,DCLK2 |
8.975e-04 | -7.02 | presynaptic membrane | cellular component | GO:0042734 | 168 | 4 | 19108 | 49 |
NRXN1,SLC1A2,GPM6A,CNTN1 |
9.082e-04 | -7.00 | basal_(triple-negative)_carcinoma | COSMIC cancer mutations | basal_(triple-negative)_carcinoma | 2981 | 18 | 16828 | 48 |
LRP1B,CNTN1,SLC4A4,SYNE1,KALRN,PARD3,NTM,NAV2,MSI2,FMN2,TRPM3,NTRK2,ATP1A2,MACF1,ADCY2,NRCAM,NEBL,NRG3 |
9.082e-04 | -7.00 | breast-carcinoma-basal_(triple-negative)_carcinoma | COSMIC cancer mutations | breast-carcinoma-basal_(triple-negative)_carcinoma | 2981 | 18 | 16828 | 48 |
SLC4A4,LRP1B,CNTN1,NRCAM,ADCY2,MACF1,NRG3,NEBL,FMN2,MSI2,NTM,NAV2,SYNE1,PARD3,KALRN,ATP1A2,NTRK2,TRPM3 |
9.179e-04 | -6.99 | cerebrum | COSMIC cancer mutations | cerebrum | 67 | 3 | 16828 | 48 |
SYNE1,LRP1B,CNTN1 |
9.621e-04 | -6.95 | dendrite | cellular component | GO:0030425 | 620 | 7 | 19108 | 49 |
FAT3,ADCY2,NTRK2,ATP1A2,CTNND2,GPM6A,SYNE1 |
9.796e-04 | -6.93 | dendritic spine | cellular component | GO:0043197 | 172 | 4 | 19108 | 49 |
NTRK2,GPM6A,SYNE1,ATP1A2 |
9.803e-04 | -6.93 | dendritic tree | cellular component | GO:0097447 | 622 | 7 | 19108 | 49 |
ATP1A2,NTRK2,ADCY2,FAT3,SYNE1,GPM6A,CTNND2 |
9.906e-04 | -6.92 | salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma | 561 | 7 | 16828 | 48 |
NRCAM,CAMK2G,RYR3,SYNE1,LRP1B,NTRK2,TNIK |
1.016e-03 | -6.89 | spleen | COSMIC cancer mutations | spleen | 408 | 6 | 16828 | 48 |
TNIK,LRP1B,SYNE1,NTM,ADCY2,SORBS1 |
1.022e-03 | -6.89 | neuron spine | cellular component | GO:0044309 | 174 | 4 | 19108 | 49 |
GPM6A,ATP1A2,SYNE1,NTRK2 |
1.037e-03 | -6.87 | Ig-like_dom | interpro domains | IPR007110 | 432 | 6 | 18521 | 50 |
NTRK2,NRCAM,CNTN1,KALRN,LSAMP,NTM |
1.057e-03 | -6.85 | metal ion transmembrane transporter activity | molecular function | GO:0046873 | 442 | 6 | 18094 | 48 |
ATP1A2,SLC1A2,SLC4A4,TRPM3,RYR3,GPM6A |
1.155e-03 | -6.76 | AFDN (afadin, adherens junction formation factor) | protein interactions | 4301 | 309 | 5 | 19454 | 50 |
PARD3,SORBS1,NRXN1,MACF1,DTNA |
1.165e-03 | -6.76 | bone-femur-chondrosarcoma | COSMIC cancer mutations | bone-femur-chondrosarcoma | 419 | 6 | 16828 | 48 |
LRP1B,ADCY2,DPP6,NAV2,SLC4A4,HPSE2 |
1.178e-03 | -6.74 | central_nervous_system-brain-glioma-oligodendroglioma_Grade_II | COSMIC cancer mutations | central_nervous_system-brain-glioma-oligodendroglioma_Grade_II | 73 | 3 | 16828 | 48 |
MACF1,SYNE1,NAV2 |
1.178e-03 | -6.74 | parotid | COSMIC cancer mutations | parotid | 578 | 7 | 16828 | 48 |
LRP1B,SYNE1,NTRK2,TNIK,NRCAM,CAMK2G,RYR3 |
1.186e-03 | -6.74 | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 6023 | 28 | 16828 | 48 |
NAV2,PARD3,NTRK2,ATP1A2,TRPM3,NRCAM,RORA,NEBL,CTNND2,SLC4A4,ABLIM1,DTNA,KALRN,SYNE1,DGKG,NKAIN3,NAV3,MACF1,ADCY2,TNC,RYR3,NRG3,FAT3,LRP1B,CNTN1,DCLK2,CAMK2G,SOX5 |
1.194e-03 | -6.73 | PDZD2 (PDZ domain containing 2) | protein interactions | 23037 | 20 | 2 | 19454 | 50 |
CTNND2,NRXN1 |
1.218e-03 | -6.71 | Adrenergic signaling in cardiomyocytes | KEGG pathways | hsa04261 | 144 | 4 | 7161 | 24 |
PLCB1,CAMK2G,ATP1A2,ADCY2 |
1.218e-03 | -6.71 | Adrenergic signaling in cardiomyocytes | KEGG pathways | ko04261 | 144 | 4 | 7161 | 24 |
PLCB1,CAMK2G,ADCY2,ATP1A2 |
1.222e-03 | -6.71 | KIF20A (kinesin family member 20A) | protein interactions | 10112 | 1044 | 9 | 19454 | 50 |
NAV3,MACF1,PARD3,NEBL,MSI2,NAV2,SYNE1,RORA,ABLIM1 |
1.224e-03 | -6.71 | cervix-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | cervix-carcinoma-squamous_cell_carcinoma | 11789 | 43 | 16828 | 48 |
NEBL,NRCAM,RORA,LSAMP,ATP1A2,NTRK2,MGAT4C,TRPM3,NAV2,PARD3,GPM6A,SLC1A2,ABLIM1,SLC4A4,SORBS1,NHSL1,PITPNC1,SFXN5,CTNND2,PLCB1,RYR3,TNC,FAT3,NRG3,NAV3,ADCY2,GPC5,MACF1,DGKG,DTNA,FMN2,NTM,RFX4,KALRN,SYNE1,HPSE2,NRXN1,DCLK2,SOX5,CNTN1,TNIK,DPP6,LRP1B |
1.225e-03 | -6.70 | oligodendroglioma_Grade_II | COSMIC cancer mutations | oligodendroglioma_Grade_II | 74 | 3 | 16828 | 48 |
SYNE1,MACF1,NAV2 |
1.236e-03 | -6.70 | neural retina development | biological process | GO:0003407 | 77 | 3 | 18204 | 50 |
NTRK2,GPM6A,FAT3 |
1.238e-03 | -6.69 | cervix | COSMIC cancer mutations | cervix | 11793 | 43 | 16828 | 48 |
PARD3,GPM6A,NAV2,TRPM3,MGAT4C,NTRK2,ATP1A2,RORA,LSAMP,NRCAM,NEBL,CTNND2,SFXN5,PITPNC1,NHSL1,SORBS1,SLC4A4,SLC1A2,ABLIM1,KALRN,SYNE1,RFX4,NTM,FMN2,DTNA,DGKG,GPC5,MACF1,ADCY2,NAV3,FAT3,NRG3,TNC,RYR3,PLCB1,LRP1B,DPP6,TNIK,CNTN1,SOX5,DCLK2,NRXN1,HPSE2 |
1.239e-03 | -6.69 | functioning | COSMIC cancer mutations | functioning | 1803 | 13 | 16828 | 48 |
NHSL1,CNTN1,SLC1A2,HPSE2,SOX5,NTRK2,DGKG,TRPM3,FMN2,SYNE1,RFX4,NRG3,NRCAM |
1.239e-03 | -6.69 | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | 1803 | 13 | 16828 | 48 |
SLC1A2,HPSE2,SOX5,NHSL1,CNTN1,NRG3,NRCAM,DGKG,NTRK2,TRPM3,FMN2,SYNE1,RFX4 |
1.246e-03 | -6.69 | somatodendritic compartment | cellular component | GO:0036477 | 842 | 8 | 19108 | 49 |
FAT3,ADCY2,NTRK2,ATP1A2,NRXN1,CTNND2,GPM6A,SYNE1 |
1.277e-03 | -6.66 | postsynaptic density | cellular component | GO:0014069 | 317 | 5 | 19108 | 49 |
TNIK,NRCAM,CTNND2,KALRN,NTRK2 |
1.313e-03 | -6.64 | ATP binding | molecular function | GO:0005524 | 1467 | 11 | 18094 | 48 |
NAV2,ADCY2,DGKG,NAV3,NTRK2,TNIK,CAMK2G,MAPK10,DCLK2,ATP1A2,KALRN |
1.318e-03 | -6.63 | TENM1 (teneurin transmembrane protein 1) | protein interactions | 10178 | 21 | 2 | 19454 | 50 |
SORBS1,MACF1 |
1.349e-03 | -6.61 | EF-hand | gene3d domains | 1.10.238.10 | 272 | 5 | 14470 | 44 |
RYR3,DGKG,MACF1,PLCB1,DTNA |
1.361e-03 | -6.60 | adherens junction | cellular component | GO:0005912 | 188 | 4 | 19108 | 49 |
CTNNA2,PARD3,CTNND2,SORBS1 |
1.380e-03 | -6.59 | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 7434 | 32 | 16828 | 48 |
TNC,RYR3,NRG3,FAT3,NKAIN3,NAV3,MACF1,ADCY2,DGKG,FMN2,DTNA,KALRN,SYNE1,DCLK2,NRXN1,CAMK2G,SOX5,TNIK,CNTN1,LRP1B,NEBL,NRCAM,RORA,NTRK2,ATP1A2,TRPM3,NAV2,PARD3,SLC4A4,ABLIM1,SORBS1,CTNND2 |
1.397e-03 | -6.57 | stress fiber | cellular component | GO:0001725 | 86 | 3 | 19108 | 49 |
SORBS1,NEBL,ABLIM1 |
1.397e-03 | -6.57 | contractile actin filament bundle | cellular component | GO:0097517 | 86 | 3 | 19108 | 49 |
ABLIM1,NEBL,SORBS1 |
1.405e-03 | -6.57 | signaling | biological process | GO:0023052 | 4968 | 24 | 18204 | 50 |
SLC1A2,ADCY2,MAPK10,CNTN1,RYR3,PLCB1,FMN2,DTNA,NRXN1,PITPNC1,PARD3,ATP1A2,DCLK2,CTNND2,NTRK2,SORBS1,CAMK2G,DGKG,NRG3,KALRN,TNIK,MACF1,RORA,TNC |
1.414e-03 | -6.56 | Ser/Thr_kinase_AS | interpro domains | IPR008271 | 308 | 5 | 18521 | 50 |
TNIK,DCLK2,KALRN,MAPK10,CAMK2G |
1.425e-03 | -6.55 | behavior | biological process | GO:0007610 | 619 | 7 | 18204 | 50 |
PLCB1,NTRK2,ATP1A2,NRXN1,NAV2,CNTN1,SLC1A2 |
1.446e-03 | -6.54 | monoatomic ion transmembrane transport | biological process | GO:0034220 | 804 | 8 | 18204 | 50 |
SLC4A4,ATP1A2,TRPM3,PLCB1,GPM6A,SFXN5,SLC1A2,RYR3 |
1.473e-03 | -6.52 | leg | COSMIC cancer mutations | leg | 969 | 9 | 16828 | 48 |
NEBL,SLC4A4,NRG3,PLCB1,CNTN1,SYNE1,LRP1B,NTM,FMN2 |
1.484e-03 | -6.51 | APC (APC regulator of WNT signaling pathway) | protein interactions | 324 | 327 | 5 | 19454 | 50 |
SYNE1,NAV2,MACF1,NAV3,PARD3 |
1.489e-03 | -6.51 | Oxytocin signaling pathway | KEGG pathways | ko04921 | 152 | 4 | 7161 | 24 |
PLCB1,ADCY2,RYR3,CAMK2G |
1.489e-03 | -6.51 | Oxytocin signaling pathway | KEGG pathways | hsa04921 | 152 | 4 | 7161 | 24 |
PLCB1,ADCY2,CAMK2G,RYR3 |
1.537e-03 | -6.48 | cellular component organization | biological process | GO:0016043 | 5636 | 26 | 18204 | 50 |
ABLIM1,NRCAM,GPM6A,NRG3,KALRN,NRXN1,NAV2,TNIK,MACF1,TNC,SLC1A2,HPSE2,NEBL,CNTN1,PITPNC1,FAT3,CTNNA2,RYR3,PARD3,TRPM3,CTNND2,DCLK2,FMN2,SORBS1,RFX4,SYNE1 |
1.546e-03 | -6.47 | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-virilizing_syndrome_producing | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-virilizing_syndrome_producing | 298 | 5 | 16828 | 48 |
TNC,ATP1A2,LRP1B,CTNND2,FMN2 |
1.548e-03 | -6.47 | SFN (stratifin) | protein interactions | 2810 | 671 | 7 | 19454 | 50 |
TNIK,ABLIM1,MACF1,NAV2,FMN2,SORBS1,PARD3 |
1.567e-03 | -6.46 | chondrosarcoma | COSMIC cancer mutations | chondrosarcoma | 1181 | 10 | 16828 | 48 |
DPP6,LRP1B,KALRN,NAV2,CNTN1,ADCY2,LSAMP,NAV3,HPSE2,SLC4A4 |
1.582e-03 | -6.45 | TIMM10B (translocase of inner mitochondrial membrane 10B) | protein interactions | 26515 | 23 | 2 | 19454 | 50 |
HPSE2,MSI2 |
1.587e-03 | -6.45 | asymmetric synapse | cellular component | GO:0032279 | 333 | 5 | 19108 | 49 |
NRCAM,NTRK2,CTNND2,KALRN,TNIK |
1.589e-03 | -6.44 | regulation of sodium ion transport | biological process | GO:0002028 | 84 | 3 | 18204 | 50 |
CNTN1,NKAIN3,ATP1A2 |
1.603e-03 | -6.44 | serous_carcinoma | COSMIC cancer mutations | serous_carcinoma | 10987 | 41 | 16828 | 48 |
TNIK,CNTN1,DPP6,LRP1B,HPSE2,CAMK2G,NRXN1,DCLK2,SOX5,DGKG,MSI2,DTNA,FMN2,NTM,SYNE1,KALRN,RYR3,PLCB1,TNC,FAT3,NRG3,NAV3,ADCY2,MACF1,GPC5,NHSL1,SFXN5,CTNND2,SLC1A2,SLC4A4,SORBS1,ATP1A2,MGAT4C,NTRK2,TRPM3,NAV2,PARD3,NEBL,NRCAM,LSAMP,RORA |
1.614e-03 | -6.43 | regulation of membrane potential | biological process | GO:0042391 | 463 | 6 | 18204 | 50 |
NRCAM,SYNE1,SLC4A4,NTRK2,ATP1A2,NRXN1 |
1.628e-03 | -6.42 | Bile secretion | KEGG pathways | hsa04976 | 71 | 3 | 7161 | 24 |
SLC4A4,ATP1A2,ADCY2 |
1.628e-03 | -6.42 | Bile secretion | KEGG pathways | ko04976 | 71 | 3 | 7161 | 24 |
SLC4A4,ATP1A2,ADCY2 |
1.655e-03 | -6.40 | DGUOK (deoxyguanosine kinase) | protein interactions | 1716 | 91 | 3 | 19454 | 50 |
GPM6A,NTM,CNTN1 |
1.655e-03 | -6.40 | TRIO (trio Rho guanine nucleotide exchange factor) | protein interactions | 7204 | 91 | 3 | 19454 | 50 |
NAV3,PARD3,NAV2 |
1.695e-03 | -6.38 | Adherens junction | KEGG pathways | ko04520 | 72 | 3 | 7161 | 24 |
CTNNA2,PARD3,SORBS1 |
1.695e-03 | -6.38 | Adherens junction | KEGG pathways | hsa04520 | 72 | 3 | 7161 | 24 |
CTNNA2,PARD3,SORBS1 |
1.695e-03 | -6.38 | actomyosin | cellular component | GO:0042641 | 92 | 3 | 19108 | 49 |
ABLIM1,NEBL,SORBS1 |
1.700e-03 | -6.38 | transport across blood-brain barrier | biological process | GO:0150104 | 86 | 3 | 18204 | 50 |
ATP1A2,SLC1A2,SLC4A4 |
1.700e-03 | -6.38 | vascular transport | biological process | GO:0010232 | 86 | 3 | 18204 | 50 |
ATP1A2,SLC1A2,SLC4A4 |
1.734e-03 | -6.36 | femur | COSMIC cancer mutations | femur | 1197 | 10 | 16828 | 48 |
SLC4A4,NRG3,HPSE2,RYR3,GPC5,ADCY2,LRP1B,DPP6,NAV2,FMN2 |
1.743e-03 | -6.35 | Actinin_actin-bd_CS | interpro domains | IPR001589 | 23 | 2 | 18521 | 50 |
MACF1,SYNE1 |
1.776e-03 | -6.33 | Prot_kinase_dom | interpro domains | IPR000719 | 480 | 6 | 18521 | 50 |
KALRN,TNIK,DCLK2,NTRK2,CAMK2G,MAPK10 |
1.782e-03 | -6.33 | HS-GAG degradation | REACTOME pathways | R-HSA-2024096 | 21 | 2 | 10285 | 31 |
HPSE2,GPC5 |
1.813e-03 | -6.31 | bone-femur-other-chondroblastoma | COSMIC cancer mutations | bone-femur-other-chondroblastoma | 183 | 4 | 16828 | 48 |
NRG3,RYR3,LRP1B,GPC5 |
1.825e-03 | -6.31 | adenyl ribonucleotide binding | molecular function | GO:0032559 | 1528 | 11 | 18094 | 48 |
KALRN,ATP1A2,DCLK2,TNIK,MAPK10,CAMK2G,ADCY2,NAV2,DGKG,NAV3,NTRK2 |
1.835e-03 | -6.30 | Thyroid hormone synthesis | KEGG pathways | ko04918 | 74 | 3 | 7161 | 24 |
PLCB1,ATP1A2,ADCY2 |
1.835e-03 | -6.30 | Thyroid hormone synthesis | KEGG pathways | hsa04918 | 74 | 3 | 7161 | 24 |
PLCB1,ADCY2,ATP1A2 |
1.853e-03 | -6.29 | postsynaptic specialization | cellular component | GO:0099572 | 345 | 5 | 19108 | 49 |
NRCAM,CTNND2,KALRN,NTRK2,TNIK |
1.870e-03 | -6.28 | ADAMTS13 (ADAM metallopeptidase with thrombospondin type 1 motif 13) | protein interactions | 11093 | 25 | 2 | 19454 | 50 |
MACF1,FAT3 |
1.913e-03 | -6.26 | human chr3q27.2-q27.3 | chromosome location | human chr3q27.2-q27.3 | 1 | 1 | 26134 | 50 |
DGKG |
1.913e-03 | -6.26 | human chr3q21.1-q21.2 | chromosome location | human chr3q21.1-q21.2 | 1 | 1 | 26134 | 50 |
KALRN |
1.913e-03 | -6.26 | human chr4q31.23-q31.3 | chromosome location | human chr4q31.23-q31.3 | 1 | 1 | 26134 | 50 |
DCLK2 |
1.913e-03 | -6.26 | human chr10p11.22-p11.21 | chromosome location | human chr10p11.22-p11.21 | 1 | 1 | 26134 | 50 |
PARD3 |
1.913e-03 | -6.26 | human chr9q21.12-q21.13 | chromosome location | human chr9q21.12-q21.13 | 1 | 1 | 26134 | 50 |
TRPM3 |
1.913e-03 | -6.26 | human chr3q26.2-q26.31 | chromosome location | human chr3q26.2-q26.31 | 1 | 1 | 26134 | 50 |
TNIK |
1.913e-03 | -6.26 | human chr15q13.3-q14 | chromosome location | human chr15q13.3-q14 | 1 | 1 | 26134 | 50 |
RYR3 |
1.913e-03 | -6.26 | human chr2q22.1-q22.2 | chromosome location | human chr2q22.1-q22.2 | 1 | 1 | 26134 | 50 |
LRP1B |
1.913e-03 | -6.26 | human chr12q21.31-q21.32 | chromosome location | human chr12q21.31-q21.32 | 1 | 1 | 26134 | 50 |
MGAT4C |
1.915e-03 | -6.26 | actin filament bundle | cellular component | GO:0032432 | 96 | 3 | 19108 | 49 |
ABLIM1,SORBS1,NEBL |
1.921e-03 | -6.25 | FN3 | smart domains | SM00060 | 149 | 4 | 9717 | 35 |
KALRN,TNC,NRCAM,CNTN1 |
1.972e-03 | -6.23 | cellular component assembly | biological process | GO:0022607 | 2472 | 15 | 18204 | 50 |
NRG3,NRCAM,ABLIM1,GPM6A,TNIK,NRXN1,RYR3,PARD3,SLC1A2,NEBL,CNTN1,RFX4,FMN2,SORBS1,TRPM3 |
1.987e-03 | -6.22 | PLCB3 (phospholipase C beta 3) | protein interactions | 5331 | 97 | 3 | 19454 | 50 |
PARD3,PLCB1,CAMK2G |
2.023e-03 | -6.20 | NRCAM (neuronal cell adhesion molecule) | protein interactions | 4897 | 26 | 2 | 19454 | 50 |
MACF1,NRCAM |
2.026e-03 | -6.20 | calcium ion binding | molecular function | GO:0005509 | 683 | 7 | 18094 | 48 |
FAT3,LRP1B,MACF1,NRXN1,PLCB1,DGKG,RYR3 |
2.035e-03 | -6.20 | skin-neck-malignant_melanoma | COSMIC cancer mutations | skin-neck-malignant_melanoma | 1223 | 10 | 16828 | 48 |
TNC,PLCB1,GPC5,ADCY2,ATP1A2,CNTN1,TRPM3,SYNE1,LRP1B,CTNND2 |
2.047e-03 | -6.19 | FRS2 (fibroblast growth factor receptor substrate 2) | protein interactions | 10818 | 98 | 3 | 19454 | 50 |
NTRK2,PARD3,SORBS1 |
2.077e-03 | -6.18 | phosphotransferase activity, alcohol group as acceptor | molecular function | GO:0016773 | 686 | 7 | 18094 | 48 |
NTRK2,DGKG,CAMK2G,MAPK10,TNIK,DCLK2,KALRN |
2.084e-03 | -6.17 | skin-upper_back-malignant_melanoma | COSMIC cancer mutations | skin-upper_back-malignant_melanoma | 319 | 5 | 16828 | 48 |
MACF1,SYNE1,KALRN,GPC5,CNTN1 |
2.136e-03 | -6.15 | neck | COSMIC cancer mutations | neck | 1231 | 10 | 16828 | 48 |
ADCY2,GPC5,PLCB1,TNC,SYNE1,LRP1B,CTNND2,CNTN1,ATP1A2,TRPM3 |
2.141e-03 | -6.15 | virilizing_syndrome_producing | COSMIC cancer mutations | virilizing_syndrome_producing | 321 | 5 | 16828 | 48 |
ATP1A2,TNC,FMN2,CTNND2,LRP1B |
2.152e-03 | -6.14 | EGF-type_Asp/Asn_hydroxyl_site | interpro domains | IPR000152 | 95 | 3 | 18521 | 50 |
FAT3,NRXN1,LRP1B |
2.176e-03 | -6.13 | FN3_dom | interpro domains | IPR003961 | 203 | 4 | 18521 | 50 |
KALRN,CNTN1,TNC,NRCAM |
2.176e-03 | -6.13 | FN3_sf | interpro domains | IPR036116 | 203 | 4 | 18521 | 50 |
NRCAM,TNC,CNTN1,KALRN |
2.178e-03 | -6.13 | CXADR (CXADR Ig-like cell adhesion molecule) | protein interactions | 1525 | 357 | 5 | 19454 | 50 |
NEBL,PARD3,SORBS1,MACF1,TNIK |
2.181e-03 | -6.13 | SH3BP5 (SH3 domain binding protein 5) | protein interactions | 9467 | 27 | 2 | 19454 | 50 |
SYNE1,MAPK10 |
2.181e-03 | -6.13 | KCNJ12 (potassium inwardly rectifying channel subfamily J member 12) | protein interactions | 3768 | 27 | 2 | 19454 | 50 |
ABLIM1,DTNA |
2.183e-03 | -6.13 | intracellular signal transduction | biological process | GO:0035556 | 1505 | 11 | 18204 | 50 |
TNIK,DGKG,NRG3,KALRN,ATP1A2,DCLK2,PLCB1,FMN2,MAPK10,ADCY2,RYR3 |
2.200e-03 | -6.12 | haematopoietic_and_lymphoid_tissue-spleen-lymphoid_neoplasm-marginal_zone_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-spleen-lymphoid_neoplasm-marginal_zone_lymphoma | 323 | 5 | 16828 | 48 |
ADCY2,LRP1B,SORBS1,SYNE1,NTM |
2.238e-03 | -6.10 | modulation of chemical synaptic transmission | biological process | GO:0050804 | 494 | 6 | 18204 | 50 |
NRXN1,ATP1A2,NTRK2,PLCB1,NRG3,SYNE1 |
2.261e-03 | -6.09 | regulation of trans-synaptic signaling | biological process | GO:0099177 | 495 | 6 | 18204 | 50 |
ATP1A2,NRXN1,NTRK2,NRG3,PLCB1,SYNE1 |
2.319e-03 | -6.07 | poly(U) RNA binding | molecular function | GO:0008266 | 27 | 2 | 18094 | 48 |
MSI2,RBMS3 |
2.342e-03 | -6.06 | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | 3507 | 19 | 16828 | 48 |
PLCB1,RYR3,MACF1,GPC5,ADCY2,NAV3,TRPM3,DGKG,ATP1A2,PARD3,SYNE1,NAV2,FMN2,SLC4A4,HPSE2,DCLK2,CNTN1,CTNND2,LRP1B |
2.345e-03 | -6.06 | LRRC7 (leucine rich repeat containing 7) | protein interactions | 57554 | 28 | 2 | 19454 | 50 |
CAMK2G,CTNND2 |
2.351e-03 | -6.05 | upper_back | COSMIC cancer mutations | upper_back | 328 | 5 | 16828 | 48 |
MACF1,KALRN,GPC5,SYNE1,CNTN1 |
2.368e-03 | -6.05 | neuron to neuron synapse | cellular component | GO:0098984 | 365 | 5 | 19108 | 49 |
TNIK,NTRK2,CTNND2,KALRN,NRCAM |
2.399e-03 | -6.03 | calcium ion transmembrane transport | biological process | GO:0070588 | 205 | 4 | 18204 | 50 |
PLCB1,RYR3,GPM6A,TRPM3 |
2.446e-03 | -6.01 | marginal_zone_lymphoma | COSMIC cancer mutations | marginal_zone_lymphoma | 331 | 5 | 16828 | 48 |
LRP1B,SORBS1,SYNE1,ADCY2,NTM |
2.458e-03 | -6.01 | EGF_1 | prosite domains | PS00022 | 174 | 4 | 12186 | 40 |
LRP1B,NRG3,TNC,FAT3 |
2.463e-03 | -6.01 | Aldosterone synthesis and secretion | KEGG pathways | hsa04925 | 82 | 3 | 7161 | 24 |
CAMK2G,ADCY2,PLCB1 |
2.463e-03 | -6.01 | Aldosterone synthesis and secretion | KEGG pathways | ko04925 | 82 | 3 | 7161 | 24 |
ADCY2,CAMK2G,PLCB1 |
2.484e-03 | -6.00 | protein kinase C-activating G protein-coupled receptor signaling pathway | biological process | GO:0007205 | 27 | 2 | 18204 | 50 |
DGKG,PARD3 |
2.545e-03 | -5.97 | ACTININ_1 | prosite domains | PS00019 | 23 | 2 | 12186 | 40 |
SYNE1,MACF1 |
2.545e-03 | -5.97 | ACTININ_2 | prosite domains | PS00020 | 23 | 2 | 12186 | 40 |
SYNE1,MACF1 |
2.557e-03 | -5.97 | IG | smart domains | SM00409 | 394 | 6 | 9717 | 35 |
KALRN,LSAMP,NTRK2,NTM,NRCAM,CNTN1 |
2.570e-03 | -5.96 | Itga7 (integrin subunit alpha 7) | protein interactions | 81008 | 1 | 1 | 19454 | 50 |
TNC |
2.570e-03 | -5.96 | Cntnap2 (contactin associated protein-like 2) | protein interactions | 66797 | 1 | 1 | 19454 | 50 |
CNTN1 |
2.570e-03 | -5.96 | Sytl1 (synaptotagmin-like 1) | protein interactions | 269589 | 1 | 1 | 19454 | 50 |
NRXN1 |
2.570e-03 | -5.96 | Bdnf (brain derived neurotrophic factor) | protein interactions | 12064 | 1 | 1 | 19454 | 50 |
NTRK2 |
2.570e-03 | -5.96 | App (amyloid beta precursor protein) | protein interactions | 100689222 | 1 | 1 | 19454 | 50 |
LRP1B |
2.570e-03 | -5.96 | Dynlt1 (dynein light chain Tctex-type 1) | protein interactions | 83462 | 1 | 1 | 19454 | 50 |
NTRK2 |
2.570e-03 | -5.96 | Agtrap (angiotensin II, type I receptor-associated protein) | protein interactions | 11610 | 1 | 1 | 19454 | 50 |
PITPNC1 |
2.585e-03 | -5.96 | IG_LIKE | prosite domains | PS50835 | 430 | 6 | 12186 | 40 |
CNTN1,KALRN,NTRK2,NTM,NRCAM,LSAMP |
2.585e-03 | -5.96 | Pkinase | pfam domains | PF00069 | 347 | 5 | 17795 | 49 |
MAPK10,CAMK2G,TNIK,DCLK2,KALRN |
2.602e-03 | -5.95 | inorganic molecular entity transmembrane transporter activity | molecular function | GO:0015318 | 714 | 7 | 18094 | 48 |
SLC1A2,ATP1A2,SLC14A1,TRPM3,RYR3,GPM6A,SLC4A4 |
2.603e-03 | -5.95 | MAPRE3 (microtubule associated protein RP/EB family member 3) | protein interactions | 22924 | 224 | 4 | 19454 | 50 |
GPM6A,ABLIM1,NAV2,MACF1 |
2.609e-03 | -5.95 | Proximal tubule bicarbonate reclamation | KEGG pathways | hsa04964 | 23 | 2 | 7161 | 24 |
ATP1A2,SLC4A4 |
2.609e-03 | -5.95 | Proximal tubule bicarbonate reclamation | KEGG pathways | ko04964 | 23 | 2 | 7161 | 24 |
ATP1A2,SLC4A4 |
2.636e-03 | -5.94 | protein serine kinase activity | molecular function | GO:0106310 | 362 | 5 | 18094 | 48 |
DCLK2,KALRN,CAMK2G,MAPK10,TNIK |
2.653e-03 | -5.93 | brain-derived neurotrophic factor receptor activity | molecular function | GO:0060175 | 1 | 1 | 18094 | 48 |
NTRK2 |
2.700e-03 | -5.91 | SORBS1_SH3_2 | interpro domains | IPR035611 | 1 | 1 | 18521 | 50 |
SORBS1 |
2.700e-03 | -5.91 | Contactin-1_Ig1 | interpro domains | IPR036992 | 1 | 1 | 18521 | 50 |
CNTN1 |
2.700e-03 | -5.91 | C1_DGKgamma_rpt2 | interpro domains | IPR047475 | 1 | 1 | 18521 | 50 |
DGKG |
2.700e-03 | -5.91 | CH_SYNE1_rpt1 | interpro domains | IPR047290 | 1 | 1 | 18521 | 50 |
SYNE1 |
2.700e-03 | -5.91 | Contactin-1_Ig6 | interpro domains | IPR047101 | 1 | 1 | 18521 | 50 |
CNTN1 |
2.700e-03 | -5.91 | SORBS1_SH3_1 | interpro domains | IPR035610 | 1 | 1 | 18521 | 50 |
SORBS1 |
2.700e-03 | -5.91 | Nebulette_SH3 | interpro domains | IPR035631 | 1 | 1 | 18521 | 50 |
NEBL |
2.700e-03 | -5.91 | SORBS1_SH3 | interpro domains | IPR035606 | 1 | 1 | 18521 | 50 |
SORBS1 |
2.700e-03 | -5.91 | CH_SYNE1_rpt2 | interpro domains | IPR047291 | 1 | 1 | 18521 | 50 |
SYNE1 |
2.700e-03 | -5.91 | NTRK2 | interpro domains | IPR020455 | 1 | 1 | 18521 | 50 |
NTRK2 |
2.700e-03 | -5.91 | PLC-beta1_EF | interpro domains | IPR028400 | 1 | 1 | 18521 | 50 |
PLCB1 |
2.700e-03 | -5.91 | RBMS3_RRM2 | interpro domains | IPR034406 | 1 | 1 | 18521 | 50 |
RBMS3 |
2.700e-03 | -5.91 | Contactin-1_Ig3 | interpro domains | IPR047100 | 1 | 1 | 18521 | 50 |
CNTN1 |
2.729e-03 | -5.90 | ErbB signaling pathway | KEGG pathways | ko04012 | 85 | 3 | 7161 | 24 |
CAMK2G,NRG3,MAPK10 |
2.729e-03 | -5.90 | ErbB signaling pathway | KEGG pathways | hsa04012 | 85 | 3 | 7161 | 24 |
CAMK2G,MAPK10,NRG3 |
2.730e-03 | -5.90 | Kinase-like_dom_sf | interpro domains | IPR011009 | 523 | 6 | 18521 | 50 |
NTRK2,TNIK,DCLK2,KALRN,MAPK10,CAMK2G |
2.747e-03 | -5.90 | regulation of nucleus organization | biological process | GO:1903353 | 1 | 1 | 18204 | 50 |
SYNE1 |
2.747e-03 | -5.90 | trans-synaptic signaling by neuropeptide, modulating synaptic transmission | biological process | GO:0099551 | 1 | 1 | 18204 | 50 |
NTRK2 |
2.747e-03 | -5.90 | trans-synaptic signaling by neuropeptide | biological process | GO:0099540 | 1 | 1 | 18204 | 50 |
NTRK2 |
2.747e-03 | -5.90 | chemorepulsion involved in interneuron migration from the subpallium to the cortex | biological process | GO:0021842 | 1 | 1 | 18204 | 50 |
NRG3 |
2.747e-03 | -5.90 | regulation of CD24 production | biological process | GO:2000559 | 1 | 1 | 18204 | 50 |
PLCB1 |
2.747e-03 | -5.90 | response to glyceraldehyde | biological process | GO:1905630 | 1 | 1 | 18204 | 50 |
PLCB1 |
2.747e-03 | -5.90 | homologous chromosome movement towards spindle pole in meiosis I anaphase | biological process | GO:0051758 | 1 | 1 | 18204 | 50 |
FMN2 |
2.747e-03 | -5.90 | olfactory cortex development | biological process | GO:0021989 | 1 | 1 | 18204 | 50 |
ATP1A2 |
2.747e-03 | -5.90 | negative regulation of calcium:sodium antiporter activity | biological process | GO:1903280 | 1 | 1 | 18204 | 50 |
ATP1A2 |
2.747e-03 | -5.90 | cellular response to glyceraldehyde | biological process | GO:1905631 | 1 | 1 | 18204 | 50 |
PLCB1 |
2.747e-03 | -5.90 | directional guidance of interneurons involved in migration from the subpallium to the cortex | biological process | GO:0021840 | 1 | 1 | 18204 | 50 |
NRG3 |
2.747e-03 | -5.90 | positive regulation of CD24 production | biological process | GO:2000560 | 1 | 1 | 18204 | 50 |
PLCB1 |
2.777e-03 | -5.89 | cellular component organization or biogenesis | biological process | GO:0071840 | 5850 | 26 | 18204 | 50 |
DCLK2,CTNND2,TRPM3,RFX4,SYNE1,FMN2,SORBS1,FAT3,PITPNC1,CTNNA2,CNTN1,SLC1A2,HPSE2,NEBL,PARD3,RYR3,MACF1,TNIK,NRXN1,NAV2,TNC,GPM6A,NRCAM,ABLIM1,KALRN,NRG3 |
2.823e-03 | -5.87 | Calcium signaling pathway | KEGG pathways | ko04020 | 181 | 4 | 7161 | 24 |
PLCB1,ADCY2,CAMK2G,RYR3 |
2.823e-03 | -5.87 | Calcium signaling pathway | KEGG pathways | hsa04020 | 181 | 4 | 7161 | 24 |
PLCB1,ADCY2,RYR3,CAMK2G |
2.857e-03 | -5.86 | nuclear outer membrane | cellular component | GO:0005640 | 31 | 2 | 19108 | 49 |
NAV3,SYNE1 |
2.859e-03 | -5.86 | poly-pyrimidine tract binding | molecular function | GO:0008187 | 30 | 2 | 18094 | 48 |
MSI2,RBMS3 |
2.862e-03 | -5.86 | ACTB (actin beta) | protein interactions | 60 | 958 | 8 | 19454 | 50 |
FMN2,MACF1,SFXN5,SORBS1,NEBL,ABLIM1,DTNA,NHSL1 |
2.863e-03 | -5.86 | myelination in peripheral nervous system | biological process | GO:0022011 | 29 | 2 | 18204 | 50 |
PARD3,NTRK2 |
2.863e-03 | -5.86 | peripheral nervous system axon ensheathment | biological process | GO:0032292 | 29 | 2 | 18204 | 50 |
NTRK2,PARD3 |
2.863e-03 | -5.86 | DST (dystonin) | protein interactions | 667 | 230 | 4 | 19454 | 50 |
TNIK,NTRK2,ATP1A2,PARD3 |
2.866e-03 | -5.85 | beta-catenin binding | molecular function | GO:0008013 | 107 | 3 | 18094 | 48 |
CTNND2,RORA,CTNNA2 |
2.899e-03 | -5.84 | adenyl nucleotide binding | molecular function | GO:0030554 | 1620 | 11 | 18094 | 48 |
MAPK10,CAMK2G,TNIK,NTRK2,DGKG,NAV3,ADCY2,NAV2,ATP1A2,KALRN,DCLK2 |
3.005e-03 | -5.81 | SH3_domain | interpro domains | IPR001452 | 222 | 4 | 18521 | 50 |
NEBL,KALRN,SORBS1,MACF1 |
3.060e-03 | -5.79 | Ig-like_fold | interpro domains | IPR013783 | 721 | 7 | 18521 | 50 |
CNTN1,NTRK2,NRCAM,LSAMP,NTM,KALRN,TNC |
3.062e-03 | -5.79 | neurotransmitter uptake | biological process | GO:0001504 | 30 | 2 | 18204 | 50 |
SLC1A2,ATP1A2 |
3.088e-03 | -5.78 | anion binding | molecular function | GO:0043168 | 2412 | 14 | 18094 | 48 |
PARD3,MAPK10,NAV3,KALRN,DCLK2,PLCB1,CAMK2G,TNIK,NTRK2,DGKG,NAV2,ADCY2,PITPNC1,ATP1A2 |
3.093e-03 | -5.78 | MARK3 (microtubule affinity regulating kinase 3) | protein interactions | 4140 | 235 | 4 | 19454 | 50 |
DTNA,MACF1,NTRK2,PARD3 |
3.108e-03 | -5.77 | Muscle contraction | REACTOME pathways | R-HSA-397014 | 204 | 4 | 10285 | 31 |
RYR3,ATP1A2,CAMK2G,SORBS1 |
3.152e-03 | -5.76 | kinase activity | molecular function | GO:0016301 | 739 | 7 | 18094 | 48 |
KALRN,DCLK2,TNIK,CAMK2G,MAPK10,DGKG,NTRK2 |
3.181e-03 | -5.75 | PROTEIN_KINASE_ST | prosite domains | PS00108 | 308 | 5 | 12186 | 40 |
CAMK2G,KALRN,TNIK,DCLK2,MAPK10 |
3.202e-03 | -5.74 | presynapse | cellular component | GO:0098793 | 569 | 6 | 19108 | 49 |
NTRK2,SLC1A2,NRXN1,GPM6A,TNIK,CNTN1 |
3.237e-03 | -5.73 | LCOR (ligand dependent nuclear receptor corepressor) | protein interactions | 84458 | 238 | 4 | 19454 | 50 |
NAV3,NRCAM,MACF1,LRP1B |
3.252e-03 | -5.73 | NTKRECEPTOR2 | prints domains | PR01941 | 1 | 1 | 5227 | 17 |
NTRK2 |
3.301e-03 | -5.71 | axon guidance | biological process | GO:0007411 | 224 | 4 | 18204 | 50 |
CNTN1,NRCAM,NRXN1,KALRN |
3.301e-03 | -5.71 | neuron projection guidance | biological process | GO:0097485 | 224 | 4 | 18204 | 50 |
KALRN,CNTN1,NRCAM,NRXN1 |
3.329e-03 | -5.71 | skin-arm-malignant_melanoma | COSMIC cancer mutations | skin-arm-malignant_melanoma | 1308 | 10 | 16828 | 48 |
SLC4A4,SORBS1,MACF1,ATP1A2,TRPM3,NAV2,NTM,SYNE1,LRP1B,KALRN |
3.375e-03 | -5.69 | cell migration | biological process | GO:0016477 | 921 | 8 | 18204 | 50 |
CTNNA2,FAT3,GPM6A,NRCAM,NRG3,NTRK2,GPC5,FMN2 |
3.391e-03 | -5.69 | Ion channel transport | REACTOME pathways | R-HSA-983712 | 209 | 4 | 10285 | 31 |
CAMK2G,RYR3,ATP1A2,TRPM3 |
3.401e-03 | -5.68 | Protein_kinase_ATP_BS | interpro domains | IPR017441 | 377 | 5 | 18521 | 50 |
NTRK2,TNIK,DCLK2,KALRN,CAMK2G |
3.441e-03 | -5.67 | HAX1 (HCLS1 associated protein X-1) | protein interactions | 10456 | 397 | 5 | 19454 | 50 |
DPP6,NTM,CNTN1,MAPK10,GPM6A |
3.462e-03 | -5.67 | Transferase(Phosphotransferase) domain 1 | gene3d domains | 1.10.510.10 | 490 | 6 | 14470 | 44 |
DCLK2,KALRN,TNIK,CAMK2G,NTRK2,MAPK10 |
3.472e-03 | -5.66 | monoatomic ion transmembrane transporter activity | molecular function | GO:0015075 | 752 | 7 | 18094 | 48 |
TRPM3,RYR3,GPM6A,SFXN5,SLC4A4,SLC1A2,ATP1A2 |
3.504e-03 | -5.65 | FN3 | prosite domains | PS50853 | 192 | 4 | 12186 | 40 |
TNC,NRCAM,CNTN1,KALRN |
3.578e-03 | -5.63 | phosphorylation | biological process | GO:0016310 | 729 | 7 | 18204 | 50 |
KALRN,MAPK10,DGKG,CAMK2G,TNIK,NTRK2,DCLK2 |
3.590e-03 | -5.63 | Neuronal System | REACTOME pathways | R-HSA-112316 | 349 | 5 | 10285 | 31 |
NRXN1,ADCY2,PLCB1,CAMK2G,SLC1A2 |
3.602e-03 | -5.63 | DELLA | smart domains | SM01129 | 1 | 1 | 9717 | 35 |
MACF1 |
3.674e-03 | -5.61 | cell-cell adhesion | biological process | GO:0098609 | 546 | 6 | 18204 | 50 |
NRXN1,CTNND2,NRCAM,CTNNA2,FAT3,CNTN1 |
3.688e-03 | -5.60 | calcium channel activity | molecular function | GO:0005262 | 117 | 3 | 18094 | 48 |
GPM6A,TRPM3,RYR3 |
3.692e-03 | -5.60 | dendrite development | biological process | GO:0016358 | 113 | 3 | 18204 | 50 |
CTNNA2,FAT3,CTNND2 |
3.697e-03 | -5.60 | response to auditory stimulus | biological process | GO:0010996 | 33 | 2 | 18204 | 50 |
ATP1A2,NRXN1 |
3.775e-03 | -5.58 | arm | COSMIC cancer mutations | arm | 1331 | 10 | 16828 | 48 |
MACF1,SORBS1,SLC4A4,KALRN,LRP1B,SYNE1,NAV2,NTM,TRPM3,ATP1A2 |
3.857e-03 | -5.56 | SLC5A5 (solute carrier family 5 member 5) | protein interactions | 6528 | 36 | 2 | 19454 | 50 |
SFXN5,CAMK2G |
3.879e-03 | -5.55 | Transmission across Chemical Synapses | REACTOME pathways | R-HSA-112315 | 217 | 4 | 10285 | 31 |
CAMK2G,SLC1A2,ADCY2,PLCB1 |
3.903e-03 | -5.55 | cAMP signaling pathway | KEGG pathways | hsa04024 | 198 | 4 | 7161 | 24 |
ADCY2,ATP1A2,CAMK2G,MAPK10 |
3.903e-03 | -5.55 | cAMP signaling pathway | KEGG pathways | ko04024 | 198 | 4 | 7161 | 24 |
MAPK10,CAMK2G,ADCY2,ATP1A2 |
3.969e-03 | -5.53 | NCK2 (NCK adaptor protein 2) | protein interactions | 8440 | 252 | 4 | 19454 | 50 |
SORBS1,TNIK,NHSL1,NTRK2 |
3.976e-03 | -5.53 | salivary_gland-submandibular-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | salivary_gland-submandibular-carcinoma-adenoid_cystic_carcinoma | 33 | 2 | 16828 | 48 |
LRP1B,NAV2 |
4.031e-03 | -5.51 | protein kinase activity | molecular function | GO:0004672 | 577 | 6 | 18094 | 48 |
NTRK2,TNIK,CAMK2G,MAPK10,DCLK2,KALRN |
4.068e-03 | -5.50 | large_intestine-caecum-adenoma | COSMIC cancer mutations | large_intestine-caecum-adenoma | 229 | 4 | 16828 | 48 |
HPSE2,KALRN,LRP1B,CTNND2 |
4.094e-03 | -5.50 | transporter activity | molecular function | GO:0005215 | 1211 | 9 | 18094 | 48 |
SFXN5,ATP1A2,PITPNC1,SLC1A2,GPM6A,RYR3,TRPM3,SLC4A4,SLC14A1 |
4.099e-03 | -5.50 | proteoglycan binding | molecular function | GO:0043394 | 36 | 2 | 18094 | 48 |
HPSE2,TNC |
4.119e-03 | -5.49 | EGF | smart domains | SM00181 | 184 | 4 | 9717 | 35 |
NRXN1,TNC,FAT3,LRP1B |
4.145e-03 | -5.49 | cellular process | biological process | GO:0009987 | 14996 | 48 | 18204 | 50 |
DGKG,KALRN,MSI2,NRG3,SLC4A4,RORA,TNIK,TNC,MGAT4C,PITPNC1,LSAMP,SOX5,SORBS1,NHSL1,ABLIM1,NRCAM,GPC5,NRXN1,CNTN1,FAT3,SLC1A2,MAPK10,NTM,FMN2,NAV3,RFX4,PLCB1,GPM6A,CAMK2G,SLC14A1,MACF1,CTNNA2,SFXN5,PARD3,DCLK2,CTNND2,NTRK2,ATP1A2,DTNA,NAV2,LRP1B,DPP6,HPSE2,NEBL,ADCY2,RYR3,TRPM3,SYNE1 |
4.196e-03 | -5.47 | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | 114 | 3 | 16828 | 48 |
SLC1A2,RYR3,SOX5 |
4.251e-03 | -5.46 | ASX_HYDROXYL | prosite domains | PS00010 | 100 | 3 | 12186 | 40 |
FAT3,NRXN1,LRP1B |
4.364e-03 | -5.43 | regulation of metal ion transport | biological process | GO:0010959 | 393 | 5 | 18204 | 50 |
CAMK2G,CNTN1,NKAIN3,ATP1A2,DPP6 |
4.370e-03 | -5.43 | striated muscle contraction | biological process | GO:0006941 | 120 | 3 | 18204 | 50 |
RYR3,ATP1A2,DTNA |
4.370e-03 | -5.43 | regulation of nervous system process | biological process | GO:0031644 | 120 | 3 | 18204 | 50 |
PARD3,SYNE1,NRXN1 |
4.408e-03 | -5.42 | Laminin_G_2 | pfam domains | PF02210 | 36 | 2 | 17795 | 49 |
NRXN1,FAT3 |
4.445e-03 | -5.42 | Melanogenesis | KEGG pathways | ko04916 | 101 | 3 | 7161 | 24 |
PLCB1,CAMK2G,ADCY2 |
4.445e-03 | -5.42 | Retrograde endocannabinoid signaling | KEGG pathways | ko04723 | 101 | 3 | 7161 | 24 |
MAPK10,ADCY2,PLCB1 |
4.445e-03 | -5.42 | Melanogenesis | KEGG pathways | hsa04916 | 101 | 3 | 7161 | 24 |
PLCB1,CAMK2G,ADCY2 |
4.445e-03 | -5.42 | Retrograde endocannabinoid signaling | KEGG pathways | hsa04723 | 101 | 3 | 7161 | 24 |
ADCY2,MAPK10,PLCB1 |
4.449e-03 | -5.42 | PROTEIN_KINASE_DOM | prosite domains | PS50011 | 480 | 6 | 12186 | 40 |
CAMK2G,NTRK2,TNIK,DCLK2,KALRN,MAPK10 |
4.451e-03 | -5.41 | monoatomic ion transport | biological process | GO:0006811 | 964 | 8 | 18204 | 50 |
SLC4A4,TRPM3,ATP1A2,PLCB1,GPM6A,SLC1A2,SFXN5,RYR3 |
4.455e-03 | -5.41 | inorganic cation transmembrane transporter activity | molecular function | GO:0022890 | 589 | 6 | 18094 | 48 |
TRPM3,RYR3,GPM6A,SLC4A4,SLC1A2,ATP1A2 |
4.494e-03 | -5.41 | DIRAS3 (DIRAS family GTPase 3) | protein interactions | 9077 | 261 | 4 | 19454 | 50 |
PARD3,FMN2,MACF1,DTNA |
4.570e-03 | -5.39 | Glucagon signaling pathway | KEGG pathways | hsa04922 | 102 | 3 | 7161 | 24 |
PLCB1,CAMK2G,ADCY2 |
4.570e-03 | -5.39 | Glucagon signaling pathway | KEGG pathways | ko04922 | 102 | 3 | 7161 | 24 |
PLCB1,ADCY2,CAMK2G |
4.601e-03 | -5.38 | SH3 Domains | gene3d domains | 2.30.30.40 | 223 | 4 | 14470 | 44 |
NEBL,SORBS1,MACF1,KALRN |
4.631e-03 | -5.38 | positive regulation of glucose import | biological process | GO:0046326 | 37 | 2 | 18204 | 50 |
SLC1A2,SORBS1 |
4.718e-03 | -5.36 | submandibular | COSMIC cancer mutations | submandibular | 36 | 2 | 16828 | 48 |
NAV2,LRP1B |
4.723e-03 | -5.36 | carbohydrate derivative binding | molecular function | GO:0097367 | 2251 | 13 | 18094 | 48 |
DCLK2,HPSE2,KALRN,NAV3,MAPK10,TNC,ATP1A2,NAV2,ADCY2,NTRK2,DGKG,TNIK,CAMK2G |
4.735e-03 | -5.35 | large_intestine-colon-carcinoma | COSMIC cancer mutations | large_intestine-colon-carcinoma | 2612 | 15 | 16828 | 48 |
SYNE1,KALRN,PARD3,NAV2,FMN2,TRPM3,MACF1,GPC5,ADCY2,RORA,NAV3,NRG3,TNC,LRP1B,NRXN1 |
4.788e-03 | -5.34 | action potential | biological process | GO:0001508 | 124 | 3 | 18204 | 50 |
NRCAM,ATP1A2,NTRK2 |
4.944e-03 | -5.31 | calcium ion transport | biological process | GO:0006816 | 251 | 4 | 18204 | 50 |
PLCB1,RYR3,GPM6A,TRPM3 |
4.945e-03 | -5.31 | NUFIP1 (nuclear FMR1 interacting protein 1) | protein interactions | 26747 | 134 | 3 | 19454 | 50 |
NTM,CNTN1,GPM6A |
4.966e-03 | -5.31 | cellular component biogenesis | biological process | GO:0044085 | 2716 | 15 | 18204 | 50 |
NEBL,SLC1A2,CNTN1,RYR3,PARD3,TRPM3,RFX4,SORBS1,FMN2,NRCAM,ABLIM1,GPM6A,NRG3,TNIK,NRXN1 |
5.068e-03 | -5.28 | EGF_2 | prosite domains | PS01186 | 213 | 4 | 12186 | 40 |
NRG3,TNC,FAT3,LRP1B |
5.127e-03 | -5.27 | RHOB (ras homolog family member B) | protein interactions | 388 | 832 | 7 | 19454 | 50 |
TNIK,PLCB1,MACF1,FMN2,DTNA,ABLIM1,PARD3 |
5.134e-03 | -5.27 | EST1 (Est1p) | protein interactions | 850934 | 2 | 1 | 19454 | 50 |
NAV2 |
5.134e-03 | -5.27 | C16orf46 (chromosome 16 open reading frame 46) | protein interactions | 123775 | 2 | 1 | 19454 | 50 |
FAT3 |
5.134e-03 | -5.27 | cellular response to alkaloid | biological process | GO:0071312 | 39 | 2 | 18204 | 50 |
RYR3,SLC1A2 |
5.138e-03 | -5.27 | phosphate-containing compound metabolic process | biological process | GO:0006796 | 1681 | 11 | 18204 | 50 |
KALRN,DGKG,CAMK2G,ADCY2,MAPK10,PLCB1,RORA,DCLK2,NTRK2,ATP1A2,TNIK |
5.198e-03 | -5.26 | RDX (radixin) | protein interactions | 5962 | 272 | 4 | 19454 | 50 |
MACF1,ABLIM1,NEBL,MAPK10 |
5.231e-03 | -5.25 | glial cell development | biological process | GO:0021782 | 128 | 3 | 18204 | 50 |
PARD3,CNTN1,NTRK2 |
5.231e-03 | -5.25 | myelination | biological process | GO:0042552 | 128 | 3 | 18204 | 50 |
PARD3,NTRK2,CNTN1 |
5.265e-03 | -5.25 | FLOT2 (flotillin 2) | protein interactions | 2319 | 273 | 4 | 19454 | 50 |
NTRK2,SLC14A1,PARD3,SOX5 |
5.283e-03 | -5.24 | Axon guidance | REACTOME pathways | R-HSA-422475 | 549 | 6 | 10285 | 31 |
ABLIM1,NRCAM,CNTN1,NRG3,KALRN,CAMK2G |
5.299e-03 | -5.24 | heparanase activity | molecular function | GO:0030305 | 2 | 1 | 18094 | 48 |
HPSE2 |
5.329e-03 | -5.23 | TRIM67 (tripartite motif containing 67) | protein interactions | 440730 | 4804 | 21 | 19454 | 50 |
CNTN1,NRCAM,PLCB1,MACF1,TNC,TNIK,LSAMP,ATP1A2,CAMK2G,SYNE1,DTNA,GPM6A,PITPNC1,DCLK2,KALRN,SLC4A4,MSI2,PARD3,NTM,CTNND2,CTNNA2 |
5.370e-03 | -5.23 | protein serine/threonine kinase activity | molecular function | GO:0004674 | 428 | 5 | 18094 | 48 |
TNIK,KALRN,CAMK2G,MAPK10,DCLK2 |
5.390e-03 | -5.22 | mast_cell_neoplasm | COSMIC cancer mutations | mast_cell_neoplasm | 248 | 4 | 16828 | 48 |
HPSE2,NRG3,ADCY2,GPC5 |
5.390e-03 | -5.22 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | 248 | 4 | 16828 | 48 |
ADCY2,GPC5,NRG3,HPSE2 |
5.392e-03 | -5.22 | LRP1-like_beta_prop | interpro domains | IPR032485 | 2 | 1 | 18521 | 50 |
LRP1B |
5.392e-03 | -5.22 | Formin_Cappuccino_subfam | interpro domains | IPR001265 | 2 | 1 | 18521 | 50 |
FMN2 |
5.392e-03 | -5.22 | Contactin-1_2_Ig1 | interpro domains | IPR047102 | 2 | 1 | 18521 | 50 |
CNTN1 |
5.392e-03 | -5.22 | Kalirin_TRIO_PH_1 | interpro domains | IPR047054 | 2 | 1 | 18521 | 50 |
KALRN |
5.392e-03 | -5.22 | Glyco_hydro_79 | interpro domains | IPR005199 | 2 | 1 | 18521 | 50 |
HPSE2 |
5.392e-03 | -5.22 | Kalirin_TRIO_SH3_2 | interpro domains | IPR047053 | 2 | 1 | 18521 | 50 |
KALRN |
5.392e-03 | -5.22 | Distrobrevin | interpro domains | IPR017432 | 2 | 1 | 18521 | 50 |
DTNA |
5.392e-03 | -5.22 | MSI_RRM2 | interpro domains | IPR034126 | 2 | 1 | 18521 | 50 |
MSI2 |
5.392e-03 | -5.22 | Par3/HAL_N | interpro domains | IPR021922 | 2 | 1 | 18521 | 50 |
PARD3 |
5.392e-03 | -5.22 | Anc-1/SYNE1/2-like | interpro domains | IPR039906 | 2 | 1 | 18521 | 50 |
SYNE1 |
5.392e-03 | -5.22 | Kalirin_TRIO_SH3_1 | interpro domains | IPR028570 | 2 | 1 | 18521 | 50 |
KALRN |
5.392e-03 | -5.22 | Urea_transporter | interpro domains | IPR004937 | 2 | 1 | 18521 | 50 |
SLC14A1 |
5.392e-03 | -5.22 | PLC-beta_CS | interpro domains | IPR009535 | 2 | 1 | 18521 | 50 |
PLCB1 |
5.395e-03 | -5.22 | cyclic purine nucleotide metabolic process | biological process | GO:0052652 | 40 | 2 | 18204 | 50 |
ADCY2,RORA |
5.440e-03 | -5.21 | sarcoplasmic reticulum membrane | cellular component | GO:0033017 | 43 | 2 | 19108 | 49 |
RYR3,CAMK2G |
5.461e-03 | -5.21 | axon ensheathment | biological process | GO:0008366 | 130 | 3 | 18204 | 50 |
NTRK2,CNTN1,PARD3 |
5.461e-03 | -5.21 | ensheathment of neurons | biological process | GO:0007272 | 130 | 3 | 18204 | 50 |
NTRK2,CNTN1,PARD3 |
5.467e-03 | -5.21 | central_nervous_system-brain-glioma-oligodendroglioma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-oligodendroglioma_Grade_III | 249 | 4 | 16828 | 48 |
SYNE1,MACF1,NAV2,MGAT4C |
5.476e-03 | -5.21 | Laminin_G | interpro domains | IPR001791 | 41 | 2 | 18521 | 50 |
NRXN1,FAT3 |
5.486e-03 | -5.21 | mesenchymal-epithelial cell signaling involved in prostate gland development | biological process | GO:0060739 | 2 | 1 | 18204 | 50 |
TNC |
5.486e-03 | -5.21 | negative regulation of monocyte extravasation | biological process | GO:2000438 | 2 | 1 | 18204 | 50 |
PLCB1 |
5.486e-03 | -5.21 | phosphatidylinositol catabolic process | biological process | GO:0031161 | 2 | 1 | 18204 | 50 |
PLCB1 |
5.486e-03 | -5.21 | negative regulation of mini excitatory postsynaptic potential | biological process | GO:0061886 | 2 | 1 | 18204 | 50 |
SYNE1 |
5.486e-03 | -5.21 | activation of meiosis involved in egg activation | biological process | GO:0060466 | 2 | 1 | 18204 | 50 |
PLCB1 |
5.486e-03 | -5.21 | cellular response to fluoride | biological process | GO:1902618 | 2 | 1 | 18204 | 50 |
PLCB1 |
5.500e-03 | -5.20 | UT | pfam domains | PF03253 | 2 | 1 | 17795 | 49 |
SLC14A1 |
5.500e-03 | -5.20 | DUF5050 | pfam domains | PF16472 | 2 | 1 | 17795 | 49 |
LRP1B |
5.500e-03 | -5.20 | Par3_HAL_N_term | pfam domains | PF12053 | 2 | 1 | 17795 | 49 |
PARD3 |
5.500e-03 | -5.20 | SH3-RhoG_link | pfam domains | PF16609 | 2 | 1 | 17795 | 49 |
KALRN |
5.500e-03 | -5.20 | Glyco_hydro_79n | pfam domains | PF03662 | 2 | 1 | 17795 | 49 |
HPSE2 |
5.500e-03 | -5.20 | DUF1154 | pfam domains | PF06631 | 2 | 1 | 17795 | 49 |
PLCB1 |
5.612e-03 | -5.18 | calcium ion transmembrane transporter activity | molecular function | GO:0015085 | 136 | 3 | 18094 | 48 |
RYR3,GPM6A,TRPM3 |
5.614e-03 | -5.18 | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | 2659 | 15 | 16828 | 48 |
SORBS1,CAMK2G,DPP6,CTNND2,LRP1B,FAT3,RYR3,TNC,ADCY2,RORA,MACF1,TRPM3,SYNE1,FMN2,NAV2 |
5.614e-03 | -5.18 | embryonal | COSMIC cancer mutations | embryonal | 2659 | 15 | 16828 | 48 |
CAMK2G,SORBS1,DPP6,CTNND2,LRP1B,RYR3,TNC,FAT3,ADCY2,RORA,MACF1,TRPM3,FMN2,NAV2,SYNE1 |
5.662e-03 | -5.17 | cyclic nucleotide metabolic process | biological process | GO:0009187 | 41 | 2 | 18204 | 50 |
RORA,ADCY2 |
5.670e-03 | -5.17 | Immunoglobulins | gene3d domains | 2.60.40.10 | 721 | 7 | 14470 | 44 |
LSAMP,CNTN1,NTM,TNC,NRCAM,KALRN,NTRK2 |
5.697e-03 | -5.17 | amino acid transport | biological process | GO:0006865 | 132 | 3 | 18204 | 50 |
NTRK2,SLC1A2,SFXN5 |
5.717e-03 | -5.16 | SH2D1A (SH2 domain containing 1A) | protein interactions | 4068 | 44 | 2 | 19454 | 50 |
LRP1B,CAMK2G |
5.766e-03 | -5.16 | phosphorus metabolic process | biological process | GO:0006793 | 1707 | 11 | 18204 | 50 |
MAPK10,ADCY2,NTRK2,DCLK2,ATP1A2,PLCB1,CAMK2G,DGKG,KALRN,RORA,TNIK |
5.767e-03 | -5.16 | sarcolemma | cellular component | GO:0042383 | 142 | 3 | 19108 | 49 |
RYR3,ATP1A2,DTNA |
5.817e-03 | -5.15 | regulation of sequestering of calcium ion | biological process | GO:0051282 | 133 | 3 | 18204 | 50 |
RYR3,PLCB1,ATP1A2 |
5.837e-03 | -5.14 | LAM_G_DOMAIN | prosite domains | PS50025 | 35 | 2 | 12186 | 40 |
NRXN1,FAT3 |
5.862e-03 | -5.14 | SH3 | prosite domains | PS50002 | 222 | 4 | 12186 | 40 |
MACF1,NEBL,KALRN,SORBS1 |
5.922e-03 | -5.13 | SLC6A15 (solute carrier family 6 member 15) | protein interactions | 55117 | 143 | 3 | 19454 | 50 |
SFXN5,NTRK2,PARD3 |
5.922e-03 | -5.13 | GPM6A (glycoprotein M6A) | protein interactions | 2823 | 143 | 3 | 19454 | 50 |
DPP6,CNTN1,NTM |
5.934e-03 | -5.13 | Cholinergic synapse | KEGG pathways | hsa04725 | 112 | 3 | 7161 | 24 |
PLCB1,ADCY2,CAMK2G |
5.935e-03 | -5.13 | Schwann cell development | biological process | GO:0014044 | 42 | 2 | 18204 | 50 |
PARD3,NTRK2 |
5.939e-03 | -5.13 | central_nervous_system-brain-glioma-astrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_III | 1419 | 10 | 16828 | 48 |
GPC5,ADCY2,PLCB1,RYR3,NRG3,HPSE2,NAV2,LRP1B,PARD3,TRPM3 |
5.997e-03 | -5.12 | prostate | COSMIC cancer mutations | prostate | 13883 | 46 | 16828 | 48 |
SLC1A2,SLC4A4,SORBS1,SFXN5,CTNND2,ATP1A2,NTRK2,TRPM3,PARD3,HPSE2,NRXN1,DCLK2,CNTN1,DPP6,RYR3,NRG3,NKAIN3,DTNA,FMN2,NTM,ABLIM1,NHSL1,SLC14A1,PITPNC1,NEBL,NRCAM,RORA,LSAMP,MGAT4C,NAV2,GPM6A,SOX5,TNIK,LRP1B,PLCB1,TNC,FAT3,NAV3,ADCY2,MACF1,GPC5,DGKG,MSI2,RFX4,KALRN,SYNE1 |
6.037e-03 | -5.11 | Calml3 (calmodulin-like 3) | protein interactions | 70405 | 144 | 3 | 19454 | 50 |
CAMK2G,MACF1,ABLIM1 |
6.073e-03 | -5.10 | Vinculin, Vh2 four-helix bundle | gene3d domains | 1.20.120.810 | 2 | 1 | 14470 | 44 |
CTNNA2 |
6.073e-03 | -5.10 | - | gene3d domains | 6.20.350.10 | 2 | 1 | 14470 | 44 |
RYR3 |
6.159e-03 | -5.09 | monoatomic cation transmembrane transporter activity | molecular function | GO:0008324 | 630 | 6 | 18094 | 48 |
RYR3,TRPM3,GPM6A,SLC4A4,ATP1A2,SLC1A2 |
6.190e-03 | -5.08 | skin-leg-malignant_melanoma-nodular | COSMIC cancer mutations | skin-leg-malignant_melanoma-nodular | 258 | 4 | 16828 | 48 |
CNTN1,SLC4A4,FMN2,SYNE1 |
6.190e-03 | -5.08 | lung-carcinoma-bronchioloalveolar_adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-bronchioloalveolar_adenocarcinoma | 778 | 7 | 16828 | 48 |
NTRK2,TNIK,CTNND2,SOX5,ADCY2,DCLK2,CAMK2G |
6.190e-03 | -5.08 | bronchioloalveolar_adenocarcinoma | COSMIC cancer mutations | bronchioloalveolar_adenocarcinoma | 778 | 7 | 16828 | 48 |
CTNND2,NTRK2,TNIK,ADCY2,SOX5,DCLK2,CAMK2G |
6.233e-03 | -5.08 | Glutamatergic synapse | KEGG pathways | hsa04724 | 114 | 3 | 7161 | 24 |
ADCY2,PLCB1,SLC1A2 |
6.233e-03 | -5.08 | Glutamatergic synapse | KEGG pathways | ko04724 | 114 | 3 | 7161 | 24 |
ADCY2,PLCB1,SLC1A2 |
6.237e-03 | -5.08 | cell surface receptor protein tyrosine kinase signaling pathway | biological process | GO:0007169 | 428 | 5 | 18204 | 50 |
KALRN,SORBS1,NRG3,PLCB1,NTRK2 |
6.272e-03 | -5.07 | DSCR9 (Down syndrome critical region 9) | protein interactions | 257203 | 146 | 3 | 19454 | 50 |
SYNE1,KALRN,MACF1 |
6.391e-03 | -5.05 | MOB4 (MOB family member 4, phocein) | protein interactions | 25843 | 147 | 3 | 19454 | 50 |
ABLIM1,TNIK,CAMK2G |
6.435e-03 | -5.05 | cytoskeleton organization | biological process | GO:0007010 | 1251 | 9 | 18204 | 50 |
NEBL,ABLIM1,CTNNA2,PARD3,TNIK,MACF1,DCLK2,SORBS1,FMN2 |
6.441e-03 | -5.05 | membrane raft | cellular component | GO:0045121 | 290 | 4 | 19108 | 49 |
SLC1A2,ADCY2,SORBS1,ATP1A2 |
6.462e-03 | -5.04 | cytoskeleton | cellular component | GO:0005856 | 2412 | 13 | 19108 | 49 |
NAV3,DGKG,SYNE1,PARD3,MACF1,TNIK,SORBS1,FMN2,DTNA,KALRN,NEBL,CTNNA2,ABLIM1 |
6.495e-03 | -5.04 | FORMIN | prints domains | PR00828 | 2 | 1 | 5227 | 17 |
FMN2 |
6.498e-03 | -5.04 | positive regulation of glucose transmembrane transport | biological process | GO:0010828 | 44 | 2 | 18204 | 50 |
SORBS1,SLC1A2 |
6.590e-03 | -5.02 | thyroid-carcinoma | COSMIC cancer mutations | thyroid-carcinoma | 4126 | 20 | 16828 | 48 |
PLCB1,RYR3,FAT3,NAV3,MACF1,GPC5,ADCY2,LSAMP,DGKG,ATP1A2,TRPM3,NAV2,DTNA,SYNE1,PARD3,NRXN1,SOX5,TNIK,LRP1B,CTNND2 |
6.590e-03 | -5.02 | purine ribonucleoside triphosphate binding | molecular function | GO:0035639 | 1804 | 11 | 18094 | 48 |
DGKG,NTRK2,NAV2,ADCY2,CAMK2G,TNIK,ATP1A2,NAV3,MAPK10,DCLK2,KALRN |
6.597e-03 | -5.02 | membrane microdomain | cellular component | GO:0098857 | 292 | 4 | 19108 | 49 |
SLC1A2,ADCY2,SORBS1,ATP1A2 |
6.618e-03 | -5.02 | oligoastrocytoma_Grade_III | COSMIC cancer mutations | oligoastrocytoma_Grade_III | 263 | 4 | 16828 | 48 |
SYNE1,SOX5,SLC1A2,RYR3 |
6.676e-03 | -5.01 | inorganic cation transmembrane transport | biological process | GO:0098662 | 618 | 6 | 18204 | 50 |
ATP1A2,TRPM3,SLC4A4,PLCB1,GPM6A,RYR3 |
6.702e-03 | -5.01 | neurotransmitter transport | biological process | GO:0006836 | 140 | 3 | 18204 | 50 |
ATP1A2,SLC1A2,NRXN1 |
6.743e-03 | -5.00 | PFN1 (profilin 1) | protein interactions | 5216 | 466 | 5 | 19454 | 50 |
FMN2,ABLIM1,NHSL1,MACF1,CAMK2G |
6.757e-03 | -5.00 | NDEL1 (nudE neurodevelopment protein 1 like 1) | protein interactions | 81565 | 150 | 3 | 19454 | 50 |
TNIK,SYNE1,KALRN |
6.788e-03 | -4.99 | acidic amino acid transport | biological process | GO:0015800 | 45 | 2 | 18204 | 50 |
NTRK2,SLC1A2 |
6.853e-03 | -4.98 | cell-cell signaling | biological process | GO:0007267 | 822 | 7 | 18204 | 50 |
PLCB1,TNC,NTRK2,NRXN1,CAMK2G,DTNA,SLC1A2 |
6.875e-03 | -4.98 | transmembrane transport | biological process | GO:0055085 | 1264 | 9 | 18204 | 50 |
RYR3,SFXN5,SLC1A2,SLC14A1,GPM6A,PLCB1,ATP1A2,TRPM3,SLC4A4 |
6.881e-03 | -4.98 | TNIK (TRAF2 and NCK interacting kinase) | protein interactions | 23043 | 151 | 3 | 19454 | 50 |
MACF1,SYNE1,TNIK |
6.884e-03 | -4.98 | large_intestine-adenoma | COSMIC cancer mutations | large_intestine-adenoma | 266 | 4 | 16828 | 48 |
RYR3,NAV3,SOX5,LRP1B |
6.890e-03 | -4.98 | learning or memory | biological process | GO:0007611 | 276 | 4 | 18204 | 50 |
NRXN1,ATP1A2,NTRK2,PLCB1 |
7.021e-03 | -4.96 | Neurotrophin signaling pathway | KEGG pathways | ko04722 | 119 | 3 | 7161 | 24 |
CAMK2G,MAPK10,NTRK2 |
7.021e-03 | -4.96 | Neurotrophin signaling pathway | KEGG pathways | hsa04722 | 119 | 3 | 7161 | 24 |
NTRK2,MAPK10,CAMK2G |
7.084e-03 | -4.95 | neuron recognition | biological process | GO:0008038 | 46 | 2 | 18204 | 50 |
NRCAM,NTM |
7.213e-03 | -4.93 | system process | biological process | GO:0003008 | 2015 | 12 | 18204 | 50 |
RYR3,SLC1A2,CTNNA2,PLCB1,ATP1A2,NTRK2,ABLIM1,NRCAM,DTNA,NRXN1,NAV2,SLC4A4 |
7.295e-03 | -4.92 | haematopoietic_and_lymphoid_tissue-small_intestine-lymphoid_neoplasm-enteropathy_type_T_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-small_intestine-lymphoid_neoplasm-enteropathy_type_T_cell_lymphoma | 45 | 2 | 16828 | 48 |
MACF1,MGAT4C |
7.295e-03 | -4.92 | enteropathy_type_T_cell_lymphoma | COSMIC cancer mutations | enteropathy_type_T_cell_lymphoma | 45 | 2 | 16828 | 48 |
MACF1,MGAT4C |
7.312e-03 | -4.92 | metal ion transport | biological process | GO:0030001 | 630 | 6 | 18204 | 50 |
PLCB1,SLC4A4,TRPM3,ATP1A2,RYR3,GPM6A |
7.330e-03 | -4.92 | MAGI3 (membrane associated guanylate kinase, WW and PDZ domain containing 3) | protein interactions | 260425 | 50 | 2 | 19454 | 50 |
NRCAM,PARD3 |
7.386e-03 | -4.91 | regulation of neuron migration | biological process | GO:2001222 | 47 | 2 | 18204 | 50 |
CTNNA2,NRG3 |
7.386e-03 | -4.91 | Schwann cell differentiation | biological process | GO:0014037 | 47 | 2 | 18204 | 50 |
NTRK2,PARD3 |
7.455e-03 | -4.90 | PROTEIN_KINASE_ATP | prosite domains | PS00107 | 377 | 5 | 12186 | 40 |
DCLK2,NTRK2,TNIK,KALRN,CAMK2G |
7.521e-03 | -4.89 | adult behavior | biological process | GO:0030534 | 146 | 3 | 18204 | 50 |
NRXN1,SLC1A2,ATP1A2 |
7.525e-03 | -4.89 | CEP19 (centrosomal protein 19) | protein interactions | 84984 | 156 | 3 | 19454 | 50 |
FMN2,PARD3,ABLIM1 |
7.586e-03 | -4.88 | regulation of localization | biological process | GO:0032879 | 2028 | 12 | 18204 | 50 |
DPP6,GPC5,CAMK2G,PLCB1,SYNE1,SORBS1,ATP1A2,DCLK2,NKAIN3,RYR3,SLC1A2,CNTN1 |
7.617e-03 | -4.88 | FAM171B (family with sequence similarity 171 member B) | protein interactions | 165215 | 51 | 2 | 19454 | 50 |
NTRK2,PARD3 |
7.617e-03 | -4.88 | Ndc80 (NDC80 kinetochore complex component) | protein interactions | 67052 | 51 | 2 | 19454 | 50 |
NHSL1,MACF1 |
7.646e-03 | -4.87 | monoatomic cation transmembrane transport | biological process | GO:0098655 | 636 | 6 | 18204 | 50 |
SLC4A4,GPM6A,ATP1A2,TRPM3,PLCB1,RYR3 |
7.675e-03 | -4.87 | S_TKc | smart domains | SM00220 | 348 | 5 | 9717 | 35 |
MAPK10,CAMK2G,KALRN,DCLK2,TNIK |
7.691e-03 | -4.87 | Itgb1 (integrin subunit beta 1) | protein interactions | 24511 | 3 | 1 | 19454 | 50 |
TNC |
7.691e-03 | -4.87 | Lrrc7 (leucine rich repeat containing 7) | protein interactions | 117284 | 3 | 1 | 19454 | 50 |
CAMK2G |
7.691e-03 | -4.87 | QRFPR (pyroglutamylated RFamide peptide receptor) | protein interactions | 84109 | 3 | 1 | 19454 | 50 |
NTM |
7.691e-03 | -4.87 | TULP1 (TUB like protein 1) | protein interactions | 7287 | 3 | 1 | 19454 | 50 |
NRXN1 |
7.691e-03 | -4.87 | BCO1 (beta-carotene oxygenase 1) | protein interactions | 53630 | 3 | 1 | 19454 | 50 |
ABLIM1 |
7.832e-03 | -4.85 | response to organic cyclic compound | biological process | GO:0014070 | 843 | 7 | 18204 | 50 |
RORA,ATP1A2,TNC,PLCB1,ADCY2,SLC1A2,RYR3 |
7.909e-03 | -4.84 | SH2B2 (SH2B adaptor protein 2) | protein interactions | 10603 | 52 | 2 | 19454 | 50 |
SORBS1,NTRK2 |
7.938e-03 | -4.84 | JUN kinase activity | molecular function | GO:0004705 | 3 | 1 | 18094 | 48 |
MAPK10 |
7.938e-03 | -4.84 | cysteine transmembrane transporter activity | molecular function | GO:0033229 | 3 | 1 | 18094 | 48 |
SLC1A2 |
7.938e-03 | -4.84 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity | molecular function | GO:0008454 | 3 | 1 | 18094 | 48 |
MGAT4C |
7.938e-03 | -4.84 | urea channel activity | molecular function | GO:0015265 | 3 | 1 | 18094 | 48 |
SLC14A1 |
8.007e-03 | -4.83 | modulation of excitatory postsynaptic potential | biological process | GO:0098815 | 49 | 2 | 18204 | 50 |
NRXN1,SYNE1 |
8.021e-03 | -4.83 | YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta) | protein interactions | 7534 | 1138 | 8 | 19454 | 50 |
SORBS1,PARD3,ABLIM1,NAV2,CAMK2G,NHSL1,PITPNC1,MACF1 |
8.030e-03 | -4.82 | Non-integrin membrane-ECM interactions | REACTOME pathways | R-HSA-3000171 | 45 | 2 | 10285 | 31 |
NRXN1,TNC |
8.078e-03 | -4.82 | DAG_kinase_typeI_N | interpro domains | IPR029477 | 3 | 1 | 18521 | 50 |
DGKG |
8.078e-03 | -4.82 | ROR_rcpt | interpro domains | IPR003079 | 3 | 1 | 18521 | 50 |
RORA |
8.078e-03 | -4.82 | SPRY2_RyR | interpro domains | IPR035764 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | Ryan_recept | interpro domains | IPR013333 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | Myelin_PLP | interpro domains | IPR001614 | 3 | 1 | 18521 | 50 |
GPM6A |
8.078e-03 | -4.82 | NR_DBD_ROR | interpro domains | IPR044101 | 3 | 1 | 18521 | 50 |
RORA |
8.078e-03 | -4.82 | NTRK_LRRCT | interpro domains | IPR031635 | 3 | 1 | 18521 | 50 |
NTRK2 |
8.078e-03 | -4.82 | RYDR_Jsol | interpro domains | IPR048581 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | SPRY3_RyR | interpro domains | IPR035762 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | Myelin_PLP_CS | interpro domains | IPR018237 | 3 | 1 | 18521 | 50 |
GPM6A |
8.078e-03 | -4.82 | Vinculin_CS | interpro domains | IPR000633 | 3 | 1 | 18521 | 50 |
CTNNA2 |
8.078e-03 | -4.82 | SPRY1_RyR | interpro domains | IPR035761 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | Ryanrecept_TM4-6 | interpro domains | IPR009460 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | SoHo_dom | interpro domains | IPR003127 | 3 | 1 | 18521 | 50 |
SORBS1 |
8.078e-03 | -4.82 | Ryanodine_rcpt | interpro domains | IPR003032 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | DGK_typeI_N_sf | interpro domains | IPR038199 | 3 | 1 | 18521 | 50 |
DGKG |
8.078e-03 | -4.82 | PLC-beta_C | interpro domains | IPR014815 | 3 | 1 | 18521 | 50 |
PLCB1 |
8.078e-03 | -4.82 | NTRK | interpro domains | IPR020777 | 3 | 1 | 18521 | 50 |
NTRK2 |
8.078e-03 | -4.82 | Neuregulin | interpro domains | IPR040180 | 3 | 1 | 18521 | 50 |
NRG3 |
8.078e-03 | -4.82 | MAPK_JNK | interpro domains | IPR008351 | 3 | 1 | 18521 | 50 |
MAPK10 |
8.078e-03 | -4.82 | AKAP6/CEP68 | interpro domains | IPR026696 | 3 | 1 | 18521 | 50 |
SYNE1 |
8.218e-03 | -4.80 | vagus nerve development | biological process | GO:0021564 | 3 | 1 | 18204 | 50 |
NAV2 |
8.218e-03 | -4.80 | meiotic chromosome movement towards spindle pole | biological process | GO:0016344 | 3 | 1 | 18204 | 50 |
FMN2 |
8.218e-03 | -4.80 | nuclear matrix anchoring at nuclear membrane | biological process | GO:0090292 | 3 | 1 | 18204 | 50 |
SYNE1 |
8.218e-03 | -4.80 | cysteine transport | biological process | GO:0042883 | 3 | 1 | 18204 | 50 |
SLC1A2 |
8.218e-03 | -4.80 | formin-nucleated actin cable assembly | biological process | GO:0070649 | 3 | 1 | 18204 | 50 |
FMN2 |
8.218e-03 | -4.80 | cysteine transmembrane transport | biological process | GO:1903712 | 3 | 1 | 18204 | 50 |
SLC1A2 |
8.218e-03 | -4.80 | response to ionomycin | biological process | GO:1904636 | 3 | 1 | 18204 | 50 |
PLCB1 |
8.218e-03 | -4.80 | formin-nucleated actin cable organization | biological process | GO:0110009 | 3 | 1 | 18204 | 50 |
FMN2 |
8.218e-03 | -4.80 | regulation of retrograde trans-synaptic signaling by endocanabinoid | biological process | GO:0099178 | 3 | 1 | 18204 | 50 |
PLCB1 |
8.218e-03 | -4.80 | regulation of calcium:sodium antiporter activity | biological process | GO:1903279 | 3 | 1 | 18204 | 50 |
ATP1A2 |
8.218e-03 | -4.80 | bud outgrowth involved in lung branching | biological process | GO:0060447 | 3 | 1 | 18204 | 50 |
TNC |
8.218e-03 | -4.80 | cellular response to ionomycin | biological process | GO:1904637 | 3 | 1 | 18204 | 50 |
PLCB1 |
8.218e-03 | -4.80 | neuroligin clustering involved in postsynaptic membrane assembly | biological process | GO:0097118 | 3 | 1 | 18204 | 50 |
NRXN1 |
8.218e-03 | -4.80 | trans-synaptic signaling by BDNF, modulating synaptic transmission | biological process | GO:0099183 | 3 | 1 | 18204 | 50 |
NTRK2 |
8.218e-03 | -4.80 | cardiac muscle thin filament assembly | biological process | GO:0071691 | 3 | 1 | 18204 | 50 |
NEBL |
8.218e-03 | -4.80 | radial glia guided migration of Purkinje cell | biological process | GO:0021942 | 3 | 1 | 18204 | 50 |
CTNNA2 |
8.218e-03 | -4.80 | mammary placode formation | biological process | GO:0060596 | 3 | 1 | 18204 | 50 |
NRG3 |
8.220e-03 | -4.80 | skin-back-malignant_melanoma | COSMIC cancer mutations | skin-back-malignant_melanoma | 280 | 4 | 16828 | 48 |
ATP1A2,TNIK,LRP1B,SYNE1 |
8.238e-03 | -4.80 | LRRCT_2 | pfam domains | PF16920 | 3 | 1 | 17795 | 49 |
NTRK2 |
8.238e-03 | -4.80 | RyR | pfam domains | PF02026 | 3 | 1 | 17795 | 49 |
RYR3 |
8.238e-03 | -4.80 | Sorb | pfam domains | PF02208 | 3 | 1 | 17795 | 49 |
SORBS1 |
8.238e-03 | -4.80 | RR_TM4-6 | pfam domains | PF06459 | 3 | 1 | 17795 | 49 |
RYR3 |
8.238e-03 | -4.80 | Myelin_PLP | pfam domains | PF01275 | 3 | 1 | 17795 | 49 |
GPM6A |
8.238e-03 | -4.80 | DAG_kinase_N | pfam domains | PF14513 | 3 | 1 | 17795 | 49 |
DGKG |
8.238e-03 | -4.80 | PLC-beta_C | pfam domains | PF08703 | 3 | 1 | 17795 | 49 |
PLCB1 |
8.238e-03 | -4.80 | SR_plectin_7 | pfam domains | PF21097 | 3 | 1 | 17795 | 49 |
MACF1 |
8.238e-03 | -4.80 | RYDR_Jsol | pfam domains | PF21119 | 3 | 1 | 17795 | 49 |
RYR3 |
8.244e-03 | -4.80 | transmembrane transporter activity | molecular function | GO:0022857 | 1110 | 8 | 18094 | 48 |
TRPM3,GPM6A,RYR3,SLC4A4,SLC14A1,SFXN5,ATP1A2,SLC1A2 |
8.266e-03 | -4.80 | central_nervous_system-temporoparietal-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-temporoparietal-glioma-astrocytoma_Grade_IV | 48 | 2 | 16828 | 48 |
PARD3,RYR3 |
8.317e-03 | -4.79 | synaptic signaling | biological process | GO:0099536 | 459 | 5 | 18204 | 50 |
PLCB1,NRXN1,SLC1A2,NTRK2,DTNA |
8.343e-03 | -4.79 | DSCAM (DS cell adhesion molecule) | protein interactions | 1826 | 162 | 3 | 19454 | 50 |
SYNE1,KALRN,MACF1 |
8.398e-03 | -4.78 | cell-cell adhesion mediator activity | molecular function | GO:0098632 | 52 | 2 | 18094 | 48 |
CNTN1,NRCAM |
8.476e-03 | -4.77 | sodium ion transmembrane transporter activity | molecular function | GO:0015081 | 158 | 3 | 18094 | 48 |
ATP1A2,SLC1A2,SLC4A4 |
8.480e-03 | -4.77 | nuclear membrane | cellular component | GO:0031965 | 314 | 4 | 19108 | 49 |
NRXN1,PLCB1,NAV3,SYNE1 |
8.541e-03 | -4.76 | protein localization to membrane | biological process | GO:0072657 | 462 | 5 | 18204 | 50 |
MACF1,TNIK,NRXN1,PARD3,DPP6 |
8.554e-03 | -4.76 | SNCA (synuclein alpha) | protein interactions | 6622 | 696 | 6 | 19454 | 50 |
PLCB1,CAMK2G,MACF1,NTRK2,TNIK,GPM6A |
8.620e-03 | -4.75 | purine ribonucleotide binding | molecular function | GO:0032555 | 1871 | 11 | 18094 | 48 |
TNIK,CAMK2G,MAPK10,NAV2,ADCY2,DGKG,NTRK2,NAV3,ATP1A2,KALRN,DCLK2 |
8.702e-03 | -4.74 | hindbrain development | biological process | GO:0030902 | 154 | 3 | 18204 | 50 |
CTNNA2,RORA,CNTN1 |
8.730e-03 | -4.74 | Cardiac conduction | REACTOME pathways | R-HSA-5576891 | 142 | 3 | 10285 | 31 |
CAMK2G,RYR3,ATP1A2 |
8.736e-03 | -4.74 | PLC beta mediated events | REACTOME pathways | R-HSA-112043 | 47 | 2 | 10285 | 31 |
ADCY2,PLCB1 |
8.748e-03 | -4.74 | ZYX (zyxin) | protein interactions | 7791 | 316 | 4 | 19454 | 50 |
SORBS1,NEBL,ABLIM1,MACF1 |
8.814e-03 | -4.73 | SYN1 (synapsin I) | protein interactions | 6853 | 55 | 2 | 19454 | 50 |
GPM6A,CAMK2G |
8.814e-03 | -4.73 | PLCB1 (phospholipase C beta 1) | protein interactions | 23236 | 55 | 2 | 19454 | 50 |
PARD3,PLCB1 |
8.846e-03 | -4.73 | regulation of monoatomic ion transport | biological process | GO:0043269 | 466 | 5 | 18204 | 50 |
DPP6,NKAIN3,CNTN1,CAMK2G,ATP1A2 |
8.869e-03 | -4.73 | mannosyl-glycoprotein N-acetylglucosaminyltransferases | BIOCYC pathways | META_PWY-7426 | 8 | 1 | 902 | 1 |
MGAT4C |
8.917e-03 | -4.72 | SCLT1 (sodium channel and clathrin linker 1) | protein interactions | 132320 | 166 | 3 | 19454 | 50 |
ATP1A2,NEBL,ABLIM1 |
8.954e-03 | -4.72 | Dopaminergic synapse | KEGG pathways | ko04728 | 130 | 3 | 7161 | 24 |
PLCB1,MAPK10,CAMK2G |
8.954e-03 | -4.72 | Dopaminergic synapse | KEGG pathways | hsa04728 | 130 | 3 | 7161 | 24 |
MAPK10,CAMK2G,PLCB1 |
9.013e-03 | -4.71 | retina development in camera-type eye | biological process | GO:0060041 | 156 | 3 | 18204 | 50 |
NTRK2,GPM6A,FAT3 |
9.023e-03 | -4.71 | LamG | smart domains | SM00282 | 40 | 2 | 9717 | 35 |
FAT3,NRXN1 |
9.095e-03 | -4.70 | - | gene3d domains | 6.10.250.2510 | 3 | 1 | 14470 | 44 |
CTNNA2 |
9.095e-03 | -4.70 | Diacylglycerol kinase alpha | gene3d domains | 1.10.238.110 | 3 | 1 | 14470 | 44 |
DGKG |
9.095e-03 | -4.70 | - | gene3d domains | 1.10.490.160 | 3 | 1 | 14470 | 44 |
RYR3 |
9.098e-03 | -4.70 | G-protein mediated events | REACTOME pathways | R-HSA-112040 | 48 | 2 | 10285 | 31 |
PLCB1,ADCY2 |
9.125e-03 | -4.70 | L1CAM (L1 cell adhesion molecule) | protein interactions | 3897 | 56 | 2 | 19454 | 50 |
GPM6A,CNTN1 |
9.207e-03 | -4.69 | ribonucleotide binding | molecular function | GO:0032553 | 1888 | 11 | 18094 | 48 |
DCLK2,KALRN,ATP1A2,NAV2,ADCY2,NAV3,DGKG,NTRK2,TNIK,CAMK2G,MAPK10 |
9.280e-03 | -4.68 | transferase activity, transferring phosphorus-containing groups | molecular function | GO:0016772 | 903 | 7 | 18094 | 48 |
MAPK10,CAMK2G,TNIK,NTRK2,DGKG,KALRN,DCLK2 |
9.295e-03 | -4.68 | MAPRE1 (microtubule associated protein RP/EB family member 1) | protein interactions | 22919 | 504 | 5 | 19454 | 50 |
NAV3,MACF1,CAMK2G,NAV2,ABLIM1 |
9.417e-03 | -4.67 | Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | REACTOME pathways | R-HSA-112314 | 146 | 3 | 10285 | 31 |
CAMK2G,PLCB1,ADCY2 |
9.442e-03 | -4.66 | NXPH3 (neurexophilin 3) | protein interactions | 11248 | 57 | 2 | 19454 | 50 |
CTNNA2,NRXN1 |
9.541e-03 | -4.65 | Ig-like_dom_sf | interpro domains | IPR036179 | 483 | 5 | 18521 | 50 |
CNTN1,NTRK2,NRCAM,LSAMP,NTM |
9.564e-03 | -4.65 | side of membrane | cellular component | GO:0098552 | 715 | 6 | 19108 | 49 |
LSAMP,DTNA,GPC5,NTM,CNTN1,NRCAM |
9.616e-03 | -4.64 | Calcium Regulation in the Cardiac Cell | WikiPathways | WP536 | 151 | 3 | 5310 | 16 |
RYR3,ADCY2,CAMK2G |
9.663e-03 | -4.64 | response to abiotic stimulus | biological process | GO:0009628 | 1100 | 8 | 18204 | 50 |
TNC,FMN2,SYNE1,NRXN1,ATP1A2,RORA,SLC1A2,MAPK10 |
9.686e-03 | -4.64 | Disopyramide Action Pathway | SMPDB pathways | SMP0000325 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Quinidine Action Pathway | SMPDB pathways | SMP0000323 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Timolol Action Pathway | SMPDB pathways | SMP0000659 | 57 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
9.686e-03 | -4.64 | Dobutamine Action Pathway | SMPDB pathways | SMP0000662 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Mexiletine Action Pathway | SMPDB pathways | SMP0000329 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Nimodipine Action Pathway | SMPDB pathways | SMP0000380 | 57 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
9.686e-03 | -4.64 | Amlodipine Action Pathway | SMPDB pathways | SMP0000376 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Amiodarone Action Pathway | SMPDB pathways | SMP0000665 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Isoprenaline Action Pathway | SMPDB pathways | SMP0000663 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Betaxolol Action Pathway | SMPDB pathways | SMP0000299 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Practolol Action Pathway | SMPDB pathways | SMP0000669 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Nebivolol Action Pathway | SMPDB pathways | SMP0000366 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Pindolol Action Pathway | SMPDB pathways | SMP0000306 | 57 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
9.686e-03 | -4.64 | Bopindolol Action Pathway | SMPDB pathways | SMP0000657 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Epinephrine Action Pathway | SMPDB pathways | SMP0000661 | 57 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
9.686e-03 | -4.64 | Oxprenolol Action Pathway | SMPDB pathways | SMP0000304 | 57 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
9.686e-03 | -4.64 | Alprenolol Action Pathway | SMPDB pathways | SMP0000297 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Metipranolol Action Pathway | SMPDB pathways | SMP0000667 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Isradipine Action Pathway | SMPDB pathways | SMP0000378 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Muscle/Heart Contraction | SMPDB pathways | SMP0000588 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Tocainide Action Pathway | SMPDB pathways | SMP0000330 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Bisoprolol Action Pathway | SMPDB pathways | SMP0000300 | 57 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
9.686e-03 | -4.64 | Ibutilide Action Pathway | SMPDB pathways | SMP0000332 | 57 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
9.686e-03 | -4.64 | Metoprolol Action Pathway | SMPDB pathways | SMP0000302 | 57 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
9.686e-03 | -4.64 | Carteolol Action Pathway | SMPDB pathways | SMP0000658 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Felodipine Action Pathway | SMPDB pathways | SMP0000377 | 57 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
9.686e-03 | -4.64 | Nisoldipine Action Pathway | SMPDB pathways | SMP0000381 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Penbutolol Action Pathway | SMPDB pathways | SMP0000305 | 57 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
9.686e-03 | -4.64 | Atenolol Action Pathway | SMPDB pathways | SMP0000298 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Nadolol Action Pathway | SMPDB pathways | SMP0000303 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Bevantolol Action Pathway | SMPDB pathways | SMP0000668 | 57 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
9.686e-03 | -4.64 | Bupranolol Action Pathway | SMPDB pathways | SMP0000670 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Levobunolol Action Pathway | SMPDB pathways | SMP0000666 | 57 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
9.686e-03 | -4.64 | Procainamide (Antiarrhythmic) Action Pathway | SMPDB pathways | SMP0000324 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Flecainide Action Pathway | SMPDB pathways | SMP0000331 | 57 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
9.686e-03 | -4.64 | Esmolol Action Pathway | SMPDB pathways | SMP0000301 | 57 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
9.686e-03 | -4.64 | Acebutolol Action Pathway | SMPDB pathways | SMP0000296 | 57 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
9.686e-03 | -4.64 | Sotalol Action Pathway | SMPDB pathways | SMP0000660 | 57 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
9.686e-03 | -4.64 | Nitrendipine Action Pathway | SMPDB pathways | SMP0000382 | 57 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
9.686e-03 | -4.64 | Verapamil Action Pathway | SMPDB pathways | SMP0000375 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Fosphenytoin (Antiarrhythmic) Action Pathway | SMPDB pathways | SMP0000326 | 57 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
9.686e-03 | -4.64 | Arbutamine Action Pathway | SMPDB pathways | SMP0000664 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Nifedipine Action Pathway | SMPDB pathways | SMP0000379 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Propranolol Action Pathway | SMPDB pathways | SMP0000307 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.686e-03 | -4.64 | Diltiazem Action Pathway | SMPDB pathways | SMP0000359 | 57 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
9.714e-03 | -4.63 | cell motility | biological process | GO:0048870 | 1101 | 8 | 18204 | 50 |
NRG3,NRCAM,GPM6A,CTNNA2,FAT3,FMN2,GPC5,NTRK2 |
9.727e-03 | -4.63 | NTKRECEPTOR | prints domains | PR01939 | 3 | 1 | 5227 | 17 |
NTRK2 |
9.727e-03 | -4.63 | RYANODINER | prints domains | PR00795 | 3 | 1 | 5227 | 17 |
RYR3 |
9.727e-03 | -4.63 | JNKMAPKINASE | prints domains | PR01772 | 3 | 1 | 5227 | 17 |
MAPK10 |
9.727e-03 | -4.63 | MYELINPLP | prints domains | PR00214 | 3 | 1 | 5227 | 17 |
GPM6A |
9.727e-03 | -4.63 | RORNUCRECPTR | prints domains | PR01293 | 3 | 1 | 5227 | 17 |
RORA |
9.749e-03 | -4.63 | Gastrin-CREB signalling pathway via PKC and MAPK | REACTOME pathways | R-HSA-881907 | 443 | 5 | 10285 | 31 |
NRG3,PLCB1,DGKG,CAMK2G,KALRN |
9.763e-03 | -4.63 | CILK1 (ciliogenesis associated kinase 1) | protein interactions | 22858 | 58 | 2 | 19454 | 50 |
CAMK2G,MSI2 |
9.816e-03 | -4.62 | VINCULIN_1 | prosite domains | PS00663 | 3 | 1 | 12186 | 40 |
CTNNA2 |
9.816e-03 | -4.62 | MYELIN_PLP_2 | prosite domains | PS01004 | 3 | 1 | 12186 | 40 |
GPM6A |
9.816e-03 | -4.62 | SOHO | prosite domains | PS50831 | 3 | 1 | 12186 | 40 |
SORBS1 |
9.816e-03 | -4.62 | MYELIN_PLP_1 | prosite domains | PS00575 | 3 | 1 | 12186 | 40 |
GPM6A |
9.833e-03 | -4.62 | ROR2 (receptor tyrosine kinase like orphan receptor 2) | protein interactions | 4920 | 327 | 4 | 19454 | 50 |
SORBS1,PARD3,TNIK,DTNA |
9.834e-03 | -4.62 | large_intestine-colon | COSMIC cancer mutations | large_intestine-colon | 1291 | 9 | 16828 | 48 |
SYNE1,KALRN,LRP1B,DPP6,NAV2,FMN2,TNC,ADCY2,NAV3 |
9.871e-03 | -4.62 | cell-cell junction | cellular component | GO:0005911 | 513 | 5 | 19108 | 49 |
CTNNA2,ATP1A2,PARD3,CTNND2,SORBS1 |
1.002e-02 | -4.60 | Labetalol Action Pathway | SMPDB pathways | SMP0000368 | 58 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
1.002e-02 | -4.60 | Carvedilol Action Pathway | SMPDB pathways | SMP0000367 | 58 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
1.022e-02 | -4.58 | extrinsic component of membrane | cellular component | GO:0019898 | 175 | 3 | 19108 | 49 |
KALRN,DTNA,CTNNA2 |
1.022e-02 | -4.58 | tenascin complex | cellular component | GO:0090733 | 4 | 1 | 19108 | 49 |
TNC |
1.022e-02 | -4.58 | internode region of axon | cellular component | GO:0033269 | 4 | 1 | 19108 | 49 |
PARD3 |
1.024e-02 | -4.58 | IGKV@ (immunoglobulin kappa variable cluster) | protein interactions | 3519 | 4 | 1 | 19454 | 50 |
LRP1B |
1.024e-02 | -4.58 | CALML4 (calmodulin like 4) | protein interactions | 91860 | 4 | 1 | 19454 | 50 |
CAMK2G |
1.024e-02 | -4.58 | Nme2 (NME/NM23 nucleoside diphosphate kinase 2) | protein interactions | 18103 | 4 | 1 | 19454 | 50 |
RORA |
1.024e-02 | -4.58 | CCDC126 (coiled-coil domain containing 126) | protein interactions | 90693 | 4 | 1 | 19454 | 50 |
GPM6A |
1.024e-02 | -4.58 | CLBA1 (clathrin binding box of aftiphilin containing 1) | protein interactions | 122616 | 4 | 1 | 19454 | 50 |
FAT3 |
1.036e-02 | -4.57 | release of sequestered calcium ion into cytosol | biological process | GO:0051209 | 56 | 2 | 18204 | 50 |
PLCB1,RYR3 |
1.036e-02 | -4.57 | Lidocaine (Antiarrhythmic) Action Pathway | SMPDB pathways | SMP0000328 | 59 | 2 | 1369 | 4 |
PLCB1,ATP1A2 |
1.040e-02 | -4.57 | export from cell | biological process | GO:0140352 | 485 | 5 | 18204 | 50 |
CAMK2G,NTRK2,SLC4A4,NRXN1,ATP1A2 |
1.041e-02 | -4.57 | parathyroid-carcinoma | COSMIC cancer mutations | parathyroid-carcinoma | 300 | 4 | 16828 | 48 |
MACF1,GPC5,SYNE1,RYR3 |
1.042e-02 | -4.56 | BTN2A1 (butyrophilin subfamily 2 member A1) | protein interactions | 11120 | 60 | 2 | 19454 | 50 |
FMN2,PLCB1 |
1.050e-02 | -4.56 | response to light stimulus | biological process | GO:0009416 | 312 | 4 | 18204 | 50 |
SLC1A2,MAPK10,ATP1A2,SYNE1 |
1.054e-02 | -4.55 | Apelin signaling pathway | KEGG pathways | hsa04371 | 138 | 3 | 7161 | 24 |
ADCY2,RYR3,PLCB1 |
1.057e-02 | -4.55 | ryanodine-sensitive calcium-release channel activity | molecular function | GO:0005219 | 4 | 1 | 18094 | 48 |
RYR3 |
1.057e-02 | -4.55 | citrate transmembrane transporter activity | molecular function | GO:0015137 | 4 | 1 | 18094 | 48 |
SFXN5 |
1.057e-02 | -4.55 | brain-derived neurotrophic factor binding | molecular function | GO:0048403 | 4 | 1 | 18094 | 48 |
NTRK2 |
1.057e-02 | -4.55 | tricarboxylic acid transmembrane transporter activity | molecular function | GO:0015142 | 4 | 1 | 18094 | 48 |
SFXN5 |
1.058e-02 | -4.55 | astrocytoma_Grade_III | COSMIC cancer mutations | astrocytoma_Grade_III | 1544 | 10 | 16828 | 48 |
ADCY2,GPC5,PLCB1,RYR3,NRG3,HPSE2,NAV2,LRP1B,PARD3,TRPM3 |
1.062e-02 | -4.55 | Endocrine and other factor-regulated calcium reabsorption | KEGG pathways | hsa04961 | 47 | 2 | 7161 | 24 |
PLCB1,ATP1A2 |
1.062e-02 | -4.55 | Endocrine and other factor-regulated calcium reabsorption | KEGG pathways | ko04961 | 47 | 2 | 7161 | 24 |
ATP1A2,PLCB1 |
1.072e-02 | -4.54 | negative regulation of sequestering of calcium ion | biological process | GO:0051283 | 57 | 2 | 18204 | 50 |
PLCB1,RYR3 |
1.072e-02 | -4.54 | visual behavior | biological process | GO:0007632 | 57 | 2 | 18204 | 50 |
ATP1A2,SLC1A2 |
1.076e-02 | -4.53 | PCN-like_spectrin-like_rpt | interpro domains | IPR049538 | 4 | 1 | 18521 | 50 |
MACF1 |
1.076e-02 | -4.53 | PLC-beta_PH | interpro domains | IPR037862 | 4 | 1 | 18521 | 50 |
PLCB1 |
1.076e-02 | -4.53 | PLC-beta_C_sf | interpro domains | IPR042531 | 4 | 1 | 18521 | 50 |
PLCB1 |
1.076e-02 | -4.53 | AbLIM_anchor | interpro domains | IPR032402 | 4 | 1 | 18521 | 50 |
ABLIM1 |
1.076e-02 | -4.53 | Nebulin_repeat | interpro domains | IPR000900 | 4 | 1 | 18521 | 50 |
NEBL |
1.076e-02 | -4.53 | Neurofascin/L1/NrCAM_C | interpro domains | IPR026966 | 4 | 1 | 18521 | 50 |
NRCAM |
1.076e-02 | -4.53 | NHS-like | interpro domains | IPR024845 | 4 | 1 | 18521 | 50 |
NHSL1 |
1.076e-02 | -4.53 | Ca/CaM-dep_prot_kinase-assoc | interpro domains | IPR013543 | 4 | 1 | 18521 | 50 |
CAMK2G |
1.076e-02 | -4.53 | PLC-beta | interpro domains | IPR016280 | 4 | 1 | 18521 | 50 |
PLCB1 |
1.076e-02 | -4.53 | Desmoplakin_Spectrin-like | interpro domains | IPR041573 | 4 | 1 | 18521 | 50 |
MACF1 |
1.076e-02 | -4.53 | KASH | interpro domains | IPR012315 | 4 | 1 | 18521 | 50 |
SYNE1 |
1.076e-02 | -4.53 | TRPM_tetra_sf | interpro domains | IPR037162 | 4 | 1 | 18521 | 50 |
TRPM3 |
1.076e-02 | -4.53 | Glyco_transf_54 | interpro domains | IPR006759 | 4 | 1 | 18521 | 50 |
MGAT4C |
1.076e-02 | -4.53 | TRPM_tetra | interpro domains | IPR032415 | 4 | 1 | 18521 | 50 |
TRPM3 |
1.076e-02 | -4.53 | Alpha_catenin | interpro domains | IPR001033 | 4 | 1 | 18521 | 50 |
CTNNA2 |
1.076e-02 | -4.53 | Na/K-Atpase_Interacting | interpro domains | IPR008516 | 4 | 1 | 18521 | 50 |
NKAIN3 |
1.077e-02 | -4.53 | oligodendroglioma_Grade_III | COSMIC cancer mutations | oligodendroglioma_Grade_III | 303 | 4 | 16828 | 48 |
NAV2,SYNE1,MACF1,MGAT4C |
1.077e-02 | -4.53 | Sorb | smart domains | SM00459 | 3 | 1 | 9717 | 35 |
SORBS1 |
1.077e-02 | -4.53 | PLP | smart domains | SM00002 | 3 | 1 | 9717 | 35 |
GPM6A |
1.077e-02 | -4.53 | ERBB4 (erb-b2 receptor tyrosine kinase 4) | protein interactions | 2066 | 178 | 3 | 19454 | 50 |
NTRK2,KALRN,NRG3 |
1.077e-02 | -4.53 | CEP63 (centrosomal protein 63) | protein interactions | 80254 | 178 | 3 | 19454 | 50 |
MACF1,SYNE1,TNIK |
1.082e-02 | -4.53 | positive regulation of cellular component organization | biological process | GO:0051130 | 1122 | 8 | 18204 | 50 |
CNTN1,GPM6A,NRXN1,MACF1,NTRK2,PLCB1,NAV3,SYNE1 |
1.084e-02 | -4.52 | lung-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-squamous_cell_carcinoma | 14664 | 47 | 16828 | 48 |
TRPM3,ATP1A2,NTRK2,PARD3,SLC1A2,SLC4A4,SORBS1,SFXN5,CTNND2,NRG3,RYR3,NKAIN3,DTNA,FMN2,NTM,HPSE2,NRXN1,DCLK2,CNTN1,DPP6,NEBL,LSAMP,RORA,NRCAM,MGAT4C,GPM6A,NAV2,ABLIM1,PITPNC1,NHSL1,SLC14A1,FAT3,PLCB1,TNC,ADCY2,GPC5,MACF1,NAV3,DGKG,RFX4,SYNE1,KALRN,MSI2,SOX5,CAMK2G,TNIK,LRP1B |
1.085e-02 | -4.52 | adrenal_cortical_adenoma | COSMIC cancer mutations | adrenal_cortical_adenoma | 161 | 3 | 16828 | 48 |
LRP1B,ADCY2,FMN2 |
1.088e-02 | -4.52 | Myometrial Relaxation and Contraction Pathways | WikiPathways | WP289 | 158 | 3 | 5310 | 16 |
CAMK2G,ADCY2,RYR3 |
1.094e-02 | -4.52 | germ_cell_tumour | COSMIC cancer mutations | germ_cell_tumour | 867 | 7 | 16828 | 48 |
SYNE1,NTRK2,TNIK,CNTN1,MACF1,DCLK2,CAMK2G |
1.094e-02 | -4.52 | positive regulation of mesenchymal stem cell differentiation | biological process | GO:2000741 | 4 | 1 | 18204 | 50 |
SOX5 |
1.094e-02 | -4.52 | response to fluoride | biological process | GO:1902617 | 4 | 1 | 18204 | 50 |
PLCB1 |
1.094e-02 | -4.52 | trans-synaptic signaling by BDNF | biological process | GO:0099191 | 4 | 1 | 18204 | 50 |
NTRK2 |
1.094e-02 | -4.52 | regulation of amino acid uptake involved in synaptic transmission | biological process | GO:0051941 | 4 | 1 | 18204 | 50 |
ATP1A2 |
1.094e-02 | -4.52 | brain-derived neurotrophic factor receptor signaling pathway | biological process | GO:0031547 | 4 | 1 | 18204 | 50 |
NTRK2 |
1.094e-02 | -4.52 | nuclear matrix organization | biological process | GO:0043578 | 4 | 1 | 18204 | 50 |
SYNE1 |
1.094e-02 | -4.52 | regulation of mini excitatory postsynaptic potential | biological process | GO:0061884 | 4 | 1 | 18204 | 50 |
SYNE1 |
1.094e-02 | -4.52 | response to glycoside | biological process | GO:1903416 | 4 | 1 | 18204 | 50 |
ATP1A2 |
1.094e-02 | -4.52 | regulation of glutamate uptake involved in transmission of nerve impulse | biological process | GO:0051946 | 4 | 1 | 18204 | 50 |
ATP1A2 |
1.094e-02 | -4.52 | regulation of systemic arterial blood pressure by baroreceptor feedback | biological process | GO:0003025 | 4 | 1 | 18204 | 50 |
NAV2 |
1.094e-02 | -4.52 | negative regulation of protein kinase C signaling | biological process | GO:0090038 | 4 | 1 | 18204 | 50 |
DGKG |
1.097e-02 | -4.51 | TRPM_tetra | pfam domains | PF16519 | 4 | 1 | 17795 | 49 |
TRPM3 |
1.097e-02 | -4.51 | KASH | pfam domains | PF10541 | 4 | 1 | 17795 | 49 |
SYNE1 |
1.097e-02 | -4.51 | NKAIN | pfam domains | PF05640 | 4 | 1 | 17795 | 49 |
NKAIN3 |
1.097e-02 | -4.51 | Glyco_transf_54 | pfam domains | PF04666 | 4 | 1 | 17795 | 49 |
MGAT4C |
1.097e-02 | -4.51 | Bravo_FIGEY | pfam domains | PF13882 | 4 | 1 | 17795 | 49 |
NRCAM |
1.097e-02 | -4.51 | CaMKII_AD | pfam domains | PF08332 | 4 | 1 | 17795 | 49 |
CAMK2G |
1.097e-02 | -4.51 | PH_14 | pfam domains | PF17787 | 4 | 1 | 17795 | 49 |
PLCB1 |
1.097e-02 | -4.51 | NHS | pfam domains | PF15273 | 4 | 1 | 17795 | 49 |
NHSL1 |
1.097e-02 | -4.51 | Nebulin | pfam domains | PF00880 | 4 | 1 | 17795 | 49 |
NEBL |
1.097e-02 | -4.51 | AbLIM_anchor | pfam domains | PF16182 | 4 | 1 | 17795 | 49 |
ABLIM1 |
1.097e-02 | -4.51 | Spectrin_3 | pfam domains | PF21019 | 4 | 1 | 17795 | 49 |
MACF1 |
1.097e-02 | -4.51 | Spectrin_4 | pfam domains | PF21020 | 4 | 1 | 17795 | 49 |
MACF1 |
1.097e-02 | -4.51 | Spectrin_2 | pfam domains | PF18373 | 4 | 1 | 17795 | 49 |
MACF1 |
1.103e-02 | -4.51 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-peripheral_T_cell_lymphoma_unspecified | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-peripheral_T_cell_lymphoma_unspecified | 162 | 3 | 16828 | 48 |
RYR3,MACF1,SYNE1 |
1.110e-02 | -4.50 | ARHGAP29 (Rho GTPase activating protein 29) | protein interactions | 9411 | 62 | 2 | 19454 | 50 |
CAMK2G,PARD3 |
1.117e-02 | -4.49 | parathyroid | COSMIC cancer mutations | parathyroid | 476 | 5 | 16828 | 48 |
RYR3,GPM6A,GPC5,SYNE1,MACF1 |
1.132e-02 | -4.48 | cognition | biological process | GO:0050890 | 319 | 4 | 18204 | 50 |
ATP1A2,NRXN1,NTRK2,PLCB1 |
1.141e-02 | -4.47 | Heparan sulfate/heparin (HS-GAG) metabolism | REACTOME pathways | R-HSA-1638091 | 54 | 2 | 10285 | 31 |
HPSE2,GPC5 |
1.143e-02 | -4.47 | human chr4q34.2 | chromosome location | human chr4q34.2 | 6 | 1 | 26134 | 50 |
GPM6A |
1.155e-02 | -4.46 | cellular response to endogenous stimulus | biological process | GO:0071495 | 1135 | 8 | 18204 | 50 |
SLC1A2,RYR3,NTRK2,SOX5,ATP1A2,SORBS1,PLCB1,TNC |
1.161e-02 | -4.46 | Cell adhesion molecules (CAMs) | KEGG pathways | hsa04514 | 143 | 3 | 7161 | 24 |
CNTN1,NRCAM,NRXN1 |
1.161e-02 | -4.46 | Wnt signaling pathway | KEGG pathways | ko04310 | 143 | 3 | 7161 | 24 |
CAMK2G,MAPK10,PLCB1 |
1.161e-02 | -4.46 | Wnt signaling pathway | KEGG pathways | hsa04310 | 143 | 3 | 7161 | 24 |
CAMK2G,MAPK10,PLCB1 |
1.161e-02 | -4.46 | Cell adhesion molecules (CAMs) | KEGG pathways | ko04514 | 143 | 3 | 7161 | 24 |
CNTN1,NRCAM,NRXN1 |
1.163e-02 | -4.45 | back | COSMIC cancer mutations | back | 310 | 4 | 16828 | 48 |
SYNE1,LRP1B,ATP1A2,TNIK |
1.165e-02 | -4.45 | Activation of PKC Through G Protein-Coupled Receptor | SMPDB pathways | SMP0000749 | 4 | 1 | 1369 | 4 |
PLCB1 |
1.166e-02 | -4.45 | ion binding | molecular function | GO:0043167 | 6007 | 24 | 18094 | 48 |
MAPK10,PARD3,MACF1,FAT3,RYR3,DTNA,ABLIM1,DCLK2,CAMK2G,TNIK,RORA,DGKG,ATP1A2,SLC1A2,NAV3,KALRN,PLCB1,MGAT4C,NTRK2,ADCY2,NAV2,PITPNC1,NRXN1,LRP1B |
1.182e-02 | -4.44 | export across plasma membrane | biological process | GO:0140115 | 60 | 2 | 18204 | 50 |
ATP1A2,SLC4A4 |
1.182e-02 | -4.44 | regulation of glucose import | biological process | GO:0046324 | 60 | 2 | 18204 | 50 |
SLC1A2,SORBS1 |
1.187e-02 | -4.43 | lower_third | COSMIC cancer mutations | lower_third | 7961 | 31 | 16828 | 48 |
SORBS1,SLC4A4,CTNND2,RORA,NEBL,PARD3,NAV2,TRPM3,NTRK2,MGAT4C,ATP1A2,SOX5,DCLK2,NRXN1,HPSE2,LRP1B,DPP6,CNTN1,GPC5,MACF1,ADCY2,NAV3,FAT3,NRG3,TNC,PLCB1,RYR3,SYNE1,KALRN,FMN2,DGKG |
1.198e-02 | -4.42 | peripheral_T_cell_lymphoma_unspecified | COSMIC cancer mutations | peripheral_T_cell_lymphoma_unspecified | 167 | 3 | 16828 | 48 |
RYR3,MACF1,SYNE1 |
1.200e-02 | -4.42 | Neurotransmitter uptake and Metabolism In Glial Cells | REACTOME pathways | R-HSA-112313 | 4 | 1 | 10285 | 31 |
SLC1A2 |
1.200e-02 | -4.42 | Astrocytic Glutamate-Glutamine Uptake And Metabolism | REACTOME pathways | R-HSA-210455 | 4 | 1 | 10285 | 31 |
SLC1A2 |
1.204e-02 | -4.42 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-medullomyoblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-medullomyoblastoma | 485 | 5 | 16828 | 48 |
LSAMP,LRP1B,CNTN1,RYR3,SLC4A4 |
1.204e-02 | -4.42 | medullomyoblastoma | COSMIC cancer mutations | medullomyoblastoma | 485 | 5 | 16828 | 48 |
CNTN1,RYR3,SLC4A4,LSAMP,LRP1B |
1.205e-02 | -4.42 | primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | primitive_neuroectodermal_tumour-medulloblastoma | 15350 | 48 | 16828 | 48 |
CAMK2G,RBMS3,SOX5,LRP1B,TNIK,NAV3,ADCY2,MACF1,GPC5,PLCB1,TNC,FAT3,MSI2,RFX4,KALRN,SYNE1,DGKG,ABLIM1,NHSL1,SLC14A1,PITPNC1,NRCAM,LSAMP,RORA,NEBL,NAV2,GPM6A,MGAT4C,NRXN1,DCLK2,HPSE2,DPP6,CNTN1,NKAIN3,RYR3,NRG3,DTNA,FMN2,NTM,SORBS1,SLC1A2,SLC4A4,SFXN5,CTNND2,PARD3,ATP1A2,NTRK2,TRPM3 |
1.205e-02 | -4.42 | Phospholipase D signaling pathway | KEGG pathways | hsa04072 | 145 | 3 | 7161 | 24 |
PLCB1,DGKG,ADCY2 |
1.205e-02 | -4.42 | Phospholipase D signaling pathway | KEGG pathways | ko04072 | 145 | 3 | 7161 | 24 |
ADCY2,DGKG,PLCB1 |
1.211e-02 | -4.41 | - | gene3d domains | 2.30.29.240 | 4 | 1 | 14470 | 44 |
PLCB1 |
1.211e-02 | -4.41 | Phospholipase C beta, distal C-terminal domain | gene3d domains | 1.20.1230.10 | 4 | 1 | 14470 | 44 |
PLCB1 |
1.211e-02 | -4.41 | TRPM, tetramerisation domain | gene3d domains | 1.20.5.1010 | 4 | 1 | 14470 | 44 |
TRPM3 |
1.211e-02 | -4.41 | - | gene3d domains | 1.20.58.1060 | 4 | 1 | 14470 | 44 |
MACF1 |
1.212e-02 | -4.41 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | 2081 | 12 | 16828 | 48 |
TNIK,LRP1B,SLC4A4,SOX5,CAMK2G,DCLK2,ATP1A2,NTRK2,SYNE1,KALRN,DTNA,ADCY2 |
1.222e-02 | -4.40 | purine nucleotide binding | molecular function | GO:0017076 | 1964 | 11 | 18094 | 48 |
KALRN,ATP1A2,DCLK2,TNIK,CAMK2G,MAPK10,NAV2,ADCY2,DGKG,NTRK2,NAV3 |
1.224e-02 | -4.40 | testis-germ_cell_tumour-non_seminoma | COSMIC cancer mutations | testis-germ_cell_tumour-non_seminoma | 487 | 5 | 16828 | 48 |
MACF1,CAMK2G,DCLK2,TNIK,NTRK2 |
1.234e-02 | -4.40 | establishment of localization | biological process | GO:0051234 | 3887 | 18 | 18204 | 50 |
SFXN5,SLC1A2,PITPNC1,RYR3,PARD3,ATP1A2,TRPM3,NTRK2,PLCB1,FMN2,SLC14A1,CAMK2G,GPM6A,KALRN,LRP1B,NRXN1,SLC4A4,MACF1 |
1.234e-02 | -4.39 | salivary_gland-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | salivary_gland-carcinoma-adenoid_cystic_carcinoma | 488 | 5 | 16828 | 48 |
RYR3,MGAT4C,RORA,CTNND2,SYNE1 |
1.249e-02 | -4.38 | central nervous system neuron differentiation | biological process | GO:0021953 | 176 | 3 | 18204 | 50 |
RORA,DCLK2,NTRK2 |
1.259e-02 | -4.38 | primary_central_nervous_system_lymphoma | COSMIC cancer mutations | primary_central_nervous_system_lymphoma | 683 | 6 | 16828 | 48 |
NRG3,MACF1,NRXN1,PARD3,SYNE1,LRP1B |
1.259e-02 | -4.38 | haematopoietic_and_lymphoid_tissue-central_nervous_system-lymphoid_neoplasm-primary_central_nervous_system_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-central_nervous_system-lymphoid_neoplasm-primary_central_nervous_system_lymphoma | 683 | 6 | 16828 | 48 |
MACF1,SYNE1,PARD3,LRP1B,NRXN1,NRG3 |
1.275e-02 | -4.36 | non_seminoma | COSMIC cancer mutations | non_seminoma | 492 | 5 | 16828 | 48 |
MACF1,CAMK2G,DCLK2,TNIK,NTRK2 |
1.276e-02 | -4.36 | calcium- and calmodulin-dependent protein kinase complex | cellular component | GO:0005954 | 5 | 1 | 19108 | 49 |
CAMK2G |
1.279e-02 | -4.36 | LINC02694 (long intergenic non-protein coding RNA 2694) | protein interactions | 400359 | 5 | 1 | 19454 | 50 |
FAT3 |
1.279e-02 | -4.36 | RFX4 (regulatory factor X4) | protein interactions | 5992 | 5 | 1 | 19454 | 50 |
RFX4 |
1.279e-02 | -4.36 | CAMK2N2 (calcium/calmodulin dependent protein kinase II inhibitor 2) | protein interactions | 94032 | 5 | 1 | 19454 | 50 |
CAMK2G |
1.279e-02 | -4.36 | SLC10A3 (solute carrier family 10 member 3) | protein interactions | 8273 | 5 | 1 | 19454 | 50 |
SORBS1 |
1.279e-02 | -4.36 | SYT13 (synaptotagmin 13) | protein interactions | 57586 | 5 | 1 | 19454 | 50 |
NRXN1 |
1.279e-02 | -4.36 | TMEM132E-DT (TMEM132E divergent transcript) | protein interactions | 400591 | 5 | 1 | 19454 | 50 |
FAT3 |
1.279e-02 | -4.36 | TRPM6 (transient receptor potential cation channel subfamily M member 6) | protein interactions | 140803 | 5 | 1 | 19454 | 50 |
TRPM3 |
1.287e-02 | -4.35 | PARD6A (par-6 family cell polarity regulator alpha) | protein interactions | 50855 | 67 | 2 | 19454 | 50 |
PARD3,PLCB1 |
1.287e-02 | -4.35 | ARMC1 (armadillo repeat containing 1) | protein interactions | 55156 | 67 | 2 | 19454 | 50 |
GPM6A,CNTN1 |
1.295e-02 | -4.35 | ALPHACATENIN | prints domains | PR00805 | 4 | 1 | 5227 | 17 |
CTNNA2 |
1.304e-02 | -4.34 | SH3_9 | pfam domains | PF14604 | 63 | 2 | 17795 | 49 |
NEBL,SORBS1 |
1.307e-02 | -4.34 | KASH | prosite domains | PS51049 | 4 | 1 | 12186 | 40 |
SYNE1 |
1.307e-02 | -4.34 | NEBULIN | prosite domains | PS51216 | 4 | 1 | 12186 | 40 |
NEBL |
1.309e-02 | -4.34 | Ion transport by P-type ATPases | REACTOME pathways | R-HSA-936837 | 58 | 2 | 10285 | 31 |
ATP1A2,CAMK2G |
1.310e-02 | -4.34 | temporoparietal | COSMIC cancer mutations | temporoparietal | 61 | 2 | 16828 | 48 |
PARD3,RYR3 |
1.314e-02 | -4.33 | inorganic ion transmembrane transport | biological process | GO:0098660 | 715 | 6 | 18204 | 50 |
RYR3,PLCB1,GPM6A,SLC4A4,TRPM3,ATP1A2 |
1.315e-02 | -4.33 | Signalling by NGF | REACTOME pathways | R-HSA-166520 | 477 | 5 | 10285 | 31 |
NTRK2,CAMK2G,KALRN,ADCY2,NRG3 |
1.320e-02 | -4.33 | high-affinity L-glutamate transmembrane transporter activity | molecular function | GO:0005314 | 5 | 1 | 18094 | 48 |
SLC1A2 |
1.320e-02 | -4.33 | cytoskeleton-nuclear membrane anchor activity | molecular function | GO:0140444 | 5 | 1 | 18094 | 48 |
SYNE1 |
1.320e-02 | -4.33 | neuroligin family protein binding | molecular function | GO:0097109 | 5 | 1 | 18094 | 48 |
NRXN1 |
1.320e-02 | -4.33 | glutamate:sodium symporter activity | molecular function | GO:0015501 | 5 | 1 | 18094 | 48 |
SLC1A2 |
1.320e-02 | -4.33 | neurotrophin receptor activity | molecular function | GO:0005030 | 5 | 1 | 18094 | 48 |
NTRK2 |
1.320e-02 | -4.33 | syndecan binding | molecular function | GO:0045545 | 5 | 1 | 18094 | 48 |
TNC |
1.324e-02 | -4.32 | PLCH1 (phospholipase C eta 1) | protein interactions | 23007 | 68 | 2 | 19454 | 50 |
PARD3,NTRK2 |
1.332e-02 | -4.32 | human chr7q36.2 | chromosome location | human chr7q36.2 | 7 | 1 | 26134 | 50 |
DPP6 |
1.332e-02 | -4.32 | human chr4q21.3 | chromosome location | human chr4q21.3 | 7 | 1 | 26134 | 50 |
MAPK10 |
1.337e-02 | -4.31 | transport | biological process | GO:0006810 | 3615 | 17 | 18204 | 50 |
PITPNC1,SFXN5,SLC1A2,RYR3,NTRK2,ATP1A2,TRPM3,FMN2,PLCB1,SLC14A1,CAMK2G,GPM6A,KALRN,SLC4A4,MACF1,LRP1B,NRXN1 |
1.337e-02 | -4.31 | actin filament bundle assembly | biological process | GO:0051017 | 64 | 2 | 18204 | 50 |
FMN2,SORBS1 |
1.337e-02 | -4.31 | dendrite morphogenesis | biological process | GO:0048813 | 64 | 2 | 18204 | 50 |
CTNNA2,CTNND2 |
1.341e-02 | -4.31 | oesophagus-lower_third-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-adenocarcinoma | 6302 | 26 | 16828 | 48 |
NEBL,RORA,TRPM3,MGAT4C,NTRK2,PARD3,SORBS1,CTNND2,NRG3,FAT3,TNC,RYR3,PLCB1,GPC5,MACF1,ADCY2,NAV3,DGKG,SYNE1,KALRN,FMN2,SOX5,NRXN1,CNTN1,LRP1B,DPP6 |
1.343e-02 | -4.31 | Vinculin/catenin | interpro domains | IPR006077 | 5 | 1 | 18521 | 50 |
CTNNA2 |
1.343e-02 | -4.31 | Na/HCO3_transpt | interpro domains | IPR003024 | 5 | 1 | 18521 | 50 |
SLC4A4 |
1.343e-02 | -4.31 | Mtc | interpro domains | IPR004686 | 5 | 1 | 18521 | 50 |
SFXN5 |
1.343e-02 | -4.31 | EGF_Tenascin | interpro domains | IPR041161 | 5 | 1 | 18521 | 50 |
TNC |
1.343e-02 | -4.31 | PI_transfer | interpro domains | IPR001666 | 5 | 1 | 18521 | 50 |
PITPNC1 |
1.359e-02 | -4.30 | skin-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-head_neck-carcinoma-squamous_cell_carcinoma | 14191 | 46 | 16828 | 48 |
RYR3,NRG3,NKAIN3,NTM,FMN2,DTNA,HPSE2,DCLK2,NRXN1,CNTN1,DPP6,NTRK2,ATP1A2,TRPM3,PARD3,SLC4A4,SLC1A2,SORBS1,CTNND2,SFXN5,TNC,PLCB1,FAT3,NAV3,MACF1,GPC5,ADCY2,DGKG,KALRN,SYNE1,RFX4,CAMK2G,SOX5,TNIK,LRP1B,NEBL,NRCAM,LSAMP,RORA,MGAT4C,NAV2,GPM6A,ABLIM1,NHSL1,SLC14A1,PITPNC1 |
1.362e-02 | -4.30 | cell body | cellular component | GO:0044297 | 556 | 5 | 19108 | 49 |
ATP1A2,GPM6A,CTNND2,NRXN1,SLC1A2 |
1.365e-02 | -4.29 | cell adhesion mediator activity | molecular function | GO:0098631 | 67 | 2 | 18094 | 48 |
CNTN1,NRCAM |
1.366e-02 | -4.29 | response to prostaglandin D | biological process | GO:0071798 | 5 | 1 | 18204 | 50 |
TNC |
1.366e-02 | -4.29 | citrate transport | biological process | GO:0015746 | 5 | 1 | 18204 | 50 |
SFXN5 |
1.366e-02 | -4.29 | polar body extrusion after meiotic divisions | biological process | GO:0040038 | 5 | 1 | 18204 | 50 |
FMN2 |
1.366e-02 | -4.29 | synaptic signaling via neuropeptide | biological process | GO:0099538 | 5 | 1 | 18204 | 50 |
NTRK2 |
1.366e-02 | -4.29 | cellular response to prostaglandin D stimulus | biological process | GO:0071799 | 5 | 1 | 18204 | 50 |
TNC |
1.366e-02 | -4.29 | activation of meiosis | biological process | GO:0090427 | 5 | 1 | 18204 | 50 |
PLCB1 |
1.366e-02 | -4.29 | D-aspartate import across plasma membrane | biological process | GO:0070779 | 5 | 1 | 18204 | 50 |
SLC1A2 |
1.366e-02 | -4.29 | tricarboxylic acid transport | biological process | GO:0006842 | 5 | 1 | 18204 | 50 |
SFXN5 |
1.366e-02 | -4.29 | gephyrin clustering involved in postsynaptic density assembly | biological process | GO:0097116 | 5 | 1 | 18204 | 50 |
NRXN1 |
1.366e-02 | -4.29 | glossopharyngeal nerve development | biological process | GO:0021563 | 5 | 1 | 18204 | 50 |
NAV2 |
1.366e-02 | -4.29 | D-aspartate transmembrane transport | biological process | GO:0070777 | 5 | 1 | 18204 | 50 |
SLC1A2 |
1.366e-02 | -4.29 | amygdala development | biological process | GO:0021764 | 5 | 1 | 18204 | 50 |
ATP1A2 |
1.369e-02 | -4.29 | Vinculin | pfam domains | PF01044 | 5 | 1 | 17795 | 49 |
CTNNA2 |
1.369e-02 | -4.29 | IP_trans | pfam domains | PF02121 | 5 | 1 | 17795 | 49 |
PITPNC1 |
1.369e-02 | -4.29 | EGF_Tenascin | pfam domains | PF18720 | 5 | 1 | 17795 | 49 |
TNC |
1.369e-02 | -4.29 | SFXNs | pfam domains | PF03820 | 5 | 1 | 17795 | 49 |
SFXN5 |
1.377e-02 | -4.29 | regulation of dendrite morphogenesis | biological process | GO:0048814 | 65 | 2 | 18204 | 50 |
TNIK,SYNE1 |
1.377e-02 | -4.29 | positive regulation of synapse assembly | biological process | GO:0051965 | 65 | 2 | 18204 | 50 |
NRXN1,NTRK2 |
1.386e-02 | -4.28 | regulation of carbohydrate metabolic process | biological process | GO:0006109 | 183 | 3 | 18204 | 50 |
SORBS1,RORA,SLC4A4 |
1.389e-02 | -4.28 | regulation of Wnt signaling pathway | biological process | GO:0030111 | 339 | 4 | 18204 | 50 |
MACF1,GPC5,CTNND2,RBMS3 |
1.399e-02 | -4.27 | PCDH20 (protocadherin 20) | protein interactions | 64881 | 70 | 2 | 19454 | 50 |
CTNNA2,MGAT4C |
1.407e-02 | -4.26 | RAB35 (RAB35, member RAS oncogene family) | protein interactions | 11021 | 559 | 5 | 19454 | 50 |
DTNA,PLCB1,MACF1,FMN2,PARD3 |
1.408e-02 | -4.26 | seminoma | COSMIC cancer mutations | seminoma | 700 | 6 | 16828 | 48 |
DCLK2,CAMK2G,SYNE1,NTRK2,TNIK,CNTN1 |
1.418e-02 | -4.26 | retina morphogenesis in camera-type eye | biological process | GO:0060042 | 66 | 2 | 18204 | 50 |
NTRK2,FAT3 |
1.433e-02 | -4.25 | NEBU | smart domains | SM00227 | 4 | 1 | 9717 | 35 |
NEBL |
1.433e-02 | -4.25 | KASH | smart domains | SM01249 | 4 | 1 | 9717 | 35 |
SYNE1 |
1.435e-02 | -4.24 | skin-ankle-malignant_melanoma-acral_lentiginous | COSMIC cancer mutations | skin-ankle-malignant_melanoma-acral_lentiginous | 330 | 4 | 16828 | 48 |
PLCB1,NRG3,KALRN,PARD3 |
1.437e-02 | -4.24 | AKR7L (aldo-keto reductase family 7 like (gene/pseudogene)) | protein interactions | 246181 | 71 | 2 | 19454 | 50 |
PARD3,MACF1 |
1.451e-02 | -4.23 | NTRK3 (neurotrophic receptor tyrosine kinase 3) | protein interactions | 4916 | 367 | 4 | 19454 | 50 |
PARD3,ABLIM1,TNIK,NTRK2 |
1.455e-02 | -4.23 | Corticotropin Activation of Cortisol Production | SMPDB pathways | SMP0000310 | 5 | 1 | 1369 | 4 |
ADCY2 |
1.470e-02 | -4.22 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 14773 | 47 | 16828 | 48 |
LSAMP,RORA,NRCAM,NEBL,GPM6A,NAV2,MGAT4C,ABLIM1,PITPNC1,NHSL1,SLC14A1,GPC5,MACF1,ADCY2,NAV3,FAT3,TNC,PLCB1,SYNE1,KALRN,RFX4,MSI2,DGKG,SOX5,RBMS3,CAMK2G,LRP1B,TNIK,PARD3,TRPM3,NTRK2,ATP1A2,SORBS1,SLC4A4,SLC1A2,CTNND2,SFXN5,NRG3,RYR3,NTM,DTNA,FMN2,DCLK2,NRXN1,HPSE2,DPP6,CNTN1 |
1.470e-02 | -4.22 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-classic | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-classic | 14773 | 47 | 16828 | 48 |
ABLIM1,NHSL1,SLC14A1,PITPNC1,NRCAM,LSAMP,RORA,NEBL,NAV2,GPM6A,MGAT4C,CAMK2G,RBMS3,SOX5,LRP1B,TNIK,NAV3,ADCY2,MACF1,GPC5,PLCB1,TNC,FAT3,MSI2,RFX4,KALRN,SYNE1,DGKG,SORBS1,SLC1A2,SLC4A4,SFXN5,CTNND2,PARD3,ATP1A2,NTRK2,TRPM3,NRXN1,DCLK2,HPSE2,DPP6,CNTN1,RYR3,NRG3,FMN2,DTNA,NTM |
1.470e-02 | -4.22 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-desmoplastic | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-desmoplastic | 14773 | 47 | 16828 | 48 |
NEBL,NRCAM,RORA,LSAMP,MGAT4C,NAV2,GPM6A,ABLIM1,SLC14A1,NHSL1,PITPNC1,PLCB1,TNC,FAT3,NAV3,ADCY2,MACF1,GPC5,DGKG,MSI2,RFX4,KALRN,SYNE1,CAMK2G,RBMS3,SOX5,TNIK,LRP1B,ATP1A2,NTRK2,TRPM3,PARD3,SLC1A2,SLC4A4,SORBS1,SFXN5,CTNND2,RYR3,NRG3,DTNA,FMN2,NTM,HPSE2,NRXN1,DCLK2,CNTN1,DPP6 |
1.470e-02 | -4.22 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma | 14773 | 47 | 16828 | 48 |
NRG3,RYR3,NTM,DTNA,FMN2,HPSE2,DCLK2,NRXN1,CNTN1,DPP6,TRPM3,NTRK2,ATP1A2,PARD3,SLC4A4,SLC1A2,SORBS1,CTNND2,SFXN5,FAT3,TNC,PLCB1,GPC5,MACF1,ADCY2,NAV3,DGKG,SYNE1,KALRN,RFX4,MSI2,SOX5,RBMS3,CAMK2G,TNIK,LRP1B,NEBL,RORA,LSAMP,NRCAM,MGAT4C,GPM6A,NAV2,ABLIM1,PITPNC1,NHSL1,SLC14A1 |
1.474e-02 | -4.22 | classic | COSMIC cancer mutations | classic | 14774 | 47 | 16828 | 48 |
NAV2,GPM6A,MGAT4C,NRCAM,RORA,LSAMP,NEBL,NHSL1,SLC14A1,PITPNC1,ABLIM1,MSI2,SYNE1,KALRN,RFX4,DGKG,NAV3,GPC5,MACF1,ADCY2,TNC,PLCB1,FAT3,LRP1B,TNIK,RBMS3,CAMK2G,SOX5,PARD3,NTRK2,ATP1A2,TRPM3,CTNND2,SFXN5,SORBS1,SLC4A4,SLC1A2,NTM,DTNA,FMN2,RYR3,NRG3,DPP6,CNTN1,DCLK2,NRXN1,HPSE2 |
1.476e-02 | -4.22 | DPYSL3 (dihydropyrimidinase like 3) | protein interactions | 1809 | 72 | 2 | 19454 | 50 |
TNIK,GPM6A |
1.476e-02 | -4.22 | Ppp1cb (protein phosphatase 1 catalytic subunit beta) | protein interactions | 19046 | 72 | 2 | 19454 | 50 |
PARD3,ABLIM1 |
1.490e-02 | -4.21 | medulla | COSMIC cancer mutations | medulla | 14778 | 47 | 16828 | 48 |
GPC5,MACF1,ADCY2,NAV3,FAT3,TNC,PLCB1,KALRN,SYNE1,RFX4,MSI2,DGKG,SOX5,RBMS3,CAMK2G,LRP1B,TNIK,LSAMP,RORA,NRCAM,NEBL,GPM6A,NAV2,MGAT4C,ABLIM1,PITPNC1,NHSL1,SLC14A1,NRG3,RYR3,NTM,DTNA,FMN2,DCLK2,NRXN1,HPSE2,DPP6,CNTN1,PARD3,TRPM3,NTRK2,ATP1A2,SORBS1,SLC4A4,SLC1A2,CTNND2,SFXN5 |
1.495e-02 | -4.20 | desmoplastic | COSMIC cancer mutations | desmoplastic | 14779 | 47 | 16828 | 48 |
SLC4A4,SLC1A2,SORBS1,CTNND2,SFXN5,NTRK2,ATP1A2,TRPM3,PARD3,HPSE2,DCLK2,NRXN1,CNTN1,DPP6,RYR3,NRG3,NTM,FMN2,DTNA,ABLIM1,SLC14A1,NHSL1,PITPNC1,NEBL,NRCAM,RORA,LSAMP,MGAT4C,NAV2,GPM6A,RBMS3,CAMK2G,SOX5,TNIK,LRP1B,TNC,PLCB1,FAT3,NAV3,MACF1,GPC5,ADCY2,DGKG,MSI2,KALRN,SYNE1,RFX4 |
1.498e-02 | -4.20 | NGF-independant TRKA activation | REACTOME pathways | R-HSA-187024 | 5 | 1 | 10285 | 31 |
NTRK2 |
1.501e-02 | -4.20 | actin filament bundle organization | biological process | GO:0061572 | 68 | 2 | 18204 | 50 |
SORBS1,FMN2 |
1.511e-02 | -4.19 | - | gene3d domains | 6.10.140.620 | 5 | 1 | 14470 | 44 |
CAMK2G |
1.526e-02 | -4.18 | cellular response to lipid | biological process | GO:0071396 | 534 | 5 | 18204 | 50 |
ATP1A2,ADCY2,RORA,TNC,PLCB1 |
1.526e-02 | -4.18 | large_intestine-caecum-carcinoma-adenocarcinoma | COSMIC cancer mutations | large_intestine-caecum-carcinoma-adenocarcinoma | 14236 | 46 | 16828 | 48 |
SORBS1,SLC4A4,SLC1A2,CTNND2,SFXN5,PARD3,TRPM3,NTRK2,ATP1A2,DCLK2,NRXN1,HPSE2,DPP6,CNTN1,NKAIN3,NRG3,RYR3,NTM,FMN2,DTNA,ABLIM1,PITPNC1,NHSL1,SLC14A1,LSAMP,RORA,NRCAM,NEBL,GPM6A,NAV2,MGAT4C,SOX5,CAMK2G,LRP1B,TNIK,MACF1,GPC5,ADCY2,NAV3,FAT3,TNC,PLCB1,KALRN,SYNE1,RFX4,DGKG |
1.529e-02 | -4.18 | PAR polarity complex | cellular component | GO:0120157 | 6 | 1 | 19108 | 49 |
PARD3 |
1.531e-02 | -4.18 | protein localization | biological process | GO:0008104 | 1954 | 11 | 18204 | 50 |
DCLK2,MACF1,NRXN1,TNIK,LRP1B,FMN2,SYNE1,DPP6,CAMK2G,NRCAM,PARD3 |
1.531e-02 | -4.18 | pallium development | biological process | GO:0021543 | 190 | 3 | 18204 | 50 |
PLCB1,NTRK2,DCLK2 |
1.532e-02 | -4.18 | Zbtb2 (zinc finger and BTB domain containing 2) | protein interactions | 381990 | 6 | 1 | 19454 | 50 |
SORBS1 |
1.532e-02 | -4.18 | SLC12A5 (solute carrier family 12 member 5) | protein interactions | 57468 | 6 | 1 | 19454 | 50 |
GPM6A |
1.532e-02 | -4.18 | DRP2 (dystrophin related protein 2) | protein interactions | 1821 | 6 | 1 | 19454 | 50 |
DTNA |
1.532e-02 | -4.18 | SYTL3 (synaptotagmin like 3) | protein interactions | 94120 | 6 | 1 | 19454 | 50 |
NRXN1 |
1.532e-02 | -4.18 | SOX11 (SRY-box transcription factor 11) | protein interactions | 6664 | 6 | 1 | 19454 | 50 |
SOX5 |
1.532e-02 | -4.18 | Rara (retinoic acid receptor, alpha) | protein interactions | 19401 | 6 | 1 | 19454 | 50 |
MAPK10 |
1.532e-02 | -4.18 | SOX1 (SRY-box transcription factor 1) | protein interactions | 6656 | 6 | 1 | 19454 | 50 |
SOX5 |
1.532e-02 | -4.18 | CIBAR2 (CBY1 interacting BAR domain containing 2) | protein interactions | 339145 | 6 | 1 | 19454 | 50 |
CAMK2G |
1.532e-02 | -4.18 | Tiam2 (T cell lymphoma invasion and metastasis 2) | protein interactions | 24001 | 6 | 1 | 19454 | 50 |
DTNA |
1.532e-02 | -4.18 | ADCY1 (adenylate cyclase 1) | protein interactions | 107 | 6 | 1 | 19454 | 50 |
ADCY2 |
1.532e-02 | -4.18 | SMOC2 (SPARC related modular calcium binding 2) | protein interactions | 64094 | 6 | 1 | 19454 | 50 |
TNC |
1.532e-02 | -4.18 | CYRIA (CYFIP related Rac1 interactor A) | protein interactions | 81553 | 6 | 1 | 19454 | 50 |
GPM6A |
1.532e-02 | -4.18 | SPATA4 (spermatogenesis associated 4) | protein interactions | 132851 | 6 | 1 | 19454 | 50 |
FAT3 |
1.535e-02 | -4.18 | Immunoglobulin | interpro domains | IPR013151 | 70 | 2 | 18521 | 50 |
NTM,CNTN1 |
1.550e-02 | -4.17 | LIM | pfam domains | PF00412 | 69 | 2 | 17795 | 49 |
NEBL,ABLIM1 |
1.552e-02 | -4.17 | CASK (calcium/calmodulin dependent serine protein kinase) | protein interactions | 8573 | 204 | 3 | 19454 | 50 |
NRXN1,ABLIM1,DTNA |
1.554e-02 | -4.16 | central_nervous_system-brainstem-glioma | COSMIC cancer mutations | central_nervous_system-brainstem-glioma | 338 | 4 | 16828 | 48 |
TNC,HPSE2,GPC5,LRP1B |
1.566e-02 | -4.16 | haematopoietic_and_lymphoid_tissue-soft_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-soft_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 67 | 2 | 16828 | 48 |
LRP1B,SYNE1 |
1.573e-02 | -4.15 | caecum | COSMIC cancer mutations | caecum | 14248 | 46 | 16828 | 48 |
TRPM3,ATP1A2,NTRK2,PARD3,SLC1A2,SLC4A4,SORBS1,SFXN5,CTNND2,NRG3,RYR3,NKAIN3,FMN2,DTNA,NTM,HPSE2,NRXN1,DCLK2,CNTN1,DPP6,NEBL,RORA,LSAMP,NRCAM,MGAT4C,GPM6A,NAV2,ABLIM1,PITPNC1,NHSL1,SLC14A1,FAT3,PLCB1,TNC,ADCY2,GPC5,MACF1,NAV3,DGKG,RFX4,SYNE1,KALRN,SOX5,CAMK2G,TNIK,LRP1B |
1.575e-02 | -4.15 | cellular macromolecule localization | biological process | GO:0070727 | 1962 | 11 | 18204 | 50 |
DCLK2,MACF1,TNIK,LRP1B,NRXN1,SYNE1,FMN2,DPP6,CAMK2G,NRCAM,PARD3 |
1.576e-02 | -4.15 | Znf_LIM | interpro domains | IPR001781 | 71 | 2 | 18521 | 50 |
ABLIM1,NEBL |
1.581e-02 | -4.15 | steroid hormone binding | molecular function | GO:1990239 | 6 | 1 | 18094 | 48 |
ATP1A2 |
1.581e-02 | -4.15 | calcium-induced calcium release activity | molecular function | GO:0048763 | 6 | 1 | 18094 | 48 |
RYR3 |
1.581e-02 | -4.15 | sodium:bicarbonate symporter activity | molecular function | GO:0008510 | 6 | 1 | 18094 | 48 |
SLC4A4 |
1.589e-02 | -4.14 | ovary-carcinoma | COSMIC cancer mutations | ovary-carcinoma | 933 | 7 | 16828 | 48 |
SYNE1,ATP1A2,TNIK,NTRK2,MACF1,CAMK2G,DCLK2 |
1.592e-02 | -4.14 | ig | pfam domains | PF00047 | 70 | 2 | 17795 | 49 |
NTM,CNTN1 |
1.609e-02 | -4.13 | G3BP1 (G3BP stress granule assembly factor 1) | protein interactions | 10146 | 799 | 6 | 19454 | 50 |
MACF1,MSI2,SOX5,SORBS1,CTNNA2,SYNE1 |
1.609e-02 | -4.13 | Glypican_CS | interpro domains | IPR019803 | 6 | 1 | 18521 | 50 |
GPC5 |
1.609e-02 | -4.13 | Ryanodine_IP3_receptor | interpro domains | IPR015925 | 6 | 1 | 18521 | 50 |
RYR3 |
1.609e-02 | -4.13 | Adcy_conserved_dom | interpro domains | IPR009398 | 6 | 1 | 18521 | 50 |
ADCY2 |
1.609e-02 | -4.13 | EF-hand_dom_typ1 | interpro domains | IPR015153 | 6 | 1 | 18521 | 50 |
DTNA |
1.609e-02 | -4.13 | GAR_dom | interpro domains | IPR003108 | 6 | 1 | 18521 | 50 |
MACF1 |
1.609e-02 | -4.13 | Glypican | interpro domains | IPR001863 | 6 | 1 | 18521 | 50 |
GPC5 |
1.609e-02 | -4.13 | GAR_dom_sf | interpro domains | IPR036534 | 6 | 1 | 18521 | 50 |
MACF1 |
1.609e-02 | -4.13 | Peptidase_S9B_N | interpro domains | IPR002469 | 6 | 1 | 18521 | 50 |
DPP6 |
1.609e-02 | -4.13 | RIH_dom | interpro domains | IPR000699 | 6 | 1 | 18521 | 50 |
RYR3 |
1.609e-02 | -4.13 | Desmoplakin_SH3 | interpro domains | IPR041615 | 6 | 1 | 18521 | 50 |
MACF1 |
1.609e-02 | -4.13 | Syndecan/Neurexin_dom | interpro domains | IPR027789 | 6 | 1 | 18521 | 50 |
NRXN1 |
1.609e-02 | -4.13 | P-type_ATPase_IIC | interpro domains | IPR005775 | 6 | 1 | 18521 | 50 |
ATP1A2 |
1.609e-02 | -4.13 | RyR/IP3R_RIH_dom_sf | interpro domains | IPR035910 | 6 | 1 | 18521 | 50 |
RYR3 |
1.609e-02 | -4.13 | RIH_assoc-dom | interpro domains | IPR013662 | 6 | 1 | 18521 | 50 |
RYR3 |
1.609e-02 | -4.13 | EF-hand_dom_typ2 | interpro domains | IPR015154 | 6 | 1 | 18521 | 50 |
DTNA |
1.609e-02 | -4.13 | Ins145_P3_rcpt | interpro domains | IPR014821 | 6 | 1 | 18521 | 50 |
RYR3 |
1.615e-02 | -4.13 | prostate-carcinoma-adenocarcinoma | COSMIC cancer mutations | prostate-carcinoma-adenocarcinoma | 12379 | 42 | 16828 | 48 |
LRP1B,DPP6,TNIK,CNTN1,NRXN1,SOX5,HPSE2,NTM,FMN2,KALRN,SYNE1,RFX4,DGKG,NKAIN3,NAV3,GPC5,MACF1,ADCY2,TNC,PLCB1,RYR3,NRG3,FAT3,CTNND2,SFXN5,SLC14A1,NHSL1,PITPNC1,SORBS1,ABLIM1,SLC1A2,NAV2,GPM6A,PARD3,MGAT4C,NTRK2,ATP1A2,TRPM3,NRCAM,RORA,LSAMP,NEBL |
1.616e-02 | -4.13 | PITRANSFER | prints domains | PR00391 | 5 | 1 | 5227 | 17 |
PITPNC1 |
1.616e-02 | -4.13 | NAHCO3TRSPRT | prints domains | PR01232 | 5 | 1 | 5227 | 17 |
SLC4A4 |
1.627e-02 | -4.12 | sarcoplasmic reticulum | cellular component | GO:0016529 | 76 | 2 | 19108 | 49 |
CAMK2G,RYR3 |
1.629e-02 | -4.12 | MKRN2 (makorin ring finger protein 2) | protein interactions | 23609 | 380 | 4 | 19454 | 50 |
NRCAM,MACF1,PARD3,CNTN1 |
1.633e-02 | -4.11 | RYK (receptor like tyrosine kinase) | protein interactions | 6259 | 208 | 3 | 19454 | 50 |
CNTN1,FAT3,CTNNA2 |
1.637e-02 | -4.11 | asymmetric neuroblast division | biological process | GO:0055059 | 6 | 1 | 18204 | 50 |
SOX5 |
1.637e-02 | -4.11 | mammary gland formation | biological process | GO:0060592 | 6 | 1 | 18204 | 50 |
NRG3 |
1.637e-02 | -4.11 | postsynaptic density protein 95 clustering | biological process | GO:0097119 | 6 | 1 | 18204 | 50 |
NRXN1 |
1.637e-02 | -4.11 | ERBB4-ERBB4 signaling pathway | biological process | GO:0038138 | 6 | 1 | 18204 | 50 |
NRG3 |
1.637e-02 | -4.11 | L-aspartate import across plasma membrane | biological process | GO:0140009 | 6 | 1 | 18204 | 50 |
SLC1A2 |
1.637e-02 | -4.11 | imitative learning | biological process | GO:0098596 | 6 | 1 | 18204 | 50 |
NRXN1 |
1.637e-02 | -4.11 | inositol trisphosphate metabolic process | biological process | GO:0032957 | 6 | 1 | 18204 | 50 |
PLCB1 |
1.637e-02 | -4.11 | D-amino acid transport | biological process | GO:0042940 | 6 | 1 | 18204 | 50 |
SLC1A2 |
1.637e-02 | -4.11 | establishment of meiotic spindle localization | biological process | GO:0051295 | 6 | 1 | 18204 | 50 |
FMN2 |
1.637e-02 | -4.11 | vocal learning | biological process | GO:0042297 | 6 | 1 | 18204 | 50 |
NRXN1 |
1.637e-02 | -4.11 | cellular response to ether | biological process | GO:0071362 | 6 | 1 | 18204 | 50 |
PLCB1 |
1.637e-02 | -4.11 | clustering of voltage-gated sodium channels | biological process | GO:0045162 | 6 | 1 | 18204 | 50 |
NRCAM |
1.641e-02 | -4.11 | Plectin | pfam domains | PF00681 | 6 | 1 | 17795 | 49 |
MACF1 |
1.641e-02 | -4.11 | GAS2 | pfam domains | PF02187 | 6 | 1 | 17795 | 49 |
MACF1 |
1.641e-02 | -4.11 | Syndecan | pfam domains | PF01034 | 6 | 1 | 17795 | 49 |
NRXN1 |
1.641e-02 | -4.11 | Ins145_P3_rec | pfam domains | PF08709 | 6 | 1 | 17795 | 49 |
RYR3 |
1.641e-02 | -4.11 | EF-hand_3 | pfam domains | PF09069 | 6 | 1 | 17795 | 49 |
DTNA |
1.641e-02 | -4.11 | Adcy_cons_dom | pfam domains | PF06327 | 6 | 1 | 17795 | 49 |
ADCY2 |
1.641e-02 | -4.11 | RYDR_ITPR | pfam domains | PF01365 | 6 | 1 | 17795 | 49 |
RYR3 |
1.641e-02 | -4.11 | EF-hand_2 | pfam domains | PF09068 | 6 | 1 | 17795 | 49 |
DTNA |
1.641e-02 | -4.11 | DPPIV_N | pfam domains | PF00930 | 6 | 1 | 17795 | 49 |
DPP6 |
1.641e-02 | -4.11 | SH3_10 | pfam domains | PF17902 | 6 | 1 | 17795 | 49 |
MACF1 |
1.641e-02 | -4.11 | RIH_assoc | pfam domains | PF08454 | 6 | 1 | 17795 | 49 |
RYR3 |
1.641e-02 | -4.11 | Glypican | pfam domains | PF01153 | 6 | 1 | 17795 | 49 |
GPC5 |
1.650e-02 | -4.10 | cGMP-PKG signaling pathway | KEGG pathways | hsa04022 | 163 | 3 | 7161 | 24 |
ATP1A2,ADCY2,PLCB1 |
1.650e-02 | -4.10 | cGMP-PKG signaling pathway | KEGG pathways | ko04022 | 163 | 3 | 7161 | 24 |
ATP1A2,ADCY2,PLCB1 |
1.654e-02 | -4.10 | MACF1 (microtubule actin crosslinking factor 1) | protein interactions | 23499 | 209 | 3 | 19454 | 50 |
NRXN1,TNIK,NRCAM |
1.676e-02 | -4.09 | ADGRL2 (adhesion G protein-coupled receptor L2) | protein interactions | 23266 | 77 | 2 | 19454 | 50 |
PARD3,NTRK2 |
1.685e-02 | -4.08 | locomotory behavior | biological process | GO:0007626 | 197 | 3 | 18204 | 50 |
CNTN1,ATP1A2,NAV2 |
1.685e-02 | -4.08 | protein localization to plasma membrane | biological process | GO:0072659 | 197 | 3 | 18204 | 50 |
DPP6,MACF1,TNIK |
1.694e-02 | -4.08 | signal transduction | biological process | GO:0007165 | 4637 | 20 | 18204 | 50 |
DTNA,DGKG,NRG3,KALRN,TNIK,MACF1,RORA,MAPK10,ADCY2,CNTN1,PITPNC1,RYR3,PARD3,ATP1A2,NTRK2,DCLK2,CTNND2,PLCB1,SORBS1,FMN2 |
1.700e-02 | -4.07 | autonomic_ganglia-paraganglioma-benign | COSMIC cancer mutations | autonomic_ganglia-paraganglioma-benign | 6 | 1 | 16828 | 48 |
NHSL1 |
1.700e-02 | -4.07 | localization within membrane | biological process | GO:0051668 | 549 | 5 | 18204 | 50 |
MACF1,TNIK,NRXN1,PARD3,DPP6 |
1.711e-02 | -4.07 | positive regulation of cell projection organization | biological process | GO:0031346 | 361 | 4 | 18204 | 50 |
NTRK2,GPM6A,MACF1,CNTN1 |
1.717e-02 | -4.06 | ANKRD40 (ankyrin repeat domain 40) | protein interactions | 91369 | 78 | 2 | 19454 | 50 |
MSI2,SOX5 |
1.727e-02 | -4.06 | Human Thyroid Stimulating Hormone (TSH) signaling pathway | WikiPathways | WP2032 | 68 | 2 | 5310 | 16 |
PLCB1,ADCY2 |
1.728e-02 | -4.06 | calmodulin binding | molecular function | GO:0005516 | 206 | 3 | 18094 | 48 |
CAMK2G,PLCB1,RYR3 |
1.731e-02 | -4.06 | testis | COSMIC cancer mutations | testis | 733 | 6 | 16828 | 48 |
NTRK2,TNIK,SYNE1,MACF1,DCLK2,CAMK2G |
1.740e-02 | -4.05 | Phenytoin (Antiarrhythmic) Action Pathway | SMPDB pathways | SMP0000327 | 77 | 2 | 1369 | 4 |
ATP1A2,PLCB1 |
1.744e-02 | -4.05 | Dopamine Activation of Neurological Reward System | SMPDB pathways | SMP0000308 | 6 | 1 | 1369 | 4 |
ADCY2 |
1.744e-02 | -4.05 | Phospholipase C Signaling Pathway | SMPDB pathways | SMP0063783 | 6 | 1 | 1369 | 4 |
PLCB1 |
1.744e-02 | -4.05 | Intracellular Signalling Through PGD2 receptor and Prostaglandin D2 | SMPDB pathways | SMP0000343 | 6 | 1 | 1369 | 4 |
ADCY2 |
1.747e-02 | -4.05 | small molecule binding | molecular function | GO:0036094 | 6197 | 24 | 18094 | 48 |
NAV3,KALRN,PLCB1,MGAT4C,NTRK2,ADCY2,NAV2,NRXN1,PITPNC1,LRP1B,MAPK10,PARD3,MACF1,FAT3,RYR3,DTNA,ABLIM1,DCLK2,CAMK2G,TNIK,RORA,DGKG,ATP1A2,SLC1A2 |
1.761e-02 | -4.04 | NCK1 (NCK adaptor protein 1) | protein interactions | 4690 | 214 | 3 | 19454 | 50 |
TNIK,NTRK2,NHSL1 |
1.765e-02 | -4.04 | animal organ morphogenesis | biological process | GO:0009887 | 988 | 7 | 18204 | 50 |
TNC,SOX5,NTRK2,NRG3,ABLIM1,CTNNA2,FAT3 |
1.782e-02 | -4.03 | dendritic spine head | cellular component | GO:0044327 | 7 | 1 | 19108 | 49 |
SYNE1 |
1.786e-02 | -4.03 | Nde1 (nudE neurodevelopment protein 1) | protein interactions | 67203 | 7 | 1 | 19454 | 50 |
SYNE1 |
1.786e-02 | -4.03 | SSX6P (SSX family member 6, pseudogene) | protein interactions | 280657 | 7 | 1 | 19454 | 50 |
FAT3 |
1.791e-02 | -4.02 | monoatomic cation transport | biological process | GO:0006812 | 766 | 6 | 18204 | 50 |
SLC4A4,GPM6A,ATP1A2,TRPM3,PLCB1,RYR3 |
1.793e-02 | -4.02 | large_cell | COSMIC cancer mutations | large_cell | 14845 | 47 | 16828 | 48 |
LSAMP,RORA,NRCAM,NEBL,GPM6A,NAV2,MGAT4C,ABLIM1,PITPNC1,NHSL1,SLC14A1,ADCY2,GPC5,MACF1,NAV3,FAT3,PLCB1,TNC,RFX4,KALRN,SYNE1,MSI2,DGKG,SOX5,CAMK2G,RBMS3,LRP1B,TNIK,PARD3,TRPM3,ATP1A2,NTRK2,SORBS1,SLC1A2,SLC4A4,SFXN5,CTNND2,NRG3,RYR3,FMN2,DTNA,NTM,NRXN1,DCLK2,HPSE2,DPP6,CNTN1 |
1.794e-02 | -4.02 | adrenal_gland-adrenal_gland-adrenal_cortical_adenoma-cortisol_producing | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_adenoma-cortisol_producing | 72 | 2 | 16828 | 48 |
FMN2,LRP1B |
1.794e-02 | -4.02 | cortisol_producing | COSMIC cancer mutations | cortisol_producing | 72 | 2 | 16828 | 48 |
LRP1B,FMN2 |
1.795e-02 | -4.02 | Activation of TRKA receptors | REACTOME pathways | R-HSA-187015 | 6 | 1 | 10285 | 31 |
NTRK2 |
1.811e-02 | -4.01 | IP3 receptor type 1 binding core, RIH domain | gene3d domains | 1.25.10.30 | 6 | 1 | 14470 | 44 |
RYR3 |
1.811e-02 | -4.01 | Gas2-like domain | gene3d domains | 3.30.920.20 | 6 | 1 | 14470 | 44 |
MACF1 |
1.811e-02 | -4.01 | Dipeptidylpeptidase IV, N-terminal domain | gene3d domains | 2.140.10.30 | 6 | 1 | 14470 | 44 |
DPP6 |
1.811e-02 | -4.01 | Plakin repeat | gene3d domains | 3.90.1290.10 | 6 | 1 | 14470 | 44 |
MACF1 |
1.814e-02 | -4.01 | acute_lymphoblastic_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_leukaemia | 2197 | 12 | 16828 | 48 |
ADCY2,DTNA,SYNE1,KALRN,NTRK2,ATP1A2,DCLK2,CAMK2G,SOX5,SLC4A4,LRP1B,TNIK |
1.826e-02 | -4.00 | GFAP (glial fibrillary acidic protein) | protein interactions | 2670 | 217 | 3 | 19454 | 50 |
RORA,ABLIM1,NKAIN3 |
1.836e-02 | -4.00 | sarcomere | cellular component | GO:0030017 | 218 | 3 | 19108 | 49 |
NEBL,RYR3,SYNE1 |
1.843e-02 | -3.99 | P-type sodium transporter activity | molecular function | GO:0008554 | 7 | 1 | 18094 | 48 |
ATP1A2 |
1.843e-02 | -3.99 | phosphatidic acid transfer activity | molecular function | GO:1990050 | 7 | 1 | 18094 | 48 |
PITPNC1 |
1.843e-02 | -3.99 | P-type sodium:potassium-exchanging transporter activity | molecular function | GO:0005391 | 7 | 1 | 18094 | 48 |
ATP1A2 |
1.843e-02 | -3.99 | calcium-dependent protein serine/threonine phosphatase activity | molecular function | GO:0004723 | 7 | 1 | 18094 | 48 |
CAMK2G |
1.851e-02 | -3.99 | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | 9263 | 34 | 16828 | 48 |
SLC4A4,SORBS1,PITPNC1,NHSL1,CTNND2,NEBL,LSAMP,RORA,TRPM3,ATP1A2,MGAT4C,NTRK2,NAV2,HPSE2,SOX5,CAMK2G,DCLK2,TNIK,CNTN1,LRP1B,FAT3,RYR3,PLCB1,TNC,ADCY2,MACF1,GPC5,NAV3,NKAIN3,DGKG,KALRN,SYNE1,FMN2,MSI2 |
1.852e-02 | -3.99 | regulation of axon extension | biological process | GO:0030516 | 76 | 2 | 18204 | 50 |
NRCAM,MACF1 |
1.875e-02 | -3.98 | Plectin_repeat | interpro domains | IPR001101 | 7 | 1 | 18521 | 50 |
MACF1 |
1.875e-02 | -3.98 | Plakophilin/d_Catenin | interpro domains | IPR028435 | 7 | 1 | 18521 | 50 |
CTNND2 |
1.875e-02 | -3.98 | Na-dicarboxylate_symporter_CS | interpro domains | IPR018107 | 7 | 1 | 18521 | 50 |
SLC1A2 |
1.875e-02 | -3.98 | Alpha-catenin/vinculin-like_sf | interpro domains | IPR036723 | 7 | 1 | 18521 | 50 |
CTNNA2 |
1.875e-02 | -3.98 | Na-dicarboxylate_symporter | interpro domains | IPR001991 | 7 | 1 | 18521 | 50 |
SLC1A2 |
1.875e-02 | -3.98 | Ammonium/urea_transptr | interpro domains | IPR029020 | 7 | 1 | 18521 | 50 |
SLC14A1 |
1.875e-02 | -3.98 | Na:dicarbo_symporter_sf | interpro domains | IPR036458 | 7 | 1 | 18521 | 50 |
SLC1A2 |
1.875e-02 | -3.98 | Hud_Sxl_RNA | interpro domains | IPR002343 | 7 | 1 | 18521 | 50 |
RBMS3 |
1.875e-02 | -3.98 | Plakin_repeat_sf | interpro domains | IPR035915 | 7 | 1 | 18521 | 50 |
MACF1 |
1.898e-02 | -3.96 | cellular response to interleukin-1 | biological process | GO:0071347 | 77 | 2 | 18204 | 50 |
RORA,PLCB1 |
1.898e-02 | -3.96 | regulation of synaptic transmission, glutamatergic | biological process | GO:0051966 | 77 | 2 | 18204 | 50 |
NRXN1,ATP1A2 |
1.898e-02 | -3.96 | positive regulation of axonogenesis | biological process | GO:0050772 | 77 | 2 | 18204 | 50 |
NTRK2,MACF1 |
1.905e-02 | -3.96 | kidney-Wilms_tumour | COSMIC cancer mutations | kidney-Wilms_tumour | 545 | 5 | 16828 | 48 |
DCLK2,FMN2,CAMK2G,NTRK2,TNIK |
1.907e-02 | -3.96 | observational learning | biological process | GO:0098597 | 7 | 1 | 18204 | 50 |
NRXN1 |
1.907e-02 | -3.96 | interneuron migration from the subpallium to the cortex | biological process | GO:0021830 | 7 | 1 | 18204 | 50 |
NRG3 |
1.907e-02 | -3.96 | cellular response to magnesium ion | biological process | GO:0071286 | 7 | 1 | 18204 | 50 |
RYR3 |
1.907e-02 | -3.96 | chromosome movement towards spindle pole | biological process | GO:0051305 | 7 | 1 | 18204 | 50 |
FMN2 |
1.907e-02 | -3.96 | negative regulation of Arp2/3 complex-mediated actin nucleation | biological process | GO:0034316 | 7 | 1 | 18204 | 50 |
CTNNA2 |
1.907e-02 | -3.96 | peripheral nervous system axon regeneration | biological process | GO:0014012 | 7 | 1 | 18204 | 50 |
TNC |
1.907e-02 | -3.96 | parallel actin filament bundle assembly | biological process | GO:0030046 | 7 | 1 | 18204 | 50 |
FMN2 |
1.907e-02 | -3.96 | regulation of monocyte extravasation | biological process | GO:2000437 | 7 | 1 | 18204 | 50 |
PLCB1 |
1.909e-02 | -3.96 | solute:sodium symporter activity | molecular function | GO:0015370 | 80 | 2 | 18094 | 48 |
SLC4A4,SLC1A2 |
1.912e-02 | -3.96 | SDF | pfam domains | PF00375 | 7 | 1 | 17795 | 49 |
SLC1A2 |
1.919e-02 | -3.95 | Wilms_tumour | COSMIC cancer mutations | Wilms_tumour | 546 | 5 | 16828 | 48 |
DCLK2,FMN2,CAMK2G,NTRK2,TNIK |
1.921e-02 | -3.95 | caveola | cellular component | GO:0005901 | 83 | 2 | 19108 | 49 |
ATP1A2,SORBS1 |
1.930e-02 | -3.95 | SYT1 (synaptotagmin 1) | protein interactions | 6857 | 83 | 2 | 19454 | 50 |
GPM6A,NRXN1 |
1.939e-02 | -3.94 | YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta) | protein interactions | 10971 | 1076 | 7 | 19454 | 50 |
SORBS1,PARD3,ABLIM1,NHSL1,NAV2,DCLK2,MACF1 |
1.944e-02 | -3.94 | positive regulation of carbohydrate metabolic process | biological process | GO:0045913 | 78 | 2 | 18204 | 50 |
SORBS1,SLC4A4 |
1.944e-02 | -3.94 | regulation of glucose transmembrane transport | biological process | GO:0010827 | 78 | 2 | 18204 | 50 |
SORBS1,SLC1A2 |
1.944e-02 | -3.94 | dicarboxylic acid transport | biological process | GO:0006835 | 78 | 2 | 18204 | 50 |
SLC1A2,NTRK2 |
1.954e-02 | -3.94 | SH3-like_dom_sf | interpro domains | IPR036028 | 212 | 3 | 18521 | 50 |
NEBL,KALRN,SORBS1 |
1.954e-02 | -3.94 | GLYPICAN | prosite domains | PS01207 | 6 | 1 | 12186 | 40 |
GPC5 |
1.954e-02 | -3.94 | GAR | prosite domains | PS51460 | 6 | 1 | 12186 | 40 |
MACF1 |
1.960e-02 | -3.93 | skin-leg-malignant_melanoma | COSMIC cancer mutations | skin-leg-malignant_melanoma | 549 | 5 | 16828 | 48 |
PLCB1,NRG3,NEBL,SYNE1,LRP1B |
1.961e-02 | -3.93 | G alpha (q) signalling events | REACTOME pathways | R-HSA-416476 | 192 | 3 | 10285 | 31 |
KALRN,DGKG,PLCB1 |
1.962e-02 | -3.93 | Axon guidance | KEGG pathways | ko04360 | 174 | 3 | 7161 | 24 |
ABLIM1,PARD3,CAMK2G |
1.962e-02 | -3.93 | Axon guidance | KEGG pathways | hsa04360 | 174 | 3 | 7161 | 24 |
PARD3,CAMK2G,ABLIM1 |
1.966e-02 | -3.93 | eye-uveal_tract-malignant_melanoma-spindle | COSMIC cancer mutations | eye-uveal_tract-malignant_melanoma-spindle | 363 | 4 | 16828 | 48 |
KALRN,MACF1,CTNND2,TRPM3 |
1.980e-02 | -3.92 | regulation of system process | biological process | GO:0044057 | 571 | 5 | 18204 | 50 |
PARD3,SYNE1,NRXN1,ATP1A2,CAMK2G |
1.991e-02 | -3.92 | FGFR1 (fibroblast growth factor receptor 1) | protein interactions | 2260 | 611 | 5 | 19454 | 50 |
PARD3,TNIK,ABLIM1,DTNA,NHSL1 |
2.015e-02 | -3.90 | skin-upper_arm-malignant_melanoma | COSMIC cancer mutations | skin-upper_arm-malignant_melanoma | 553 | 5 | 16828 | 48 |
LRP1B,SYNE1,FMN2,SLC4A4,PLCB1 |
2.032e-02 | -3.90 | Vasopressin Regulation of Water Homeostasis | SMPDB pathways | SMP0000322 | 7 | 1 | 1369 | 4 |
ADCY2 |
2.032e-02 | -3.90 | G-Protein Signaling Through Tubby Proteins | SMPDB pathways | SMP0089843 | 7 | 1 | 1369 | 4 |
PLCB1 |
2.034e-02 | -3.90 | zonula adherens | cellular component | GO:0005915 | 8 | 1 | 19108 | 49 |
SORBS1 |
2.038e-02 | -3.89 | LHB (luteinizing hormone subunit beta) | protein interactions | 3972 | 8 | 1 | 19454 | 50 |
NTM |
2.038e-02 | -3.89 | INSM1 (INSM transcriptional repressor 1) | protein interactions | 3642 | 8 | 1 | 19454 | 50 |
SORBS1 |
2.038e-02 | -3.89 | CARD16 (caspase recruitment domain family member 16) | protein interactions | 114769 | 8 | 1 | 19454 | 50 |
FAT3 |
2.055e-02 | -3.88 | PRKCD (protein kinase C delta) | protein interactions | 5580 | 227 | 3 | 19454 | 50 |
MACF1,CAMK2G,PLCB1 |
2.063e-02 | -3.88 | SYNJ1 (synaptojanin 1) | protein interactions | 8867 | 86 | 2 | 19454 | 50 |
SORBS1,GPM6A |
2.063e-02 | -3.88 | FAM171A1 (family with sequence similarity 171 member A1) | protein interactions | 221061 | 86 | 2 | 19454 | 50 |
NTRK2,PARD3 |
2.072e-02 | -3.88 | Cysteine Rich Protein | gene3d domains | 2.10.110.10 | 73 | 2 | 14470 | 44 |
ABLIM1,NEBL |
2.085e-02 | -3.87 | Long-term potentiation | KEGG pathways | hsa04720 | 67 | 2 | 7161 | 24 |
PLCB1,CAMK2G |
2.085e-02 | -3.87 | Long-term potentiation | KEGG pathways | ko04720 | 67 | 2 | 7161 | 24 |
CAMK2G,PLCB1 |
2.091e-02 | -3.87 | NrCAM interactions | REACTOME pathways | R-HSA-447038 | 7 | 1 | 10285 | 31 |
NRCAM |
2.092e-02 | -3.87 | phosphatidylinositol-4,5-bisphosphate binding | molecular function | GO:0005546 | 84 | 2 | 18094 | 48 |
PLCB1,PARD3 |
2.101e-02 | -3.86 | EF_hand_dom | interpro domains | IPR002048 | 218 | 3 | 18521 | 50 |
MACF1,DGKG,RYR3 |
2.103e-02 | -3.86 | PCNT (pericentrin) | protein interactions | 5116 | 229 | 3 | 19454 | 50 |
MACF1,KALRN,SYNE1 |
2.103e-02 | -3.86 | P-type potassium transmembrane transporter activity | molecular function | GO:0008556 | 8 | 1 | 18094 | 48 |
ATP1A2 |
2.103e-02 | -3.86 | sodium ion binding | molecular function | GO:0031402 | 8 | 1 | 18094 | 48 |
ATP1A2 |
2.103e-02 | -3.86 | urea transmembrane transporter activity | molecular function | GO:0015204 | 8 | 1 | 18094 | 48 |
SLC14A1 |
2.110e-02 | -3.86 | Ammonium transporter AmtB like domains | gene3d domains | 1.10.3430.10 | 7 | 1 | 14470 | 44 |
SLC14A1 |
2.110e-02 | -3.86 | Sodium:dicarboxylate symporter | gene3d domains | 1.10.3860.10 | 7 | 1 | 14470 | 44 |
SLC1A2 |
2.122e-02 | -3.85 | regulation of response to stimulus | biological process | GO:0048583 | 4104 | 18 | 18204 | 50 |
CTNNA2,MAPK10,CTNND2,NTRK2,SYNE1,RBMS3,FMN2,SORBS1,PLCB1,DGKG,CAMK2G,KALRN,RORA,GPC5,MACF1,TNIK,NRXN1,TNC |
2.127e-02 | -3.85 | ConA-like_dom_sf | interpro domains | IPR013320 | 219 | 3 | 18521 | 50 |
FAT3,RYR3,NRXN1 |
2.130e-02 | -3.85 | nucleotide binding | molecular function | GO:0000166 | 2128 | 11 | 18094 | 48 |
KALRN,DCLK2,MAPK10,NAV3,ATP1A2,CAMK2G,TNIK,DGKG,NTRK2,NAV2,ADCY2 |
2.137e-02 | -3.85 | nucleoside phosphate binding | molecular function | GO:1901265 | 2129 | 11 | 18094 | 48 |
DCLK2,ATP1A2,KALRN,NAV2,ADCY2,NAV3,NTRK2,DGKG,TNIK,CAMK2G,MAPK10 |
2.140e-02 | -3.84 | Adcy | interpro domains | IPR030672 | 8 | 1 | 18521 | 50 |
ADCY2 |
2.140e-02 | -3.84 | TRPM_SLOG | interpro domains | IPR041491 | 8 | 1 | 18521 | 50 |
TRPM3 |
2.140e-02 | -3.84 | RFX-like | interpro domains | IPR039779 | 8 | 1 | 18521 | 50 |
RFX4 |
2.140e-02 | -3.84 | Villin_headpiece_dom_sf | interpro domains | IPR036886 | 8 | 1 | 18521 | 50 |
ABLIM1 |
2.140e-02 | -3.84 | Plakin | interpro domains | IPR043197 | 8 | 1 | 18521 | 50 |
MACF1 |
2.140e-02 | -3.84 | Villin_headpiece | interpro domains | IPR003128 | 8 | 1 | 18521 | 50 |
ABLIM1 |
2.140e-02 | -3.84 | AC_N | interpro domains | IPR032628 | 8 | 1 | 18521 | 50 |
ADCY2 |
2.142e-02 | -3.84 | GAS2 | smart domains | SM00243 | 6 | 1 | 9717 | 35 |
MACF1 |
2.157e-02 | -3.84 | FYN (FYN proto-oncogene, Src family tyrosine kinase) | protein interactions | 2534 | 414 | 4 | 19454 | 50 |
NTRK2,KALRN,CNTN1,CTNND2 |
2.172e-02 | -3.83 | regulation of cell junction assembly | biological process | GO:1901888 | 217 | 3 | 18204 | 50 |
NRXN1,MACF1,NTRK2 |
2.177e-02 | -3.83 | central nervous system myelin formation | biological process | GO:0032289 | 8 | 1 | 18204 | 50 |
CNTN1 |
2.177e-02 | -3.83 | ERBB4 signaling pathway | biological process | GO:0038130 | 8 | 1 | 18204 | 50 |
NRG3 |
2.177e-02 | -3.83 | phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway | biological process | GO:0007207 | 8 | 1 | 18204 | 50 |
PLCB1 |
2.177e-02 | -3.83 | cell proliferation in external granule layer | biological process | GO:0021924 | 8 | 1 | 18204 | 50 |
RORA |
2.177e-02 | -3.83 | cell proliferation in hindbrain | biological process | GO:0021534 | 8 | 1 | 18204 | 50 |
RORA |
2.177e-02 | -3.83 | cellular response to vasopressin | biological process | GO:1904117 | 8 | 1 | 18204 | 50 |
PLCB1 |
2.177e-02 | -3.83 | regulation of synapse structural plasticity | biological process | GO:0051823 | 8 | 1 | 18204 | 50 |
CTNNA2 |
2.177e-02 | -3.83 | ion channel modulating, G protein-coupled receptor signaling pathway | biological process | GO:0099105 | 8 | 1 | 18204 | 50 |
PLCB1 |
2.177e-02 | -3.83 | regulation of L-glutamate import across plasma membrane | biological process | GO:0002036 | 8 | 1 | 18204 | 50 |
ATP1A2 |
2.177e-02 | -3.83 | response to vasopressin | biological process | GO:1904116 | 8 | 1 | 18204 | 50 |
PLCB1 |
2.177e-02 | -3.83 | cerebellar granule cell precursor proliferation | biological process | GO:0021930 | 8 | 1 | 18204 | 50 |
RORA |
2.177e-02 | -3.83 | negative regulation of dendrite development | biological process | GO:2000171 | 8 | 1 | 18204 | 50 |
FAT3 |
2.177e-02 | -3.83 | meiotic cytokinesis | biological process | GO:0033206 | 8 | 1 | 18204 | 50 |
FMN2 |
2.182e-02 | -3.82 | LSDAT_euk | pfam domains | PF18139 | 8 | 1 | 17795 | 49 |
TRPM3 |
2.182e-02 | -3.82 | DCX | pfam domains | PF03607 | 8 | 1 | 17795 | 49 |
DCLK2 |
2.182e-02 | -3.82 | AC_N | pfam domains | PF16214 | 8 | 1 | 17795 | 49 |
ADCY2 |
2.182e-02 | -3.82 | VHP | pfam domains | PF02209 | 8 | 1 | 17795 | 49 |
ABLIM1 |
2.196e-02 | -3.82 | skin-leg-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-leg-malignant_melanoma-superficial_spreading | 210 | 3 | 16828 | 48 |
NTM,LRP1B,SLC4A4 |
2.208e-02 | -3.81 | Chemokine signaling pathway | KEGG pathways | ko04062 | 182 | 3 | 7161 | 24 |
PLCB1,PARD3,ADCY2 |
2.208e-02 | -3.81 | Chemokine signaling pathway | KEGG pathways | hsa04062 | 182 | 3 | 7161 | 24 |
PARD3,ADCY2,PLCB1 |
2.224e-02 | -3.81 | glial cell differentiation | biological process | GO:0010001 | 219 | 3 | 18204 | 50 |
CNTN1,NTRK2,PARD3 |
2.224e-02 | -3.81 | bone-fibula-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-fibula-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 377 | 4 | 16828 | 48 |
MACF1,SYNE1,NRXN1,TRPM3 |
2.233e-02 | -3.80 | peripheral nervous system development | biological process | GO:0007422 | 84 | 2 | 18204 | 50 |
PARD3,NTRK2 |
2.234e-02 | -3.80 | single-stranded RNA binding | molecular function | GO:0003727 | 87 | 2 | 18094 | 48 |
RBMS3,MSI2 |
2.246e-02 | -3.80 | FGFR1OP2 (FGFR1 oncogene partner 2) | protein interactions | 26127 | 90 | 2 | 19454 | 50 |
CAMK2G,TNIK |
2.246e-02 | -3.80 | CTDSPL (CTD small phosphatase like) | protein interactions | 10217 | 90 | 2 | 19454 | 50 |
DTNA,FMN2 |
2.250e-02 | -3.79 | response to mechanical stimulus | biological process | GO:0009612 | 220 | 3 | 18204 | 50 |
NRXN1,ATP1A2,TNC |
2.256e-02 | -3.79 | EDTRNSPORT | prints domains | PR00173 | 7 | 1 | 5227 | 17 |
SLC1A2 |
2.256e-02 | -3.79 | HUDSXLRNA | prints domains | PR00961 | 7 | 1 | 5227 | 17 |
RBMS3 |
2.260e-02 | -3.79 | synovial | COSMIC cancer mutations | synovial | 8 | 1 | 16828 | 48 |
CNTN1 |
2.260e-02 | -3.79 | bone-knee-chondrosarcoma-synovial | COSMIC cancer mutations | bone-knee-chondrosarcoma-synovial | 8 | 1 | 16828 | 48 |
CNTN1 |
2.264e-02 | -3.79 | LIM_DOMAIN_1 | prosite domains | PS00478 | 71 | 2 | 12186 | 40 |
ABLIM1,NEBL |
2.264e-02 | -3.79 | LIM_DOMAIN_2 | prosite domains | PS50023 | 71 | 2 | 12186 | 40 |
ABLIM1,NEBL |
2.272e-02 | -3.78 | human chr3p24.1 | chromosome location | human chr3p24.1 | 12 | 1 | 26134 | 50 |
RBMS3 |
2.272e-02 | -3.78 | human chr6q25.2 | chromosome location | human chr6q25.2 | 12 | 1 | 26134 | 50 |
SYNE1 |
2.276e-02 | -3.78 | NA_DICARBOXYL_SYMP_1 | prosite domains | PS00713 | 7 | 1 | 12186 | 40 |
SLC1A2 |
2.276e-02 | -3.78 | NA_DICARBOXYL_SYMP_2 | prosite domains | PS00714 | 7 | 1 | 12186 | 40 |
SLC1A2 |
2.283e-02 | -3.78 | oligodendrocyte differentiation | biological process | GO:0048709 | 85 | 2 | 18204 | 50 |
CNTN1,NTRK2 |
2.285e-02 | -3.78 | flotillin complex | cellular component | GO:0016600 | 9 | 1 | 19108 | 49 |
SORBS1 |
2.290e-02 | -3.78 | Tyw3 (tRNA-yW synthesizing protein 3 homolog (S. cerevisiae)) | protein interactions | 209584 | 9 | 1 | 19454 | 50 |
CTNNA2 |
2.290e-02 | -3.78 | CUX2 (cut like homeobox 2) | protein interactions | 23316 | 9 | 1 | 19454 | 50 |
NAV3 |
2.290e-02 | -3.78 | DUX3 (double homeobox 3) | protein interactions | 26582 | 9 | 1 | 19454 | 50 |
FAT3 |
2.290e-02 | -3.78 | MMP19 (matrix metallopeptidase 19) | protein interactions | 4327 | 9 | 1 | 19454 | 50 |
SYNE1 |
2.290e-02 | -3.78 | RBPJL (recombination signal binding protein for immunoglobulin kappa J region like) | protein interactions | 11317 | 9 | 1 | 19454 | 50 |
FAT3 |
2.290e-02 | -3.78 | CAMK2N1 (calcium/calmodulin dependent protein kinase II inhibitor 1) | protein interactions | 55450 | 9 | 1 | 19454 | 50 |
CAMK2G |
2.290e-02 | -3.78 | NRXN2 (neurexin 2) | protein interactions | 9379 | 9 | 1 | 19454 | 50 |
MACF1 |
2.292e-02 | -3.78 | SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1) | protein interactions | 6654 | 91 | 2 | 19454 | 50 |
SORBS1,TNIK |
2.299e-02 | -3.77 | CAMK2A (calcium/calmodulin dependent protein kinase II alpha) | protein interactions | 815 | 237 | 3 | 19454 | 50 |
CAMK2G,GPM6A,SOX5 |
2.299e-02 | -3.77 | CLU (clusterin) | protein interactions | 1191 | 237 | 3 | 19454 | 50 |
LRP1B,TNIK,TNC |
2.320e-02 | -3.76 | Acrivastine H1-Antihistamine Action | SMPDB pathways | SMP0059881 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Chlorcyclizine H1-Antihistamine Action | SMPDB pathways | SMP0058931 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Thenyldiamine H1-Antihistamine Action | SMPDB pathways | SMP0062624 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Phenyltoloxamine H1-Antihistamine Action | SMPDB pathways | SMP0058916 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Bromodiphenhydramine H1-Antihistamine Action | SMPDB pathways | SMP0058813 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Flunarizine H1-Antihistamine Action | SMPDB pathways | SMP0061047 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Orphenadrine H1-Antihistamine Action | SMPDB pathways | SMP0058808 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Terfenadine H1-Antihistamine Action | SMPDB pathways | SMP0060208 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Betahistine H1-Antihistamine Action | SMPDB pathways | SMP0060744 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Dimetindene H1-Antihistamine Action | SMPDB pathways | SMP0057582 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Brompheniramine H1-Antihistamine Action | SMPDB pathways | SMP0057579 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Tritoqualine H1-Antihistamine Action | SMPDB pathways | SMP0062895 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Clemastine H1-Antihistamine Action | SMPDB pathways | SMP0058891 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Olopatadine H1-Antihistamine Action | SMPDB pathways | SMP0060740 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Histapyrrodine H1-Antihistamine Action | SMPDB pathways | SMP0058732 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Oxomemazine H1-Antihistamine Action | SMPDB pathways | SMP0059738 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin | SMPDB pathways | SMP0000354 | 8 | 1 | 1369 | 4 |
ADCY2 |
2.320e-02 | -3.76 | Chloropyramine H1-Antihistamine Action | SMPDB pathways | SMP0057585 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Mepyramine H1-Antihistamine Action | SMPDB pathways | SMP0057583 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Ebastine H1-Antihistamine Action | SMPDB pathways | SMP0060204 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Diphenhydramine H1-Antihistamine Action | SMPDB pathways | SMP0058785 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Quetiapine H1-Antihistamine Action | SMPDB pathways | SMP0062884 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Thonzylamine H1-Antihistamine Action | SMPDB pathways | SMP0058769 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Mizolastine H1-Antihistamine Action | SMPDB pathways | SMP0060230 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Temelastine H1-Antihistamine Action | SMPDB pathways | SMP0062880 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Triprolidine H1-Antihistamine Action | SMPDB pathways | SMP0057581 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Pimethixene H1-Antihistamine Action | SMPDB pathways | SMP0062886 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Epinastine H1-Antihistamine Action | SMPDB pathways | SMP0061191 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Histamine H1 Receptor Activation | SMPDB pathways | SMP0063452 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Chlorphenoxamine H1-Antihistamine Action | SMPDB pathways | SMP0058903 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Cetirizine H1-Antihistamine Action | SMPDB pathways | SMP0059058 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Doxepin H1-Antihistamine Action | SMPDB pathways | SMP0059872 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Tripelennamine H1-Antihistamine Action | SMPDB pathways | SMP0057587 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Lysophosphatidic Acid LPA3 Signalling | SMPDB pathways | SMP0063755 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Methdilazine H1-Antihistamine Action | SMPDB pathways | SMP0059730 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Azatadine H1-Antihistamine Action | SMPDB pathways | SMP0059865 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Emedastine H1-Antihistamine Action | SMPDB pathways | SMP0061040 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Carbinoxamine H1-Antihistamine Action | SMPDB pathways | SMP0058797 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Oxatomide H1-Antihistamine Action | SMPDB pathways | SMP0059044 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Phenbenzamine H1-Antihistamine Action | SMPDB pathways | SMP0059702 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Loratadine H1-Antihistamine Action | SMPDB pathways | SMP0060195 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Chlorphenamine H1-Antihistamine Action | SMPDB pathways | SMP0056661 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Deptropine H1-Antihistamine Action | SMPDB pathways | SMP0062883 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Mirtazapine H1-Antihistamine Action | SMPDB pathways | SMP0062885 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Fexofenadine H1-Antihistamine Action | SMPDB pathways | SMP0060218 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Rupatadine H1-Antihistamine Action | SMPDB pathways | SMP0060235 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Doxylamine H1-Antihistamine Action | SMPDB pathways | SMP0058803 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Hydroxyzine H1-Antihistamine Action | SMPDB pathways | SMP0058936 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Homochlorcyclizine H1-Antihistamine Action | SMPDB pathways | SMP0062795 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Bamipine H1-Antihistamine Action | SMPDB pathways | SMP0062882 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Astemizole H1-Antihistamine Action | SMPDB pathways | SMP0059897 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Cyproheptadine H1-Antihistamine Action | SMPDB pathways | SMP0059694 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Cinnarizine H1-Antihistamine Action | SMPDB pathways | SMP0059110 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Azelastine H1-Antihistamine Action | SMPDB pathways | SMP0060741 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Clocinizine H1-Antihistamine Action | SMPDB pathways | SMP0062788 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Tolpropamine H1-Antihistamine Action | SMPDB pathways | SMP0062621 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Methapyrilene H1-Antihistamine Action | SMPDB pathways | SMP0058741 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Levocetirizine H1-Antihistamine Action | SMPDB pathways | SMP0059114 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Buclizine H1-Antihistamine Action | SMPDB pathways | SMP0058964 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Mequitazine H1-Antihistamine Action | SMPDB pathways | SMP0059720 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Meclizine H1-Antihistamine Action | SMPDB pathways | SMP0058956 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Talastine H1-Antihistamine Action | SMPDB pathways | SMP0057586 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Thenalidine H1-Antihistamine Action | SMPDB pathways | SMP0062894 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Phenindamine H1-Antihistamine Action | SMPDB pathways | SMP0061190 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Latrepirdine H1-Antihistamine Action | SMPDB pathways | SMP0062623 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Isothipendyl H1-Antihistamine Action | SMPDB pathways | SMP0059716 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Propiomazine H1-Antihistamine Action | SMPDB pathways | SMP0062625 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Pheniramine H1-Antihistamine Action | SMPDB pathways | SMP0056662 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Pyrrobutamine H1-Antihistamine Action | SMPDB pathways | SMP0062887 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Cyclizine H1-Antihistamine Action | SMPDB pathways | SMP0058923 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Quifenadine H1-Antihistamine Action | SMPDB pathways | SMP0060743 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Mebhydrolin H1-Antihistamine Action | SMPDB pathways | SMP0061052 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Ketotifen H1-Antihistamine Action | SMPDB pathways | SMP0059868 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Hydroxyethylpromethazine H1-Antihistamine Action | SMPDB pathways | SMP0059710 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Embramine H1-Antihistamine Action | SMPDB pathways | SMP0062622 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Antazoline H1-Antihistamine Action | SMPDB pathways | SMP0057584 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Thiazinamium H1-Antihistamine Action | SMPDB pathways | SMP0060742 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Alimemazine H1-Antihistamine Action | SMPDB pathways | SMP0059689 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Levocabastine H1-Antihistamine Action | SMPDB pathways | SMP0060224 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Fenethazine H1-Antihistamine Action | SMPDB pathways | SMP0059707 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Dexchlorpheniramine H1-Antihistamine Action | SMPDB pathways | SMP0056811 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Bilastine H1-Antihistamine Action | SMPDB pathways | SMP0060170 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Diphenylpyraline H1-Antihistamine Action | SMPDB pathways | SMP0058908 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Bepotastine H1-Antihistamine Action | SMPDB pathways | SMP0060058 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Alcaftadine H1-Antihistamine Action | SMPDB pathways | SMP0062881 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Dexbrompheniramine H1-Antihistamine Action | SMPDB pathways | SMP0057580 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Promethazine H1-Antihistamine Action | SMPDB pathways | SMP0059211 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.320e-02 | -3.76 | Desloratadine H1-Antihistamine Action | SMPDB pathways | SMP0060201 | 8 | 1 | 1369 | 4 |
PLCB1 |
2.334e-02 | -3.76 | central nervous system neuron development | biological process | GO:0021954 | 86 | 2 | 18204 | 50 |
DCLK2,NTRK2 |
2.334e-02 | -3.76 | myofibril | cellular component | GO:0030016 | 239 | 3 | 19108 | 49 |
SYNE1,RYR3,NEBL |
2.346e-02 | -3.75 | cellular response to oxygen-containing compound | biological process | GO:1901701 | 1047 | 7 | 18204 | 50 |
SORBS1,PLCB1,TNC,RORA,RYR3,SLC1A2,ADCY2 |
2.352e-02 | -3.75 | organic anion transport | biological process | GO:0015711 | 398 | 4 | 18204 | 50 |
NTRK2,SLC4A4,SLC1A2,SFXN5 |
2.384e-02 | -3.74 | DISC1 (DISC1 scaffold protein) | protein interactions | 27185 | 427 | 4 | 19454 | 50 |
SYNE1,TNIK,MACF1,KALRN |
2.387e-02 | -3.74 | Free fatty acids regulate insulin secretion | REACTOME pathways | R-HSA-400451 | 8 | 1 | 10285 | 31 |
PLCB1 |
2.387e-02 | -3.74 | Release of Hh-Np from the secreting cell | REACTOME pathways | R-HSA-5362798 | 8 | 1 | 10285 | 31 |
GPC5 |
2.387e-02 | -3.74 | Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | REACTOME pathways | R-HSA-434316 | 8 | 1 | 10285 | 31 |
PLCB1 |
2.400e-02 | -3.73 | spindle | COSMIC cancer mutations | spindle | 386 | 4 | 16828 | 48 |
KALRN,CTNND2,MACF1,TRPM3 |
2.401e-02 | -3.73 | ERBIN (erbb2 interacting protein) | protein interactions | 55914 | 241 | 3 | 19454 | 50 |
NTRK2,CTNND2,PARD3 |
2.404e-02 | -3.73 | Peptidase_S9 | interpro domains | IPR001375 | 9 | 1 | 18521 | 50 |
DPP6 |
2.404e-02 | -3.73 | Doublecortin_dom | interpro domains | IPR003533 | 9 | 1 | 18521 | 50 |
DCLK2 |
2.404e-02 | -3.73 | DNA-bd_RFX | interpro domains | IPR003150 | 9 | 1 | 18521 | 50 |
RFX4 |
2.404e-02 | -3.73 | Band3_cytoplasmic_dom | interpro domains | IPR013769 | 9 | 1 | 18521 | 50 |
SLC4A4 |
2.407e-02 | -3.73 | Villin headpiece domain | gene3d domains | 1.10.950.10 | 8 | 1 | 14470 | 44 |
ABLIM1 |
2.410e-02 | -3.73 | regulation of cell growth | biological process | GO:0001558 | 401 | 4 | 18204 | 50 |
NRG3,TNC,NRCAM,MACF1 |
2.420e-02 | -3.72 | fibula | COSMIC cancer mutations | fibula | 387 | 4 | 16828 | 48 |
TRPM3,MACF1,SYNE1,NRXN1 |
2.426e-02 | -3.72 | clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | clear_cell_renal_cell_carcinoma | 13924 | 45 | 16828 | 48 |
NEBL,NRCAM,LSAMP,RORA,MGAT4C,NAV2,GPM6A,ABLIM1,NHSL1,SLC14A1,PITPNC1,PLCB1,TNC,FAT3,NAV3,ADCY2,GPC5,MACF1,DGKG,MSI2,KALRN,SYNE1,CAMK2G,SOX5,TNIK,LRP1B,ATP1A2,NTRK2,TRPM3,PARD3,SLC1A2,SLC4A4,SORBS1,SFXN5,CTNND2,RYR3,NRG3,NKAIN3,FMN2,DTNA,HPSE2,NRXN1,DCLK2,CNTN1,DPP6 |
2.426e-02 | -3.72 | kidney-carcinoma-clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-clear_cell_renal_cell_carcinoma | 13924 | 45 | 16828 | 48 |
NEBL,NRCAM,RORA,LSAMP,MGAT4C,NAV2,GPM6A,ABLIM1,NHSL1,SLC14A1,PITPNC1,PLCB1,TNC,FAT3,NAV3,ADCY2,MACF1,GPC5,DGKG,MSI2,KALRN,SYNE1,CAMK2G,SOX5,TNIK,LRP1B,ATP1A2,NTRK2,TRPM3,PARD3,SLC1A2,SLC4A4,SORBS1,SFXN5,CTNND2,RYR3,NRG3,NKAIN3,DTNA,FMN2,HPSE2,NRXN1,DCLK2,CNTN1,DPP6 |
2.435e-02 | -3.72 | WWC1 (WW and C2 domain containing 1) | protein interactions | 23286 | 94 | 2 | 19454 | 50 |
TNIK,ABLIM1 |
2.435e-02 | -3.72 | GRIN1 (glutamate ionotropic receptor NMDA type subunit 1) | protein interactions | 2902 | 94 | 2 | 19454 | 50 |
NTRK2,CAMK2G |
2.439e-02 | -3.71 | regulation of growth | biological process | GO:0040008 | 603 | 5 | 18204 | 50 |
PLCB1,NRG3,TNC,NRCAM,MACF1 |
2.446e-02 | -3.71 | hindbrain radial glia guided cell migration | biological process | GO:0021932 | 9 | 1 | 18204 | 50 |
CTNNA2 |
2.446e-02 | -3.71 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | biological process | GO:0014808 | 9 | 1 | 18204 | 50 |
RYR3 |
2.446e-02 | -3.71 | negative regulation of striated muscle contraction | biological process | GO:0045988 | 9 | 1 | 18204 | 50 |
ATP1A2 |
2.446e-02 | -3.71 | interleukin-12-mediated signaling pathway | biological process | GO:0035722 | 9 | 1 | 18204 | 50 |
PLCB1 |
2.446e-02 | -3.71 | negative regulation of actin nucleation | biological process | GO:0051126 | 9 | 1 | 18204 | 50 |
CTNNA2 |
2.446e-02 | -3.71 | positive regulation of synapse maturation | biological process | GO:0090129 | 9 | 1 | 18204 | 50 |
NRXN1 |
2.446e-02 | -3.71 | mesenchymal-epithelial cell signaling | biological process | GO:0060638 | 9 | 1 | 18204 | 50 |
TNC |
2.446e-02 | -3.71 | negative regulation of cellular extravasation | biological process | GO:0002692 | 9 | 1 | 18204 | 50 |
PLCB1 |
2.450e-02 | -3.71 | upper_arm | COSMIC cancer mutations | upper_arm | 582 | 5 | 16828 | 48 |
PLCB1,SLC4A4,FMN2,SYNE1,LRP1B |
2.452e-02 | -3.71 | Band_3_cyto | pfam domains | PF07565 | 9 | 1 | 17795 | 49 |
SLC4A4 |
2.452e-02 | -3.71 | RFX_DNA_binding | pfam domains | PF02257 | 9 | 1 | 17795 | 49 |
RFX4 |
2.452e-02 | -3.71 | Peptidase_S9 | pfam domains | PF00326 | 9 | 1 | 17795 | 49 |
DPP6 |
2.460e-02 | -3.70 | cellular localization | biological process | GO:0051641 | 2660 | 13 | 18204 | 50 |
PARD3,SLC1A2,SYNE1,FMN2,DCLK2,NRCAM,SLC14A1,CAMK2G,DPP6,TNIK,LRP1B,NRXN1,MACF1 |
2.471e-02 | -3.70 | macromolecule localization | biological process | GO:0033036 | 2376 | 12 | 18204 | 50 |
CAMK2G,NRCAM,DPP6,MACF1,TNIK,LRP1B,NRXN1,PARD3,PITPNC1,SYNE1,FMN2,DCLK2 |
2.483e-02 | -3.70 | HER-positive_carcinoma | COSMIC cancer mutations | HER-positive_carcinoma | 2025 | 11 | 16828 | 48 |
NTRK2,MSI2,NRG3,TNC,GPC5,RORA,NRCAM,CNTN1,DPP6,ABLIM1,RBMS3 |
2.483e-02 | -3.70 | breast-carcinoma-HER-positive_carcinoma | COSMIC cancer mutations | breast-carcinoma-HER-positive_carcinoma | 2025 | 11 | 16828 | 48 |
NTRK2,MSI2,NRG3,TNC,GPC5,RORA,NRCAM,CNTN1,DPP6,ABLIM1,RBMS3 |
2.483e-02 | -3.70 | STRIP1 (striatin interacting protein 1) | protein interactions | 85369 | 95 | 2 | 19454 | 50 |
CAMK2G,TNIK |
2.495e-02 | -3.69 | PLEC | smart domains | SM00250 | 7 | 1 | 9717 | 35 |
MACF1 |
2.499e-02 | -3.69 | peritoneum-appendix-other-pseudomyxoma_peritonei | COSMIC cancer mutations | peritoneum-appendix-other-pseudomyxoma_peritonei | 585 | 5 | 16828 | 48 |
TNC,PLCB1,FAT3,MACF1,SYNE1 |
2.499e-02 | -3.69 | pseudomyxoma_peritonei | COSMIC cancer mutations | pseudomyxoma_peritonei | 585 | 5 | 16828 | 48 |
FAT3,TNC,PLCB1,MACF1,SYNE1 |
2.515e-02 | -3.68 | appendix | COSMIC cancer mutations | appendix | 586 | 5 | 16828 | 48 |
SYNE1,MACF1,TNC,PLCB1,FAT3 |
2.521e-02 | -3.68 | sarcoplasm | cellular component | GO:0016528 | 96 | 2 | 19108 | 49 |
CAMK2G,RYR3 |
2.531e-02 | -3.68 | uveal_tract | COSMIC cancer mutations | uveal_tract | 587 | 5 | 16828 | 48 |
TRPM3,CTNND2,MACF1,KALRN,ADCY2 |
2.531e-02 | -3.68 | peritoneum | COSMIC cancer mutations | peritoneum | 587 | 5 | 16828 | 48 |
FAT3,TNC,PLCB1,MACF1,SYNE1 |
2.541e-02 | -3.67 | CHRDL1 (chordin like 1) | protein interactions | 91851 | 10 | 1 | 19454 | 50 |
LRP1B |
2.541e-02 | -3.67 | AXDND1 (axonemal dynein light chain domain containing 1) | protein interactions | 126859 | 10 | 1 | 19454 | 50 |
SYNE1 |
2.541e-02 | -3.67 | Vbp1 (von Hippel-Lindau binding protein 1) | protein interactions | 22327 | 10 | 1 | 19454 | 50 |
ABLIM1 |
2.541e-02 | -3.67 | SLC8A2 (solute carrier family 8 member A2) | protein interactions | 6543 | 10 | 1 | 19454 | 50 |
GPM6A |
2.541e-02 | -3.67 | IL17RE (interleukin 17 receptor E) | protein interactions | 132014 | 10 | 1 | 19454 | 50 |
FAT3 |
2.541e-02 | -3.67 | GSG1 (germ cell associated 1) | protein interactions | 83445 | 10 | 1 | 19454 | 50 |
PITPNC1 |
2.541e-02 | -3.67 | ZNF563 (zinc finger protein 563) | protein interactions | 147837 | 10 | 1 | 19454 | 50 |
LRP1B |
2.541e-02 | -3.67 | NAT8L (N-acetyltransferase 8 like) | protein interactions | 339983 | 10 | 1 | 19454 | 50 |
FAT3 |
2.541e-02 | -3.67 | CALB2 (calbindin 2) | protein interactions | 794 | 10 | 1 | 19454 | 50 |
GPM6A |
2.541e-02 | -3.67 | DOA4 (ubiquitin-specific protease DOA4) | protein interactions | 851641 | 10 | 1 | 19454 | 50 |
NAV2 |
2.546e-02 | -3.67 | regulation of biological process | biological process | GO:0050789 | 12079 | 40 | 18204 | 50 |
HPSE2,SLC1A2,MAPK10,ADCY2,CNTN1,FAT3,RYR3,NKAIN3,PLCB1,FMN2,NAV3,SYNE1,RFX4,RBMS3,NRCAM,DTNA,NRXN1,GPC5,DPP6,SFXN5,PITPNC1,CTNNA2,PARD3,SOX5,ATP1A2,NTRK2,CTNND2,DCLK2,SORBS1,GPM6A,CAMK2G,DGKG,NRG3,KALRN,MSI2,TNIK,MACF1,RORA,SLC4A4,TNC |
2.551e-02 | -3.67 | lipid binding | molecular function | GO:0008289 | 861 | 6 | 18094 | 48 |
PITPNC1,PARD3,ATP1A2,RORA,DGKG,PLCB1 |
2.579e-02 | -3.66 | biological regulation | biological process | GO:0065007 | 12501 | 41 | 18204 | 50 |
PLCB1,FMN2,NAV3,SYNE1,RFX4,RBMS3,NKAIN3,RYR3,SLC1A2,HPSE2,MAPK10,ADCY2,CNTN1,FAT3,DPP6,NAV2,NRXN1,GPC5,NRCAM,DTNA,SORBS1,ATP1A2,SOX5,DCLK2,CTNND2,NTRK2,PARD3,SFXN5,PITPNC1,CTNNA2,TNC,TNIK,MACF1,RORA,SLC4A4,NRG3,KALRN,MSI2,GPM6A,CAMK2G,DGKG |
2.581e-02 | -3.66 | BTG3 (BTG anti-proliferation factor 3) | protein interactions | 10950 | 97 | 2 | 19454 | 50 |
DCLK2,SYNE1 |
2.581e-02 | -3.66 | SYNE1 (spectrin repeat containing nuclear envelope protein 1) | protein interactions | 23345 | 97 | 2 | 19454 | 50 |
SYNE1,TNIK |
2.585e-02 | -3.66 | NCOR2 (nuclear receptor corepressor 2) | protein interactions | 9612 | 248 | 3 | 19454 | 50 |
DGKG,SOX5,TNIK |
2.595e-02 | -3.65 | contractile muscle fiber | cellular component | GO:0043292 | 249 | 3 | 19108 | 49 |
NEBL,SYNE1,RYR3 |
2.597e-02 | -3.65 | HP | prosite domains | PS51089 | 8 | 1 | 12186 | 40 |
ABLIM1 |
2.607e-02 | -3.65 | Excitatory Neural Signalling Through 5-HTR 6 and Serotonin | SMPDB pathways | SMP0000312 | 9 | 1 | 1369 | 4 |
ADCY2 |
2.607e-02 | -3.65 | Lysophosphatidic Acid LPA1 Signalling | SMPDB pathways | SMP0063746 | 9 | 1 | 1369 | 4 |
PLCB1 |
2.607e-02 | -3.65 | Excitatory Neural Signalling Through 5-HTR 7 and Serotonin | SMPDB pathways | SMP0000311 | 9 | 1 | 1369 | 4 |
ADCY2 |
2.607e-02 | -3.65 | Lysophosphatidic Acid LPA2 Signalling | SMPDB pathways | SMP0063753 | 9 | 1 | 1369 | 4 |
PLCB1 |
2.607e-02 | -3.65 | Excitatory Neural Signalling Through 5-HTR 4 and Serotonin | SMPDB pathways | SMP0000309 | 9 | 1 | 1369 | 4 |
ADCY2 |
2.607e-02 | -3.65 | Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone | SMPDB pathways | SMP0000333 | 9 | 1 | 1369 | 4 |
ADCY2 |
2.607e-02 | -3.65 | Intracellular Signalling Through Histamine H2 Receptor and Histamine | SMPDB pathways | SMP0000335 | 9 | 1 | 1369 | 4 |
ADCY2 |
2.612e-02 | -3.65 | GAN (gigaxonin) | protein interactions | 8139 | 249 | 3 | 19454 | 50 |
SYNE1,CTNNA2,PLCB1 |
2.622e-02 | -3.64 | neurotrophin binding | molecular function | GO:0043121 | 10 | 1 | 18094 | 48 |
NTRK2 |
2.622e-02 | -3.64 | phosphatidylinositol transfer activity | molecular function | GO:0008526 | 10 | 1 | 18094 | 48 |
PITPNC1 |
2.625e-02 | -3.64 | cell surface | cellular component | GO:0009986 | 896 | 6 | 19108 | 49 |
SLC1A2,NRXN1,GPC5,SLC4A4,NRCAM,ATP1A2 |
2.631e-02 | -3.64 | FRAS1 (Fraser extracellular matrix complex subunit 1) | protein interactions | 80144 | 98 | 2 | 19454 | 50 |
MGAT4C,HPSE2 |
2.645e-02 | -3.63 | protein tetramerization | biological process | GO:0051262 | 92 | 2 | 18204 | 50 |
RYR3,TRPM3 |
2.646e-02 | -3.63 | human chr2p13.2 | chromosome location | human chr2p13.2 | 14 | 1 | 26134 | 50 |
SFXN5 |
2.646e-02 | -3.63 | human chr2p16.3 | chromosome location | human chr2p16.3 | 14 | 1 | 26134 | 50 |
NRXN1 |
2.646e-02 | -3.63 | human chr9q33.1 | chromosome location | human chr9q33.1 | 14 | 1 | 26134 | 50 |
TNC |
2.648e-02 | -3.63 | ankle | COSMIC cancer mutations | ankle | 398 | 4 | 16828 | 48 |
PLCB1,NRG3,PARD3,KALRN |
2.667e-02 | -3.62 | Endothelins | Pathway Interaction DB | endothelinpathway | 53 | 2 | 2226 | 11 |
ADCY2,PLCB1 |
2.668e-02 | -3.62 | HCO3_transpt-like_TM_dom | interpro domains | IPR011531 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.668e-02 | -3.62 | Diacylglycerol_kin_accessory | interpro domains | IPR000756 | 10 | 1 | 18521 | 50 |
DGKG |
2.668e-02 | -3.62 | MIR_motif | interpro domains | IPR016093 | 10 | 1 | 18521 | 50 |
RYR3 |
2.668e-02 | -3.62 | MIR_dom_sf | interpro domains | IPR036300 | 10 | 1 | 18521 | 50 |
RYR3 |
2.668e-02 | -3.62 | HCO3_transpt_euk | interpro domains | IPR003020 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.668e-02 | -3.62 | DGK | interpro domains | IPR037607 | 10 | 1 | 18521 | 50 |
DGKG |
2.668e-02 | -3.62 | PTrfase/Anion_transptr | interpro domains | IPR016152 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.668e-02 | -3.62 | Doublecortin_dom_sf | interpro domains | IPR036572 | 10 | 1 | 18521 | 50 |
DCLK2 |
2.678e-02 | -3.62 | YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon) | protein interactions | 7531 | 1150 | 7 | 19454 | 50 |
SORBS1,PARD3,ABLIM1,CAMK2G,NAV2,DCLK2,MACF1 |
2.682e-02 | -3.62 | LIM | smart domains | SM00132 | 71 | 2 | 9717 | 35 |
ABLIM1,NEBL |
2.685e-02 | -3.62 | KRAS (KRAS proto-oncogene, GTPase) | protein interactions | 3845 | 2876 | 13 | 19454 | 50 |
MACF1,PLCB1,TNIK,RFX4,FMN2,CAMK2G,NAV2,DTNA,ABLIM1,DCLK2,SLC4A4,NAV3,PARD3 |
2.688e-02 | -3.62 | Opioid Signalling | REACTOME pathways | R-HSA-111885 | 85 | 2 | 10285 | 31 |
PLCB1,ADCY2 |
2.699e-02 | -3.61 | regulation of extent of cell growth | biological process | GO:0061387 | 93 | 2 | 18204 | 50 |
MACF1,NRCAM |
2.701e-02 | -3.61 | anchoring junction | cellular component | GO:0070161 | 902 | 6 | 19108 | 49 |
SORBS1,ATP1A2,CTNND2,TNC,PARD3,CTNNA2 |
2.704e-02 | -3.61 | Doublecortin domain | gene3d domains | 3.10.20.230 | 9 | 1 | 14470 | 44 |
DCLK2 |
2.712e-02 | -3.61 | craniopharyngioma | COSMIC cancer mutations | craniopharyngioma | 401 | 4 | 16828 | 48 |
RYR3,NRCAM,PARD3,SYNE1 |
2.712e-02 | -3.61 | craniopharyngeal_duct | COSMIC cancer mutations | craniopharyngeal_duct | 401 | 4 | 16828 | 48 |
NRCAM,PARD3,SYNE1,RYR3 |
2.714e-02 | -3.61 | establishment of centrosome localization | biological process | GO:0051660 | 10 | 1 | 18204 | 50 |
PARD3 |
2.714e-02 | -3.61 | substrate-independent telencephalic tangential interneuron migration | biological process | GO:0021843 | 10 | 1 | 18204 | 50 |
NRG3 |
2.714e-02 | -3.61 | urea transmembrane transport | biological process | GO:0071918 | 10 | 1 | 18204 | 50 |
SLC14A1 |
2.714e-02 | -3.61 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | biological process | GO:1903514 | 10 | 1 | 18204 | 50 |
RYR3 |
2.714e-02 | -3.61 | postsynaptic membrane assembly | biological process | GO:0097104 | 10 | 1 | 18204 | 50 |
NRXN1 |
2.714e-02 | -3.61 | regulation of mesenchymal stem cell differentiation | biological process | GO:2000739 | 10 | 1 | 18204 | 50 |
SOX5 |
2.714e-02 | -3.61 | trans-synaptic signaling, modulating synaptic transmission | biological process | GO:0099550 | 10 | 1 | 18204 | 50 |
NTRK2 |
2.714e-02 | -3.61 | cAMP biosynthetic process | biological process | GO:0006171 | 10 | 1 | 18204 | 50 |
ADCY2 |
2.714e-02 | -3.61 | retinal rod cell development | biological process | GO:0046548 | 10 | 1 | 18204 | 50 |
NTRK2 |
2.714e-02 | -3.61 | substrate-independent telencephalic tangential migration | biological process | GO:0021826 | 10 | 1 | 18204 | 50 |
NRG3 |
2.714e-02 | -3.61 | cellular response to cocaine | biological process | GO:0071314 | 10 | 1 | 18204 | 50 |
SLC1A2 |
2.714e-02 | -3.61 | learned vocalization behavior or vocal learning | biological process | GO:0098598 | 10 | 1 | 18204 | 50 |
NRXN1 |
2.714e-02 | -3.61 | postsynaptic density assembly | biological process | GO:0097107 | 10 | 1 | 18204 | 50 |
NRXN1 |
2.714e-02 | -3.61 | cellular response to brain-derived neurotrophic factor stimulus | biological process | GO:1990416 | 10 | 1 | 18204 | 50 |
NTRK2 |
2.719e-02 | -3.61 | extrinsic component of plasma membrane | cellular component | GO:0019897 | 100 | 2 | 19108 | 49 |
CTNNA2,DTNA |
2.720e-02 | -3.60 | HCO3_cotransp | pfam domains | PF00955 | 10 | 1 | 17795 | 49 |
SLC4A4 |
2.720e-02 | -3.60 | DAGK_acc | pfam domains | PF00609 | 10 | 1 | 17795 | 49 |
DGKG |
2.720e-02 | -3.60 | MIR | pfam domains | PF02815 | 10 | 1 | 17795 | 49 |
RYR3 |
2.731e-02 | -3.60 | APBA1 (amyloid beta precursor protein binding family A member 1) | protein interactions | 320 | 100 | 2 | 19454 | 50 |
ABLIM1,NRXN1 |
2.731e-02 | -3.60 | ATP4A (ATPase H+/K+ transporting subunit alpha) | protein interactions | 495 | 100 | 2 | 19454 | 50 |
GPM6A,ATP1A2 |
2.756e-02 | -3.59 | muscle contraction | biological process | GO:0006936 | 238 | 3 | 18204 | 50 |
DTNA,ATP1A2,RYR3 |
2.756e-02 | -3.59 | protein localization to cell periphery | biological process | GO:1990778 | 238 | 3 | 18204 | 50 |
DPP6,MACF1,TNIK |
2.772e-02 | -3.59 | EGF_Ca-bd_CS | interpro domains | IPR018097 | 96 | 2 | 18521 | 50 |
LRP1B,FAT3 |
2.777e-02 | -3.58 | adrenal_gland-adrenal_gland-adrenal_cortical_adenoma-aldosterone_producing | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_adenoma-aldosterone_producing | 91 | 2 | 16828 | 48 |
LRP1B,ADCY2 |
2.783e-02 | -3.58 | NGF signalling via TRKA from the plasma membrane | REACTOME pathways | R-HSA-187037 | 387 | 4 | 10285 | 31 |
ADCY2,NRG3,NTRK2,CAMK2G |
2.786e-02 | -3.58 | microtubule organizing center attachment site | cellular component | GO:0034992 | 11 | 1 | 19108 | 49 |
SYNE1 |
2.786e-02 | -3.58 | meiotic nuclear membrane microtubule tethering complex | cellular component | GO:0034993 | 11 | 1 | 19108 | 49 |
SYNE1 |
2.786e-02 | -3.58 | nuclear membrane protein complex | cellular component | GO:0106083 | 11 | 1 | 19108 | 49 |
SYNE1 |
2.786e-02 | -3.58 | perisynaptic extracellular matrix | cellular component | GO:0098966 | 11 | 1 | 19108 | 49 |
TNC |
2.786e-02 | -3.58 | nuclear membrane microtubule tethering complex | cellular component | GO:0106094 | 11 | 1 | 19108 | 49 |
SYNE1 |
2.792e-02 | -3.58 | SYTL1 (synaptotagmin like 1) | protein interactions | 84958 | 11 | 1 | 19454 | 50 |
NRXN1 |
2.792e-02 | -3.58 | Batf3 (basic leucine zipper transcription factor, ATF-like 3) | protein interactions | 381319 | 11 | 1 | 19454 | 50 |
MACF1 |
2.792e-02 | -3.58 | AQP5 (aquaporin 5) | protein interactions | 362 | 11 | 1 | 19454 | 50 |
ATP1A2 |
2.792e-02 | -3.58 | ADCY5 (adenylate cyclase 5) | protein interactions | 111 | 11 | 1 | 19454 | 50 |
ADCY2 |
2.792e-02 | -3.58 | SCN3A (sodium voltage-gated channel alpha subunit 3) | protein interactions | 6328 | 11 | 1 | 19454 | 50 |
CNTN1 |
2.792e-02 | -3.58 | Gtf2e2 (general transcription factor II E, polypeptide 2 (beta subunit)) | protein interactions | 68153 | 11 | 1 | 19454 | 50 |
NHSL1 |
2.792e-02 | -3.58 | SYN3 (synapsin III) | protein interactions | 8224 | 11 | 1 | 19454 | 50 |
GPM6A |
2.792e-02 | -3.58 | Cobll1 (Cobl-like 1) | protein interactions | 319876 | 11 | 1 | 19454 | 50 |
ABLIM1 |
2.792e-02 | -3.58 | Wipi2 (WD repeat domain, phosphoinositide interacting 2) | protein interactions | 74781 | 11 | 1 | 19454 | 50 |
MACF1 |
2.807e-02 | -3.57 | cardiac muscle cell differentiation | biological process | GO:0055007 | 95 | 2 | 18204 | 50 |
NEBL,SYNE1 |
2.807e-02 | -3.57 | calcium ion transmembrane import into cytosol | biological process | GO:0097553 | 95 | 2 | 18204 | 50 |
RYR3,PLCB1 |
2.809e-02 | -3.57 | enzyme-linked receptor protein signaling pathway | biological process | GO:0007167 | 626 | 5 | 18204 | 50 |
SORBS1,KALRN,PLCB1,NRG3,NTRK2 |
2.832e-02 | -3.56 | human chr12q21.2 | chromosome location | human chr12q21.2 | 15 | 1 | 26134 | 50 |
NAV3 |
2.832e-02 | -3.56 | human chr10p12.31 | chromosome location | human chr10p12.31 | 15 | 1 | 26134 | 50 |
NEBL |
2.832e-02 | -3.56 | human chr18q12.3 | chromosome location | human chr18q12.3 | 15 | 1 | 26134 | 50 |
SLC14A1 |
2.832e-02 | -3.56 | human chr8q12.3 | chromosome location | human chr8q12.3 | 15 | 1 | 26134 | 50 |
NKAIN3 |
2.838e-02 | -3.56 | response to radiation | biological process | GO:0009314 | 422 | 4 | 18204 | 50 |
SLC1A2,MAPK10,ATP1A2,SYNE1 |
2.846e-02 | -3.56 | VHP | smart domains | SM00153 | 8 | 1 | 9717 | 35 |
ABLIM1 |
2.853e-02 | -3.56 | eye | COSMIC cancer mutations | eye | 606 | 5 | 16828 | 48 |
ADCY2,KALRN,MACF1,CTNND2,TRPM3 |
2.880e-02 | -3.55 | acetylcholine receptor binding | molecular function | GO:0033130 | 11 | 1 | 18094 | 48 |
NRXN1 |
2.880e-02 | -3.55 | ATP-dependent diacylglycerol kinase activity | molecular function | GO:0004143 | 11 | 1 | 18094 | 48 |
DGKG |
2.880e-02 | -3.55 | sulfur amino acid transmembrane transporter activity | molecular function | GO:0000099 | 11 | 1 | 18094 | 48 |
SLC1A2 |
2.884e-02 | -3.55 | CSGALNACT2 (chondroitin sulfate N-acetylgalactosaminyltransferase 2) | protein interactions | 55454 | 103 | 2 | 19454 | 50 |
DPP6,MGAT4C |
2.884e-02 | -3.55 | ZDHHC5 (zinc finger DHHC-type palmitoyltransferase 5) | protein interactions | 25921 | 103 | 2 | 19454 | 50 |
NTRK2,PARD3 |
2.891e-02 | -3.54 | aldosterone_producing | COSMIC cancer mutations | aldosterone_producing | 93 | 2 | 16828 | 48 |
LRP1B,ADCY2 |
2.892e-02 | -3.54 | NAKATPASE | prints domains | PR00121 | 9 | 1 | 5227 | 17 |
ATP1A2 |
2.893e-02 | -3.54 | Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin | SMPDB pathways | SMP0000338 | 10 | 1 | 1369 | 4 |
ADCY2 |
2.893e-02 | -3.54 | Lysophosphatidic Acid LPA5 Signalling | SMPDB pathways | SMP0063757 | 10 | 1 | 1369 | 4 |
PLCB1 |
2.893e-02 | -3.54 | Lysophosphatidic Acid LPA4 Signalling | SMPDB pathways | SMP0063756 | 10 | 1 | 1369 | 4 |
PLCB1 |
2.903e-02 | -3.54 | SH3DOMAIN | prints domains | PR00452 | 83 | 2 | 5227 | 17 |
SORBS1,NEBL |
2.917e-02 | -3.53 | RFX_DBD | prosite domains | PS51526 | 9 | 1 | 12186 | 40 |
RFX4 |
2.917e-02 | -3.53 | DC | prosite domains | PS50309 | 9 | 1 | 12186 | 40 |
DCLK2 |
2.917e-02 | -3.53 | positive regulation of JNK cascade | biological process | GO:0046330 | 97 | 2 | 18204 | 50 |
PLCB1,TNIK |
2.929e-02 | -3.53 | EF-hand_7 | pfam domains | PF13499 | 97 | 2 | 17795 | 49 |
DGKG,MACF1 |
2.931e-02 | -3.53 | Tyr_kinase_rcpt_2_CS | interpro domains | IPR002011 | 11 | 1 | 18521 | 50 |
NTRK2 |
2.935e-02 | -3.53 | tat (Tat) | protein interactions | 155871 | 1718 | 9 | 19454 | 50 |
RYR3,SORBS1,SLC1A2,ADCY2,CAMK2G,TNC,PLCB1,SLC14A1,NRCAM |
2.936e-02 | -3.53 | HUNK (hormonally up-regulated Neu-associated kinase) | protein interactions | 30811 | 104 | 2 | 19454 | 50 |
SORBS1,ABLIM1 |
2.975e-02 | -3.51 | Adenylate cyclase activating pathway | REACTOME pathways | R-HSA-170660 | 10 | 1 | 10285 | 31 |
ADCY2 |
2.975e-02 | -3.51 | Acetylcholine regulates insulin secretion | REACTOME pathways | R-HSA-399997 | 10 | 1 | 10285 | 31 |
PLCB1 |
2.975e-02 | -3.51 | Activation of the AP-1 family of transcription factors | REACTOME pathways | R-HSA-450341 | 10 | 1 | 10285 | 31 |
MAPK10 |
2.975e-02 | -3.51 | Bicarbonate transporters | REACTOME pathways | R-HSA-425381 | 10 | 1 | 10285 | 31 |
SLC4A4 |
2.975e-02 | -3.51 | PI3K events in ERBB4 signaling | REACTOME pathways | R-HSA-1250342 | 10 | 1 | 10285 | 31 |
NRG3 |
2.978e-02 | -3.51 | Heparan sulfate degradation | KEGG pathways | M00078 | 9 | 1 | 7161 | 24 |
HPSE2 |
2.978e-02 | -3.51 | Heparan sulfate degradation | KEGG pathways | hsa_M00078 | 9 | 1 | 7161 | 24 |
HPSE2 |
2.980e-02 | -3.51 | organic substance transport | biological process | GO:0071702 | 1881 | 10 | 18204 | 50 |
FMN2,LRP1B,SLC4A4,NTRK2,MACF1,SFXN5,SLC1A2,SLC14A1,PITPNC1,CAMK2G |
2.981e-02 | -3.51 | lactone metabolic process | biological process | GO:1901334 | 11 | 1 | 18204 | 50 |
ATP1A2 |
2.981e-02 | -3.51 | negative regulation of neuron migration | biological process | GO:2001223 | 11 | 1 | 18204 | 50 |
NRG3 |
2.981e-02 | -3.51 | L-aspartate transmembrane transport | biological process | GO:0070778 | 11 | 1 | 18204 | 50 |
SLC1A2 |
2.981e-02 | -3.51 | cellular response to caffeine | biological process | GO:0071313 | 11 | 1 | 18204 | 50 |
RYR3 |
2.981e-02 | -3.51 | cellular response to interleukin-15 | biological process | GO:0071350 | 11 | 1 | 18204 | 50 |
PLCB1 |
2.981e-02 | -3.51 | L-ascorbic acid metabolic process | biological process | GO:0019852 | 11 | 1 | 18204 | 50 |
ATP1A2 |
2.981e-02 | -3.51 | cellular response to interleukin-12 | biological process | GO:0071349 | 11 | 1 | 18204 | 50 |
PLCB1 |
2.981e-02 | -3.51 | interleukin-15-mediated signaling pathway | biological process | GO:0035723 | 11 | 1 | 18204 | 50 |
PLCB1 |
2.981e-02 | -3.51 | pyramidal neuron development | biological process | GO:0021860 | 11 | 1 | 18204 | 50 |
DCLK2 |
2.981e-02 | -3.51 | lipid phosphorylation | biological process | GO:0046834 | 11 | 1 | 18204 | 50 |
DGKG |
2.981e-02 | -3.51 | positive regulation of acrosome reaction | biological process | GO:2000344 | 11 | 1 | 18204 | 50 |
PLCB1 |
2.981e-02 | -3.51 | negative regulation of mesenchymal cell apoptotic process | biological process | GO:2001054 | 11 | 1 | 18204 | 50 |
SYNE1 |
2.981e-02 | -3.51 | negative regulation of excitatory postsynaptic potential | biological process | GO:0090394 | 11 | 1 | 18204 | 50 |
SYNE1 |
2.981e-02 | -3.51 | establishment or maintenance of transmembrane electrochemical gradient | biological process | GO:0010248 | 11 | 1 | 18204 | 50 |
ATP1A2 |
2.981e-02 | -3.51 | glutamate secretion | biological process | GO:0014047 | 11 | 1 | 18204 | 50 |
NTRK2 |
2.981e-02 | -3.51 | L-glutamate import across plasma membrane | biological process | GO:0098712 | 11 | 1 | 18204 | 50 |
SLC1A2 |
2.981e-02 | -3.51 | ectodermal placode formation | biological process | GO:0060788 | 11 | 1 | 18204 | 50 |
NRG3 |
2.981e-02 | -3.51 | ectodermal placode morphogenesis | biological process | GO:0071697 | 11 | 1 | 18204 | 50 |
NRG3 |
2.981e-02 | -3.51 | egg activation | biological process | GO:0007343 | 11 | 1 | 18204 | 50 |
PLCB1 |
3.000e-02 | -3.51 | Helical hairpin bin | gene3d domains | 1.10.287.570 | 10 | 1 | 14470 | 44 |
SLC4A4 |
3.007e-02 | -3.50 | haemangiopericytic | COSMIC cancer mutations | haemangiopericytic | 95 | 2 | 16828 | 48 |
RYR3,SYNE1 |
3.007e-02 | -3.50 | meninges-meningioma-haemangiopericytic | COSMIC cancer mutations | meninges-meningioma-haemangiopericytic | 95 | 2 | 16828 | 48 |
SYNE1,RYR3 |
3.034e-02 | -3.50 | response to wounding | biological process | GO:0009611 | 431 | 4 | 18204 | 50 |
SLC1A2,DGKG,MACF1,TNC |
3.034e-02 | -3.50 | trans-synaptic signaling | biological process | GO:0099537 | 431 | 4 | 18204 | 50 |
NTRK2,DTNA,NRXN1,SLC1A2 |
3.035e-02 | -3.49 | synapse-associated extracellular matrix | cellular component | GO:0099535 | 12 | 1 | 19108 | 49 |
TNC |
3.035e-02 | -3.49 | sodium:potassium-exchanging ATPase complex | cellular component | GO:0005890 | 12 | 1 | 19108 | 49 |
ATP1A2 |
3.036e-02 | -3.49 | NRAS (NRAS proto-oncogene, GTPase) | protein interactions | 4893 | 683 | 5 | 19454 | 50 |
FMN2,NAV2,PLCB1,MACF1,TNIK |
3.040e-02 | -3.49 | USP6NL (USP6 N-terminal like) | protein interactions | 9712 | 106 | 2 | 19454 | 50 |
PARD3,NTRK2 |
3.042e-02 | -3.49 | ART4 (ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)) | protein interactions | 420 | 12 | 1 | 19454 | 50 |
GPM6A |
3.042e-02 | -3.49 | C2CD4A (C2 calcium dependent domain containing 4A) | protein interactions | 145741 | 12 | 1 | 19454 | 50 |
FAT3 |
3.042e-02 | -3.49 | TCF15 (transcription factor 15) | protein interactions | 6939 | 12 | 1 | 19454 | 50 |
FAT3 |
3.042e-02 | -3.49 | CA4 (carbonic anhydrase 4) | protein interactions | 762 | 12 | 1 | 19454 | 50 |
SLC4A4 |
3.042e-02 | -3.49 | LMP-1 (latent membrane protein LMP-1) | protein interactions | 3783750 | 12 | 1 | 19454 | 50 |
TNIK |
3.042e-02 | -3.49 | Pard6b (par-6 family cell polarity regulator beta) | protein interactions | 58220 | 12 | 1 | 19454 | 50 |
PARD3 |
3.042e-02 | -3.49 | PROK2 (prokineticin 2) | protein interactions | 60675 | 12 | 1 | 19454 | 50 |
LRP1B |
3.042e-02 | -3.49 | KIF26A (kinesin family member 26A) | protein interactions | 26153 | 12 | 1 | 19454 | 50 |
MAPK10 |
3.042e-02 | -3.49 | NTF4 (neurotrophin 4) | protein interactions | 4909 | 12 | 1 | 19454 | 50 |
NTRK2 |
3.058e-02 | -3.49 | CTNNB1 (catenin beta 1) | protein interactions | 1499 | 926 | 6 | 19454 | 50 |
PARD3,CTNND2,SORBS1,CTNNA2,NHSL1,DTNA |
3.074e-02 | -3.48 | regulation of transport | biological process | GO:0051049 | 1621 | 9 | 18204 | 50 |
CAMK2G,CNTN1,SLC1A2,NKAIN3,ATP1A2,SORBS1,SYNE1,PLCB1,DPP6 |
3.085e-02 | -3.48 | response to alkaloid | biological process | GO:0043279 | 100 | 2 | 18204 | 50 |
SLC1A2,RYR3 |
3.093e-02 | -3.48 | APOL2 (apolipoprotein L2) | protein interactions | 23780 | 107 | 2 | 19454 | 50 |
SFXN5,DPP6 |
3.107e-02 | -3.47 | MCAM (melanoma cell adhesion molecule) | protein interactions | 4162 | 464 | 4 | 19454 | 50 |
TNIK,CTNNA2,PLCB1,CNTN1 |
3.111e-02 | -3.47 | Post-translational modification: synthesis of GPI-anchored proteins | REACTOME pathways | R-HSA-163125 | 92 | 2 | 10285 | 31 |
LSAMP,NTM |
3.138e-02 | -3.46 | adenylate cyclase binding | molecular function | GO:0008179 | 12 | 1 | 18094 | 48 |
ADCY2 |
3.138e-02 | -3.46 | dipeptidyl-peptidase activity | molecular function | GO:0008239 | 12 | 1 | 18094 | 48 |
DPP6 |
3.138e-02 | -3.46 | protein binding involved in heterotypic cell-cell adhesion | molecular function | GO:0086080 | 12 | 1 | 18094 | 48 |
NRCAM |
3.141e-02 | -3.46 | pituitary | COSMIC cancer mutations | pituitary | 420 | 4 | 16828 | 48 |
RYR3,PARD3,SYNE1,NRCAM |
3.142e-02 | -3.46 | regulation of glucose metabolic process | biological process | GO:0010906 | 101 | 2 | 18204 | 50 |
RORA,SORBS1 |
3.147e-02 | -3.46 | CLASP1 (cytoplasmic linker associated protein 1) | protein interactions | 23332 | 108 | 2 | 19454 | 50 |
DCLK2,MACF1 |
3.147e-02 | -3.46 | FKBP1A (FKBP prolyl isomerase 1A) | protein interactions | 2280 | 108 | 2 | 19454 | 50 |
MSI2,RYR3 |
3.151e-02 | -3.46 | VCL (vinculin) | protein interactions | 7414 | 268 | 3 | 19454 | 50 |
NEBL,SORBS1,MACF1 |
3.179e-02 | -3.45 | NAD+ Signalling and Aging | SMPDB pathways | SMP0084271 | 11 | 1 | 1369 | 4 |
RORA |
3.193e-02 | -3.44 | MAP_kinase_CS | interpro domains | IPR003527 | 12 | 1 | 18521 | 50 |
MAPK10 |
3.193e-02 | -3.44 | PLC_EF-hand-like | interpro domains | IPR015359 | 12 | 1 | 18521 | 50 |
PLCB1 |
3.197e-02 | -3.44 | DCX | smart domains | SM00537 | 9 | 1 | 9717 | 35 |
DCLK2 |
3.197e-02 | -3.44 | Rap1 signaling pathway | KEGG pathways | ko04015 | 210 | 3 | 7161 | 24 |
PLCB1,ADCY2,PARD3 |
3.197e-02 | -3.44 | Rap1 signaling pathway | KEGG pathways | hsa04015 | 210 | 3 | 7161 | 24 |
ADCY2,PARD3,PLCB1 |
3.199e-02 | -3.44 | heterocyclic compound binding | molecular function | GO:1901363 | 2263 | 11 | 18094 | 48 |
NAV3,MAPK10,DCLK2,KALRN,NAV2,ADCY2,NTRK2,DGKG,TNIK,CAMK2G,ATP1A2 |
3.200e-02 | -3.44 | PRR20A (proline rich 20A) | protein interactions | 122183 | 109 | 2 | 19454 | 50 |
TRPM3,SOX5 |
3.204e-02 | -3.44 | human chr9q21.33 | chromosome location | human chr9q21.33 | 17 | 1 | 26134 | 50 |
NTRK2 |
3.208e-02 | -3.44 | HCO3TRNSPORT | prints domains | PR01231 | 10 | 1 | 5227 | 17 |
SLC4A4 |
3.236e-02 | -3.43 | MIR | prosite domains | PS50919 | 10 | 1 | 12186 | 40 |
RYR3 |
3.246e-02 | -3.43 | urinary_tract-bladder-carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma | 14050 | 45 | 16828 | 48 |
SFXN5,CTNND2,SORBS1,SLC1A2,SLC4A4,PARD3,TRPM3,ATP1A2,NTRK2,DPP6,CNTN1,NRXN1,DCLK2,HPSE2,DTNA,FMN2,NTM,NRG3,RYR3,PITPNC1,SLC14A1,ABLIM1,GPM6A,NAV2,MGAT4C,LSAMP,RORA,NRCAM,NEBL,LRP1B,TNIK,SOX5,CAMK2G,RFX4,KALRN,SYNE1,MSI2,DGKG,ADCY2,MACF1,GPC5,NAV3,FAT3,PLCB1,TNC |
3.248e-02 | -3.43 | auditory behavior | biological process | GO:0031223 | 12 | 1 | 18204 | 50 |
NRXN1 |
3.248e-02 | -3.43 | sulfur amino acid transport | biological process | GO:0000101 | 12 | 1 | 18204 | 50 |
SLC1A2 |
3.248e-02 | -3.43 | neuronal ion channel clustering | biological process | GO:0045161 | 12 | 1 | 18204 | 50 |
NRCAM |
3.248e-02 | -3.43 | response to interleukin-15 | biological process | GO:0070672 | 12 | 1 | 18204 | 50 |
PLCB1 |
3.248e-02 | -3.43 | urea transport | biological process | GO:0015840 | 12 | 1 | 18204 | 50 |
SLC14A1 |
3.248e-02 | -3.43 | response to interleukin-12 | biological process | GO:0070671 | 12 | 1 | 18204 | 50 |
PLCB1 |
3.256e-02 | -3.42 | EF-hand_like | pfam domains | PF09279 | 12 | 1 | 17795 | 49 |
PLCB1 |
3.257e-02 | -3.42 | cerebellum development | biological process | GO:0021549 | 103 | 2 | 18204 | 50 |
RORA,CNTN1 |
3.270e-02 | -3.42 | nervous system process | biological process | GO:0050877 | 1376 | 8 | 18204 | 50 |
NTRK2,NRXN1,NAV2,ATP1A2,PLCB1,CTNNA2,ABLIM1,NRCAM |
3.276e-02 | -3.42 | steroid binding | molecular function | GO:0005496 | 107 | 2 | 18094 | 48 |
ATP1A2,RORA |
3.284e-02 | -3.42 | postsynaptic cytosol | cellular component | GO:0099524 | 13 | 1 | 19108 | 49 |
PLCB1 |
3.291e-02 | -3.41 | NPR2 (natriuretic peptide receptor 2) | protein interactions | 4882 | 13 | 1 | 19454 | 50 |
CAMK2G |
3.291e-02 | -3.41 | NCAN (neurocan) | protein interactions | 1463 | 13 | 1 | 19454 | 50 |
TNC |
3.291e-02 | -3.41 | TBCC (tubulin folding cofactor C) | protein interactions | 6903 | 13 | 1 | 19454 | 50 |
NTM |
3.291e-02 | -3.41 | PCAT1 (prostate cancer associated transcript 1) | protein interactions | 100750225 | 13 | 1 | 19454 | 50 |
NAV3 |
3.291e-02 | -3.41 | MYO16 (myosin XVI) | protein interactions | 23026 | 13 | 1 | 19454 | 50 |
NRXN1 |
3.291e-02 | -3.41 | JAM2 (junctional adhesion molecule 2) | protein interactions | 58494 | 13 | 1 | 19454 | 50 |
PARD3 |
3.291e-02 | -3.41 | RNASE4 (ribonuclease A family member 4) | protein interactions | 6038 | 13 | 1 | 19454 | 50 |
LRP1B |
3.291e-02 | -3.41 | RAB3C (RAB3C, member RAS oncogene family) | protein interactions | 115827 | 13 | 1 | 19454 | 50 |
GPM6A |
3.316e-02 | -3.41 | EF_HAND_2 | prosite domains | PS50222 | 215 | 3 | 12186 | 40 |
DGKG,MACF1,RYR3 |
3.318e-02 | -3.41 | protein complex oligomerization | biological process | GO:0051259 | 256 | 3 | 18204 | 50 |
RYR3,TRPM3,SLC1A2 |
3.332e-02 | -3.40 | phosphatidylinositol bisphosphate binding | molecular function | GO:1902936 | 108 | 2 | 18094 | 48 |
PARD3,PLCB1 |
3.363e-02 | -3.39 | ING5 (inhibitor of growth family member 5) | protein interactions | 84289 | 112 | 2 | 19454 | 50 |
NAV3,NAV2 |
3.373e-02 | -3.39 | gland morphogenesis | biological process | GO:0022612 | 105 | 2 | 18204 | 50 |
TNC,NRG3 |
3.373e-02 | -3.39 | response to interleukin-1 | biological process | GO:0070555 | 105 | 2 | 18204 | 50 |
PLCB1,RORA |
3.373e-02 | -3.39 | neural precursor cell proliferation | biological process | GO:0061351 | 105 | 2 | 18204 | 50 |
RORA,SOX5 |
3.373e-02 | -3.39 | cellular response to alcohol | biological process | GO:0097306 | 105 | 2 | 18204 | 50 |
ADCY2,TNC |
3.383e-02 | -3.39 | kidney-carcinoma-chromophobe_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-chromophobe_renal_cell_carcinoma | 430 | 4 | 16828 | 48 |
NTRK2,TNIK,DCLK2,CAMK2G |
3.383e-02 | -3.39 | chromophobe_renal_cell_carcinoma | COSMIC cancer mutations | chromophobe_renal_cell_carcinoma | 430 | 4 | 16828 | 48 |
DCLK2,CAMK2G,NTRK2,TNIK |
3.395e-02 | -3.38 | potassium ion binding | molecular function | GO:0030955 | 13 | 1 | 18094 | 48 |
ATP1A2 |
3.395e-02 | -3.38 | monoatomic cation:bicarbonate symporter activity | molecular function | GO:0140410 | 13 | 1 | 18094 | 48 |
SLC4A4 |
3.408e-02 | -3.38 | organic anion transmembrane transporter activity | molecular function | GO:0008514 | 268 | 3 | 18094 | 48 |
SFXN5,SLC1A2,SLC4A4 |
3.418e-02 | -3.38 | GFI1B (growth factor independent 1B transcriptional repressor) | protein interactions | 8328 | 113 | 2 | 19454 | 50 |
KALRN,DTNA |
3.432e-02 | -3.37 | cellular response to ketone | biological process | GO:1901655 | 106 | 2 | 18204 | 50 |
TNC,ADCY2 |
3.432e-02 | -3.37 | small_intestine | COSMIC cancer mutations | small_intestine | 250 | 3 | 16828 | 48 |
MACF1,MGAT4C,TNIK |
3.457e-02 | -3.36 | TJP2 (tight junction protein 2) | protein interactions | 9414 | 278 | 3 | 19454 | 50 |
NEBL,PARD3,SORBS1 |
3.459e-02 | -3.36 | plasma membrane raft | cellular component | GO:0044853 | 114 | 2 | 19108 | 49 |
SORBS1,ATP1A2 |
3.459e-02 | -3.36 | Gap junction | KEGG pathways | ko04540 | 88 | 2 | 7161 | 24 |
PLCB1,ADCY2 |
3.459e-02 | -3.36 | Gap junction | KEGG pathways | hsa04540 | 88 | 2 | 7161 | 24 |
PLCB1,ADCY2 |
3.464e-02 | -3.36 | Lactose Degradation | SMPDB pathways | SMP0000457 | 12 | 1 | 1369 | 4 |
ATP1A2 |
3.464e-02 | -3.36 | Lactose Intolerance | SMPDB pathways | SMP0000458 | 12 | 1 | 1369 | 4 |
ATP1A2 |
3.497e-02 | -3.35 | postsynaptic membrane | cellular component | GO:0045211 | 280 | 3 | 19108 | 49 |
SYNE1,CNTN1,NRCAM |
3.500e-02 | -3.35 | Ion_trans_dom | interpro domains | IPR005821 | 109 | 2 | 18521 | 50 |
RYR3,TRPM3 |
3.514e-02 | -3.35 | regulation of respiratory gaseous exchange by nervous system process | biological process | GO:0002087 | 13 | 1 | 18204 | 50 |
ATP1A2 |
3.514e-02 | -3.35 | nervous system process involved in regulation of systemic arterial blood pressure | biological process | GO:0001976 | 13 | 1 | 18204 | 50 |
NAV2 |
3.514e-02 | -3.35 | postsynaptic specialization assembly | biological process | GO:0098698 | 13 | 1 | 18204 | 50 |
NRXN1 |
3.514e-02 | -3.35 | ectodermal placode development | biological process | GO:0071696 | 13 | 1 | 18204 | 50 |
NRG3 |
3.514e-02 | -3.35 | T-helper 17 cell differentiation | biological process | GO:0072539 | 13 | 1 | 18204 | 50 |
RORA |
3.514e-02 | -3.35 | cerebellar Purkinje cell differentiation | biological process | GO:0021702 | 13 | 1 | 18204 | 50 |
RORA |
3.514e-02 | -3.35 | prepulse inhibition | biological process | GO:0060134 | 13 | 1 | 18204 | 50 |
CTNNA2 |
3.514e-02 | -3.35 | cellular response to vitamin D | biological process | GO:0071305 | 13 | 1 | 18204 | 50 |
TNC |
3.514e-02 | -3.35 | negative regulation of cytosolic calcium ion concentration | biological process | GO:0051481 | 13 | 1 | 18204 | 50 |
ATP1A2 |
3.514e-02 | -3.35 | defense response to tumor cell | biological process | GO:0002357 | 13 | 1 | 18204 | 50 |
RBMS3 |
3.522e-02 | -3.35 | Ldl_recept_b | pfam domains | PF00058 | 13 | 1 | 17795 | 49 |
LRP1B |
3.530e-02 | -3.34 | CDH2 (cadherin 2) | protein interactions | 1000 | 115 | 2 | 19454 | 50 |
PARD3,CTNND2 |
3.530e-02 | -3.34 | SMAD7 (SMAD family member 7) | protein interactions | 4092 | 115 | 2 | 19454 | 50 |
PARD3,SOX5 |
3.530e-02 | -3.34 | DTNA (dystrobrevin alpha) | protein interactions | 1837 | 115 | 2 | 19454 | 50 |
PARD3,NTRK2 |
3.539e-02 | -3.34 | HRAS (HRas proto-oncogene, GTPase) | protein interactions | 3265 | 712 | 5 | 19454 | 50 |
TNIK,NAV2,PLCB1,MAPK10,PARD3 |
3.540e-02 | -3.34 | CHAT (choline O-acetyltransferase) | protein interactions | 1103 | 14 | 1 | 19454 | 50 |
CAMK2G |
3.540e-02 | -3.34 | CFAP58 (cilia and flagella associated protein 58) | protein interactions | 159686 | 14 | 1 | 19454 | 50 |
NAV2 |
3.540e-02 | -3.34 | BOD1L2 (biorientation of chromosomes in cell division 1 like 2) | protein interactions | 284257 | 14 | 1 | 19454 | 50 |
FMN2 |
3.540e-02 | -3.34 | RSPO1 (R-spondin 1) | protein interactions | 284654 | 14 | 1 | 19454 | 50 |
LRP1B |
3.540e-02 | -3.34 | DACT2 (dishevelled binding antagonist of beta catenin 2) | protein interactions | 168002 | 14 | 1 | 19454 | 50 |
CAMK2G |
3.540e-02 | -3.34 | PLXNA4 (plexin A4) | protein interactions | 91584 | 14 | 1 | 19454 | 50 |
GPM6A |
3.540e-02 | -3.34 | SLC1A2 (solute carrier family 1 member 2) | protein interactions | 6506 | 14 | 1 | 19454 | 50 |
SLC1A2 |
3.540e-02 | -3.34 | TPSAB1 (tryptase alpha/beta 1) | protein interactions | 7177 | 14 | 1 | 19454 | 50 |
CAMK2G |
3.540e-02 | -3.34 | FAM218A (family with sequence similarity 218 member A) | protein interactions | 152756 | 14 | 1 | 19454 | 50 |
FAT3 |
3.540e-02 | -3.34 | SYT5 (synaptotagmin 5) | protein interactions | 6861 | 14 | 1 | 19454 | 50 |
NRXN1 |
3.540e-02 | -3.34 | Asap1 (ArfGAP with SH3 domain, ankyrin repeat and PH domain1) | protein interactions | 13196 | 14 | 1 | 19454 | 50 |
MACF1 |
3.540e-02 | -3.34 | RPS14P3 (ribosomal protein S14 pseudogene 3) | protein interactions | 644068 | 14 | 1 | 19454 | 50 |
FAT3 |
3.546e-02 | -3.34 | MIR | smart domains | SM00472 | 10 | 1 | 9717 | 35 |
RYR3 |
3.546e-02 | -3.34 | DAGKa | smart domains | SM00045 | 10 | 1 | 9717 | 35 |
DGKG |
3.553e-02 | -3.34 | RECEPTOR_TYR_KIN_II | prosite domains | PS00239 | 11 | 1 | 12186 | 40 |
NTRK2 |
3.558e-02 | -3.34 | SH3 | smart domains | SM00326 | 202 | 3 | 9717 | 35 |
KALRN,NEBL,SORBS1 |
3.559e-02 | -3.34 | Defective EXT2 causes exostoses 2 | REACTOME pathways | R-HSA-3656237 | 12 | 1 | 10285 | 31 |
GPC5 |
3.559e-02 | -3.34 | Defective EXT1 causes exostoses 1, TRPS2 and CHDS | REACTOME pathways | R-HSA-3656253 | 12 | 1 | 10285 | 31 |
GPC5 |
3.560e-02 | -3.34 | MFAP5-mediated ovarian cancer cell motility and invasiveness | WikiPathways | WP3301 | 12 | 1 | 5310 | 16 |
RYR3 |
3.574e-02 | -3.33 | human chr5p15.2 | chromosome location | human chr5p15.2 | 19 | 1 | 26134 | 50 |
CTNND2 |
3.574e-02 | -3.33 | human chr11q25 | chromosome location | human chr11q25 | 19 | 1 | 26134 | 50 |
NTM |
3.574e-02 | -3.33 | human chr6q24.1 | chromosome location | human chr6q24.1 | 19 | 1 | 26134 | 50 |
NHSL1 |
3.590e-02 | -3.33 | - | gene3d domains | 3.10.450.50 | 12 | 1 | 14470 | 44 |
CAMK2G |
3.590e-02 | -3.33 | Alpha-catenin/vinculin-like | gene3d domains | 1.20.120.230 | 12 | 1 | 14470 | 44 |
CTNNA2 |
3.598e-02 | -3.32 | response to endogenous stimulus | biological process | GO:0009719 | 1402 | 8 | 18204 | 50 |
RYR3,SLC1A2,SORBS1,PLCB1,TNC,NTRK2,ATP1A2,SOX5 |
3.603e-02 | -3.32 | active monoatomic ion transmembrane transporter activity | molecular function | GO:0022853 | 274 | 3 | 18094 | 48 |
SLC1A2,ATP1A2,SLC4A4 |
3.612e-02 | -3.32 | postsynapse organization | biological process | GO:0099173 | 109 | 2 | 18204 | 50 |
CTNND2,NRXN1 |
3.620e-02 | -3.32 | regulation of canonical Wnt signaling pathway | biological process | GO:0060828 | 265 | 3 | 18204 | 50 |
RBMS3,CTNND2,GPC5 |
3.621e-02 | -3.32 | regulation of nervous system development | biological process | GO:0051960 | 456 | 4 | 18204 | 50 |
PARD3,NRXN1,NTRK2,MACF1 |
3.623e-02 | -3.32 | regulation of cellular process | biological process | GO:0050794 | 11468 | 38 | 18204 | 50 |
DTNA,NRCAM,DPP6,GPC5,NRXN1,RYR3,CNTN1,FAT3,HPSE2,SLC1A2,MAPK10,ADCY2,FMN2,NAV3,RFX4,SYNE1,RBMS3,PLCB1,MSI2,KALRN,NRG3,CAMK2G,GPM6A,DGKG,TNC,MACF1,RORA,SLC4A4,TNIK,PARD3,PITPNC1,CTNNA2,SORBS1,DCLK2,CTNND2,NTRK2,SOX5,ATP1A2 |
3.627e-02 | -3.32 | Ion_trans | pfam domains | PF00520 | 109 | 2 | 17795 | 49 |
TRPM3,RYR3 |
3.630e-02 | -3.32 | positive regulation of biological process | biological process | GO:0048518 | 6326 | 24 | 18204 | 50 |
NRCAM,NRXN1,GPC5,SLC1A2,HPSE2,CNTN1,PLCB1,SYNE1,RBMS3,RFX4,FMN2,NAV3,GPM6A,TNC,TNIK,SLC4A4,RORA,MACF1,PARD3,SFXN5,SORBS1,ATP1A2,SOX5,NTRK2 |
3.631e-02 | -3.32 | neuronal cell body | cellular component | GO:0043025 | 489 | 4 | 19108 | 49 |
GPM6A,ATP1A2,NRXN1,CTNND2 |
3.633e-02 | -3.32 | env (Envelope surface glycoprotein gp160, precursor) | protein interactions | 155971 | 1501 | 8 | 19454 | 50 |
MAPK10,TNC,MGAT4C,PLCB1,NTRK2,SLC1A2,ADCY2,CTNNA2 |
3.647e-02 | -3.31 | Dppa3 (developmental pluripotency-associated 3) | protein interactions | 73708 | 284 | 3 | 19454 | 50 |
CAMK2G,ATP1A2,MSI2 |
3.652e-02 | -3.31 | L-glutamate transmembrane transporter activity | molecular function | GO:0005313 | 14 | 1 | 18094 | 48 |
SLC1A2 |
3.652e-02 | -3.31 | microtubule minus-end binding | molecular function | GO:0051011 | 14 | 1 | 18094 | 48 |
MACF1 |
3.656e-02 | -3.31 | testis-germ_cell_tumour-seminoma | COSMIC cancer mutations | testis-germ_cell_tumour-seminoma | 648 | 5 | 16828 | 48 |
TNIK,NTRK2,CAMK2G,DCLK2,SYNE1 |
3.668e-02 | -3.31 | CAV1 (caveolin 1) | protein interactions | 857 | 719 | 5 | 19454 | 50 |
PARD3,FMN2,MACF1,DTNA,TNIK |
3.670e-02 | -3.31 | phosphatidylinositol binding | molecular function | GO:0035091 | 276 | 3 | 18094 | 48 |
PLCB1,PARD3,PITPNC1 |
3.672e-02 | -3.30 | positive regulation of cell junction assembly | biological process | GO:1901890 | 110 | 2 | 18204 | 50 |
NRXN1,NTRK2 |
3.677e-02 | -3.30 | bone-tibia-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-tibia-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 649 | 5 | 16828 | 48 |
MACF1,ABLIM1,FAT3,TRPM3,TNIK |
3.691e-02 | -3.30 | L1CAM interactions | REACTOME pathways | R-HSA-373760 | 101 | 2 | 10285 | 31 |
NRCAM,CNTN1 |
3.699e-02 | -3.30 | B4GALT2 (beta-1,4-galactosyltransferase 2) | protein interactions | 8704 | 118 | 2 | 19454 | 50 |
FAT3,CAMK2G |
3.715e-02 | -3.29 | Neurexin-like | interpro domains | IPR003585 | 14 | 1 | 18521 | 50 |
NRXN1 |
3.715e-02 | -3.29 | LDLR_classB_rpt | interpro domains | IPR000033 | 14 | 1 | 18521 | 50 |
LRP1B |
3.735e-02 | -3.29 | urinary_tract | COSMIC cancer mutations | urinary_tract | 14112 | 45 | 16828 | 48 |
ABLIM1,PITPNC1,SLC14A1,RORA,LSAMP,NRCAM,NEBL,GPM6A,NAV2,MGAT4C,SOX5,CAMK2G,LRP1B,TNIK,ADCY2,MACF1,GPC5,NAV3,FAT3,PLCB1,TNC,RFX4,KALRN,SYNE1,MSI2,DGKG,SORBS1,SLC1A2,SLC4A4,SFXN5,CTNND2,PARD3,TRPM3,ATP1A2,NTRK2,NRXN1,DCLK2,HPSE2,DPP6,CNTN1,NRG3,RYR3,FMN2,DTNA,NTM |
3.735e-02 | -3.29 | bladder | COSMIC cancer mutations | bladder | 14112 | 45 | 16828 | 48 |
DTNA,FMN2,NTM,RYR3,NRG3,DPP6,CNTN1,NRXN1,DCLK2,HPSE2,PARD3,ATP1A2,NTRK2,TRPM3,SFXN5,CTNND2,SORBS1,SLC1A2,SLC4A4,MSI2,RFX4,KALRN,SYNE1,DGKG,NAV3,ADCY2,MACF1,GPC5,PLCB1,TNC,FAT3,LRP1B,TNIK,CAMK2G,SOX5,NAV2,GPM6A,MGAT4C,NRCAM,RORA,LSAMP,NEBL,SLC14A1,PITPNC1,ABLIM1 |
3.747e-02 | -3.28 | Integrin-mediated Cell Adhesion | WikiPathways | WP185 | 103 | 2 | 5310 | 16 |
MAPK10,SORBS1 |
3.748e-02 | -3.28 | Developmental Biology | REACTOME pathways | R-HSA-1266738 | 1075 | 7 | 10285 | 31 |
NRCAM,CAMK2G,ABLIM1,CNTN1,CTNNA2,NRG3,KALRN |
3.749e-02 | -3.28 | Trehalose Degradation | SMPDB pathways | SMP0000467 | 13 | 1 | 1369 | 4 |
ATP1A2 |
3.749e-02 | -3.28 | Succinate Signalling During Inflammation | SMPDB pathways | SMP0084634 | 13 | 1 | 1369 | 4 |
PLCB1 |
3.752e-02 | -3.28 | Progesterone-mediated oocyte maturation | KEGG pathways | hsa04914 | 92 | 2 | 7161 | 24 |
ADCY2,MAPK10 |
3.752e-02 | -3.28 | Progesterone-mediated oocyte maturation | KEGG pathways | ko04914 | 92 | 2 | 7161 | 24 |
MAPK10,ADCY2 |
3.756e-02 | -3.28 | ANKRD26 (ankyrin repeat domain containing 26) | protein interactions | 22852 | 119 | 2 | 19454 | 50 |
NTRK2,PARD3 |
3.759e-02 | -3.28 | human chr11q14.3 | chromosome location | human chr11q14.3 | 20 | 1 | 26134 | 50 |
FAT3 |
3.771e-02 | -3.28 | microtubule binding | molecular function | GO:0008017 | 279 | 3 | 18094 | 48 |
DCLK2,NAV3,MACF1 |
3.779e-02 | -3.28 | regulation of skeletal muscle adaptation | biological process | GO:0014733 | 14 | 1 | 18204 | 50 |
CAMK2G |
3.779e-02 | -3.28 | negative regulation of sodium ion transmembrane transporter activity | biological process | GO:2000650 | 14 | 1 | 18204 | 50 |
ATP1A2 |
3.779e-02 | -3.28 | glutathione biosynthetic process | biological process | GO:0006750 | 14 | 1 | 18204 | 50 |
SLC1A2 |
3.779e-02 | -3.28 | interneuron migration | biological process | GO:1904936 | 14 | 1 | 18204 | 50 |
FAT3 |
3.779e-02 | -3.28 | regulation of mesenchymal cell apoptotic process | biological process | GO:2001053 | 14 | 1 | 18204 | 50 |
SYNE1 |
3.779e-02 | -3.28 | mechanosensory behavior | biological process | GO:0007638 | 14 | 1 | 18204 | 50 |
NRXN1 |
3.779e-02 | -3.28 | relaxation of cardiac muscle | biological process | GO:0055119 | 14 | 1 | 18204 | 50 |
ATP1A2 |
3.779e-02 | -3.28 | cellular response to forskolin | biological process | GO:1904322 | 14 | 1 | 18204 | 50 |
ADCY2 |
3.779e-02 | -3.28 | cellular response to purine-containing compound | biological process | GO:0071415 | 14 | 1 | 18204 | 50 |
RYR3 |
3.779e-02 | -3.28 | response to forskolin | biological process | GO:1904321 | 14 | 1 | 18204 | 50 |
ADCY2 |
3.780e-02 | -3.28 | axolemma | cellular component | GO:0030673 | 15 | 1 | 19108 | 49 |
SLC1A2 |
3.788e-02 | -3.27 | XIRP1 (xin actin binding repeat containing 1) | protein interactions | 165904 | 15 | 1 | 19454 | 50 |
NEBL |
3.788e-02 | -3.27 | TAFA5 (TAFA chemokine like family member 5) | protein interactions | 25817 | 15 | 1 | 19454 | 50 |
NEBL |
3.788e-02 | -3.27 | DEFB123 (defensin beta 123) | protein interactions | 245936 | 15 | 1 | 19454 | 50 |
LRP1B |
3.788e-02 | -3.27 | OLFM3 (olfactomedin 3) | protein interactions | 118427 | 15 | 1 | 19454 | 50 |
LRP1B |
3.788e-02 | -3.27 | PCSK1N (proprotein convertase subtilisin/kexin type 1 inhibitor) | protein interactions | 27344 | 15 | 1 | 19454 | 50 |
MGAT4C |
3.794e-02 | -3.27 | rhythmic process | biological process | GO:0048511 | 270 | 3 | 18204 | 50 |
MAPK10,NTRK2,RORA |
3.810e-02 | -3.27 | CEP128 (centrosomal protein 128) | protein interactions | 145508 | 289 | 3 | 19454 | 50 |
SORBS1,NEBL,ABLIM1 |
3.818e-02 | -3.27 | lung-middle_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-middle_lobe-carcinoma-adenocarcinoma | 1368 | 8 | 16828 | 48 |
MACF1,RYR3,HPSE2,SYNE1,CTNND2,LRP1B,ATP1A2,TRPM3 |
3.843e-02 | -3.26 | nuclear envelope | cellular component | GO:0005635 | 498 | 4 | 19108 | 49 |
NAV3,SYNE1,PLCB1,NRXN1 |
3.850e-02 | -3.26 | ERBB2 Activates PTK6 Signaling | REACTOME pathways | R-HSA-8847993 | 13 | 1 | 10285 | 31 |
NRG3 |
3.855e-02 | -3.26 | solute:monoatomic cation symporter activity | molecular function | GO:0015294 | 117 | 2 | 18094 | 48 |
SLC1A2,SLC4A4 |
3.856e-02 | -3.26 | metencephalon development | biological process | GO:0022037 | 113 | 2 | 18204 | 50 |
RORA,CNTN1 |
3.870e-02 | -3.25 | MAPK | prosite domains | PS01351 | 12 | 1 | 12186 | 40 |
MAPK10 |
3.884e-02 | -3.25 | lung-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-adenocarcinoma | 15133 | 47 | 16828 | 48 |
DGKG,MSI2,KALRN,SYNE1,RFX4,TNC,PLCB1,FAT3,NAV3,MACF1,GPC5,ADCY2,TNIK,LRP1B,CAMK2G,SOX5,MGAT4C,NAV2,GPM6A,NEBL,NRCAM,RORA,LSAMP,SLC14A1,NHSL1,PITPNC1,ABLIM1,NTM,FMN2,DTNA,RYR3,NRG3,NKAIN3,CNTN1,DPP6,HPSE2,DCLK2,NRXN1,NTRK2,ATP1A2,TRPM3,PARD3,CTNND2,SFXN5,SLC4A4,SLC1A2,SORBS1 |
3.887e-02 | -3.25 | positive regulation of multicellular organismal process | biological process | GO:0051240 | 1691 | 9 | 18204 | 50 |
PARD3,SFXN5,PLCB1,MACF1,NTRK2,RORA,NRXN1,SOX5,ATP1A2 |
3.893e-02 | -3.25 | Stimuli-sensing channels | REACTOME pathways | R-HSA-2672351 | 104 | 2 | 10285 | 31 |
RYR3,TRPM3 |
3.900e-02 | -3.24 | vascular process in circulatory system | biological process | GO:0003018 | 273 | 3 | 18204 | 50 |
SLC4A4,SLC1A2,ATP1A2 |
3.908e-02 | -3.24 | filamin binding | molecular function | GO:0031005 | 15 | 1 | 18094 | 48 |
NEBL |
3.908e-02 | -3.24 | tropomyosin binding | molecular function | GO:0005523 | 15 | 1 | 18094 | 48 |
NEBL |
3.908e-02 | -3.24 | 3'-5' DNA helicase activity | molecular function | GO:0043138 | 15 | 1 | 18094 | 48 |
NAV2 |
3.908e-02 | -3.24 | low-density lipoprotein particle receptor activity | molecular function | GO:0005041 | 15 | 1 | 18094 | 48 |
LRP1B |
3.908e-02 | -3.24 | phosphatidylglycerol binding | molecular function | GO:1901611 | 15 | 1 | 18094 | 48 |
PITPNC1 |
3.912e-02 | -3.24 | regulation of developmental process | biological process | GO:0050793 | 2540 | 12 | 18204 | 50 |
NRXN1,TNIK,MACF1,RORA,NRCAM,DGKG,SOX5,NTRK2,PLCB1,SYNE1,FAT3,PARD3 |
3.918e-02 | -3.24 | regulation of circadian rhythm | biological process | GO:0042752 | 114 | 2 | 18204 | 50 |
RORA,MAPK10 |
3.925e-02 | -3.24 | prostate-adenoma | COSMIC cancer mutations | prostate-adenoma | 1634 | 9 | 16828 | 48 |
SYNE1,LRP1B,PARD3,TRPM3,SOX5,GPC5,MACF1,DCLK2,NEBL |
3.930e-02 | -3.24 | BRK1 (BRICK1 subunit of SCAR/WAVE actin nucleating complex) | protein interactions | 55845 | 122 | 2 | 19454 | 50 |
NHSL1,DTNA |
3.930e-02 | -3.24 | SLMAP (sarcolemma associated protein) | protein interactions | 7871 | 122 | 2 | 19454 | 50 |
TNIK,CAMK2G |
3.943e-02 | -3.23 | human chr10q23.1 | chromosome location | human chr10q23.1 | 21 | 1 | 26134 | 50 |
NRG3 |
3.943e-02 | -3.23 | human chr13q31.3 | chromosome location | human chr13q31.3 | 21 | 1 | 26134 | 50 |
GPC5 |
3.947e-02 | -3.23 | EGF_CA | prosite domains | PS01187 | 96 | 2 | 12186 | 40 |
FAT3,LRP1B |
3.971e-02 | -3.23 | gliogenesis | biological process | GO:0042063 | 275 | 3 | 18204 | 50 |
PARD3,CNTN1,NTRK2 |
3.975e-02 | -3.23 | CNH_dom | interpro domains | IPR001180 | 15 | 1 | 18521 | 50 |
TNIK |
3.975e-02 | -3.23 | ATPase_P-typ_cation-transptr_C | interpro domains | IPR006068 | 15 | 1 | 18521 | 50 |
ATP1A2 |
3.975e-02 | -3.23 | Diacylglycerol_kinase_cat_dom | interpro domains | IPR001206 | 15 | 1 | 18521 | 50 |
DGKG |
3.975e-02 | -3.23 | PI-PLC_fam | interpro domains | IPR001192 | 15 | 1 | 18521 | 50 |
PLCB1 |
3.975e-02 | -3.23 | NTF2-like_dom_sf | interpro domains | IPR032710 | 15 | 1 | 18521 | 50 |
CAMK2G |
3.975e-02 | -3.23 | PLipase_C_Pinositol-sp_Y | interpro domains | IPR001711 | 15 | 1 | 18521 | 50 |
PLCB1 |
3.975e-02 | -3.23 | FH2_Formin_sf | interpro domains | IPR042201 | 15 | 1 | 18521 | 50 |
FMN2 |
3.975e-02 | -3.23 | FH2_Formin | interpro domains | IPR015425 | 15 | 1 | 18521 | 50 |
FMN2 |
3.978e-02 | -3.22 | Endocrine resistance | KEGG pathways | ko01522 | 95 | 2 | 7161 | 24 |
MAPK10,ADCY2 |
3.978e-02 | -3.22 | Endocrine resistance | KEGG pathways | hsa01522 | 95 | 2 | 7161 | 24 |
ADCY2,MAPK10 |
3.988e-02 | -3.22 | GNAQ (G protein subunit alpha q) | protein interactions | 2776 | 123 | 2 | 19454 | 50 |
GPM6A,PLCB1 |
4.017e-02 | -3.21 | ovary-carcinoma-clear_cell_carcinoma | COSMIC cancer mutations | ovary-carcinoma-clear_cell_carcinoma | 665 | 5 | 16828 | 48 |
NTRK2,TNIK,LRP1B,DCLK2,CAMK2G |
4.019e-02 | -3.21 | middle_lobe | COSMIC cancer mutations | middle_lobe | 1382 | 8 | 16828 | 48 |
MACF1,HPSE2,RYR3,LRP1B,SYNE1,CTNND2,TRPM3,ATP1A2 |
4.027e-02 | -3.21 | postsynaptic density, intracellular component | cellular component | GO:0099092 | 16 | 1 | 19108 | 49 |
TNIK |
4.033e-02 | -3.21 | Pathways in cancer | KEGG pathways | hsa05200 | 395 | 4 | 7161 | 24 |
CTNNA2,PLCB1,MAPK10,ADCY2 |
4.035e-02 | -3.21 | SYTL2 (synaptotagmin like 2) | protein interactions | 54843 | 16 | 1 | 19454 | 50 |
NRXN1 |
4.035e-02 | -3.21 | CDH12 (cadherin 12) | protein interactions | 1010 | 16 | 1 | 19454 | 50 |
CTNNA2 |
4.035e-02 | -3.21 | CAMK1G (calcium/calmodulin dependent protein kinase IG) | protein interactions | 57172 | 16 | 1 | 19454 | 50 |
CAMK2G |
4.035e-02 | -3.21 | SAPCD1 (suppressor APC domain containing 1) | protein interactions | 401251 | 16 | 1 | 19454 | 50 |
CTNNA2 |
4.035e-02 | -3.21 | GALNT13 (polypeptide N-acetylgalactosaminyltransferase 13) | protein interactions | 114805 | 16 | 1 | 19454 | 50 |
TNIK |
4.035e-02 | -3.21 | CNTNAP2 (contactin associated protein 2) | protein interactions | 26047 | 16 | 1 | 19454 | 50 |
MACF1 |
4.035e-02 | -3.21 | SYT9 (synaptotagmin 9) | protein interactions | 143425 | 16 | 1 | 19454 | 50 |
NRXN1 |
4.035e-02 | -3.21 | SYT4 (synaptotagmin 4) | protein interactions | 6860 | 16 | 1 | 19454 | 50 |
NRXN1 |
4.035e-02 | -3.21 | AMMECR1L (AMMECR1 like) | protein interactions | 83607 | 16 | 1 | 19454 | 50 |
MACF1 |
4.035e-02 | -3.21 | DUS1L (dihydrouridine synthase 1 like) | protein interactions | 64118 | 16 | 1 | 19454 | 50 |
CAMK2G |
4.043e-02 | -3.21 | protein homotrimerization | biological process | GO:0070207 | 15 | 1 | 18204 | 50 |
SLC1A2 |
4.043e-02 | -3.21 | peripheral nervous system neuron differentiation | biological process | GO:0048934 | 15 | 1 | 18204 | 50 |
NTRK2 |
4.043e-02 | -3.21 | sarcoplasmic reticulum calcium ion transport | biological process | GO:0070296 | 15 | 1 | 18204 | 50 |
RYR3 |
4.043e-02 | -3.21 | neuroblast division | biological process | GO:0055057 | 15 | 1 | 18204 | 50 |
SOX5 |
4.043e-02 | -3.21 | cerebellar Purkinje cell layer formation | biological process | GO:0021694 | 15 | 1 | 18204 | 50 |
RORA |
4.043e-02 | -3.21 | positive regulation of glycogen biosynthetic process | biological process | GO:0045725 | 15 | 1 | 18204 | 50 |
SORBS1 |
4.043e-02 | -3.21 | pyramidal neuron differentiation | biological process | GO:0021859 | 15 | 1 | 18204 | 50 |
DCLK2 |
4.043e-02 | -3.21 | regulation of neuron projection arborization | biological process | GO:0150011 | 15 | 1 | 18204 | 50 |
MACF1 |
4.043e-02 | -3.21 | negative regulation of sodium ion transmembrane transport | biological process | GO:1902306 | 15 | 1 | 18204 | 50 |
ATP1A2 |
4.043e-02 | -3.21 | peripheral nervous system neuron development | biological process | GO:0048935 | 15 | 1 | 18204 | 50 |
NTRK2 |
4.043e-02 | -3.21 | intracellular potassium ion homeostasis | biological process | GO:0030007 | 15 | 1 | 18204 | 50 |
ATP1A2 |
4.043e-02 | -3.21 | response to caffeine | biological process | GO:0031000 | 15 | 1 | 18204 | 50 |
RYR3 |
4.053e-02 | -3.21 | CRAL_TRIO_2 | pfam domains | PF13716 | 15 | 1 | 17795 | 49 |
KALRN |
4.053e-02 | -3.21 | FH2 | pfam domains | PF02181 | 15 | 1 | 17795 | 49 |
FMN2 |
4.053e-02 | -3.21 | Cation_ATPase_C | pfam domains | PF00689 | 15 | 1 | 17795 | 49 |
ATP1A2 |
4.053e-02 | -3.21 | DAGK_cat | pfam domains | PF00781 | 15 | 1 | 17795 | 49 |
DGKG |
4.053e-02 | -3.21 | CNH | pfam domains | PF00780 | 15 | 1 | 17795 | 49 |
TNIK |
4.053e-02 | -3.21 | PI-PLC-Y | pfam domains | PF00387 | 15 | 1 | 17795 | 49 |
PLCB1 |
4.059e-02 | -3.20 | ovary-carcinoma-mucinous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-mucinous_carcinoma | 456 | 4 | 16828 | 48 |
TNIK,NTRK2,CAMK2G,DCLK2 |
4.065e-02 | -3.20 | membrane protein complex | cellular component | GO:0098796 | 1261 | 7 | 19108 | 49 |
DPP6,SORBS1,RYR3,ATP1A2,SLC1A2,SYNE1,CTNNA2 |
4.079e-02 | -3.20 | TJP1 (tight junction protein 1) | protein interactions | 7082 | 297 | 3 | 19454 | 50 |
NEBL,PARD3,DTNA |
4.080e-02 | -3.20 | actin filament organization | biological process | GO:0007015 | 278 | 3 | 18204 | 50 |
NEBL,FMN2,SORBS1 |
4.099e-02 | -3.19 | Transport of inorganic cations/anions and amino acids/oligopeptides | REACTOME pathways | R-HSA-425393 | 107 | 2 | 10285 | 31 |
SLC4A4,SLC1A2 |
4.105e-02 | -3.19 | clear_cell_carcinoma | COSMIC cancer mutations | clear_cell_carcinoma | 669 | 5 | 16828 | 48 |
LRP1B,CAMK2G,DCLK2,TNIK,NTRK2 |
4.107e-02 | -3.19 | regulation of synapse assembly | biological process | GO:0051963 | 117 | 2 | 18204 | 50 |
NRXN1,NTRK2 |
4.114e-02 | -3.19 | mucinous_carcinoma | COSMIC cancer mutations | mucinous_carcinoma | 458 | 4 | 16828 | 48 |
NTRK2,TNIK,DCLK2,CAMK2G |
4.127e-02 | -3.19 | human chr3q13.31 | chromosome location | human chr3q13.31 | 22 | 1 | 26134 | 50 |
LSAMP |
4.128e-02 | -3.19 | positive regulation of cellular process | biological process | GO:0048522 | 5719 | 22 | 18204 | 50 |
TNC,MACF1,RORA,SLC4A4,TNIK,GPM6A,SORBS1,NTRK2,SOX5,PARD3,GPC5,NRXN1,NRCAM,NAV3,FMN2,RBMS3,SYNE1,RFX4,PLCB1,CNTN1,SLC1A2,HPSE2 |
4.131e-02 | -3.19 | Phosphatidylinositol signaling system | KEGG pathways | hsa04070 | 97 | 2 | 7161 | 24 |
PLCB1,DGKG |
4.131e-02 | -3.19 | Phosphatidylinositol signaling system | KEGG pathways | ko04070 | 97 | 2 | 7161 | 24 |
PLCB1,DGKG |
4.141e-02 | -3.18 | SHC1 events in ERBB4 signaling | REACTOME pathways | R-HSA-1250347 | 14 | 1 | 10285 | 31 |
NRG3 |
4.141e-02 | -3.18 | DCC mediated attractive signaling | REACTOME pathways | R-HSA-418885 | 14 | 1 | 10285 | 31 |
ABLIM1 |
4.142e-02 | -3.18 | ERK Pathway in Huntington's Disease | WikiPathways | WP3853 | 14 | 1 | 5310 | 16 |
NTRK2 |
4.163e-02 | -3.18 | adenylate cyclase activity | molecular function | GO:0004016 | 16 | 1 | 18094 | 48 |
ADCY2 |
4.163e-02 | -3.18 | MAP kinase activity | molecular function | GO:0004707 | 16 | 1 | 18094 | 48 |
MAPK10 |
4.163e-02 | -3.18 | MAP kinase kinase activity | molecular function | GO:0004708 | 16 | 1 | 18094 | 48 |
MAPK10 |
4.163e-02 | -3.18 | oxysterol binding | molecular function | GO:0008142 | 16 | 1 | 18094 | 48 |
RORA |
4.166e-02 | -3.18 | SYP (synaptophysin) | protein interactions | 6855 | 126 | 2 | 19454 | 50 |
PITPNC1,GPM6A |
4.176e-02 | -3.18 | - | gene3d domains | 2.60.200.40 | 14 | 1 | 14470 | 44 |
DGKG |
4.176e-02 | -3.18 | - | gene3d domains | 2.20.25.10 | 14 | 1 | 14470 | 44 |
TNC |
4.186e-02 | -3.17 | LDLRB | prosite domains | PS51120 | 13 | 1 | 12186 | 40 |
LRP1B |
4.193e-02 | -3.17 | cell surface receptor signaling pathway | biological process | GO:0007166 | 1992 | 10 | 18204 | 50 |
MAPK10,CNTN1,NRG3,KALRN,TNIK,MACF1,CTNND2,NTRK2,PLCB1,SORBS1 |
4.193e-02 | -3.17 | response to stimulus | biological process | GO:0050896 | 7803 | 28 | 18204 | 50 |
NRXN1,DTNA,PLCB1,FMN2,SYNE1,RBMS3,RYR3,SLC1A2,MAPK10,ADCY2,CNTN1,TNC,TNIK,MACF1,RORA,NRG3,KALRN,GPM6A,DGKG,SORBS1,SOX5,ATP1A2,NTRK2,CTNND2,DCLK2,PARD3,CTNNA2,PITPNC1 |
4.209e-02 | -3.17 | Estrogen signaling pathway | KEGG pathways | hsa04915 | 98 | 2 | 7161 | 24 |
ADCY2,PLCB1 |
4.209e-02 | -3.17 | Estrogen signaling pathway | KEGG pathways | ko04915 | 98 | 2 | 7161 | 24 |
ADCY2,PLCB1 |
4.216e-02 | -3.17 | ARRB1 (arrestin beta 1) | protein interactions | 408 | 301 | 3 | 19454 | 50 |
LRP1B,DGKG,MAPK10 |
4.230e-02 | -3.16 | EGF-like_Ca-bd_dom | interpro domains | IPR001881 | 121 | 2 | 18521 | 50 |
FAT3,LRP1B |
4.265e-02 | -3.15 | Wnt signaling pathway | biological process | GO:0016055 | 283 | 3 | 18204 | 50 |
CTNND2,MACF1,TNIK |
4.267e-02 | -3.15 | neuron projection terminus | cellular component | GO:0044306 | 128 | 2 | 19108 | 49 |
NTRK2,SLC1A2 |
4.273e-02 | -3.15 | protein complex involved in cell-matrix adhesion | cellular component | GO:0098637 | 17 | 1 | 19108 | 49 |
TNC |
4.282e-02 | -3.15 | ovary-carcinoma-endometrioid_carcinoma | COSMIC cancer mutations | ovary-carcinoma-endometrioid_carcinoma | 464 | 4 | 16828 | 48 |
CAMK2G,DCLK2,TNIK,NTRK2 |
4.282e-02 | -3.15 | DPP6 (dipeptidyl peptidase like 6) | protein interactions | 1804 | 17 | 1 | 19454 | 50 |
GPM6A |
4.282e-02 | -3.15 | SCN1B (sodium voltage-gated channel beta subunit 1) | protein interactions | 6324 | 17 | 1 | 19454 | 50 |
CNTN1 |
4.282e-02 | -3.15 | PAX4 (paired box 4) | protein interactions | 5078 | 17 | 1 | 19454 | 50 |
NTM |
4.282e-02 | -3.15 | KRTAP19-3 (keratin associated protein 19-3) | protein interactions | 337970 | 17 | 1 | 19454 | 50 |
CAMK2G |
4.282e-02 | -3.15 | TAGAP (T cell activation RhoGTPase activating protein) | protein interactions | 117289 | 17 | 1 | 19454 | 50 |
DTNA |
4.282e-02 | -3.15 | NFASC (neurofascin) | protein interactions | 23114 | 17 | 1 | 19454 | 50 |
NRCAM |
4.282e-02 | -3.15 | Shcbp1 (Shc SH2-domain binding protein 1) | protein interactions | 20419 | 17 | 1 | 19454 | 50 |
GPC5 |
4.282e-02 | -3.15 | SEPSECS (Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase) | protein interactions | 51091 | 17 | 1 | 19454 | 50 |
ABLIM1 |
4.282e-02 | -3.15 | MSANTD2 (Myb/SANT DNA binding domain containing 2) | protein interactions | 79684 | 17 | 1 | 19454 | 50 |
SOX5 |
4.282e-02 | -3.15 | FAM163B (family with sequence similarity 163 member B) | protein interactions | 642968 | 17 | 1 | 19454 | 50 |
CAMK2G |
4.286e-02 | -3.15 | ATF7IP (activating transcription factor 7 interacting protein) | protein interactions | 55729 | 128 | 2 | 19454 | 50 |
SOX5,MACF1 |
4.287e-02 | -3.15 | AGE-RAGE signaling pathway in diabetic complications | KEGG pathways | hsa04933 | 99 | 2 | 7161 | 24 |
MAPK10,PLCB1 |
4.287e-02 | -3.15 | Choline metabolism in cancer | KEGG pathways | ko05231 | 99 | 2 | 7161 | 24 |
MAPK10,DGKG |
4.287e-02 | -3.15 | AGE-RAGE signaling pathway in diabetic complications | KEGG pathways | ko04933 | 99 | 2 | 7161 | 24 |
MAPK10,PLCB1 |
4.287e-02 | -3.15 | Choline metabolism in cancer | KEGG pathways | hsa05231 | 99 | 2 | 7161 | 24 |
MAPK10,DGKG |
4.307e-02 | -3.14 | nonribosomal peptide biosynthetic process | biological process | GO:0019184 | 16 | 1 | 18204 | 50 |
SLC1A2 |
4.307e-02 | -3.14 | locomotory exploration behavior | biological process | GO:0035641 | 16 | 1 | 18204 | 50 |
ATP1A2 |
4.307e-02 | -3.14 | regulation of postsynaptic neurotransmitter receptor internalization | biological process | GO:0099149 | 16 | 1 | 18204 | 50 |
SYNE1 |
4.307e-02 | -3.14 | neuron cell-cell adhesion | biological process | GO:0007158 | 16 | 1 | 18204 | 50 |
NRXN1 |
4.307e-02 | -3.14 | regulation of respiratory system process | biological process | GO:0044065 | 16 | 1 | 18204 | 50 |
ATP1A2 |
4.307e-02 | -3.14 | response to ether | biological process | GO:0045472 | 16 | 1 | 18204 | 50 |
PLCB1 |
4.307e-02 | -3.14 | regulation of amino acid transmembrane transport | biological process | GO:1903789 | 16 | 1 | 18204 | 50 |
ATP1A2 |
4.307e-02 | -3.14 | regulation of amino acid import across plasma membrane | biological process | GO:0010958 | 16 | 1 | 18204 | 50 |
ATP1A2 |
4.311e-02 | -3.14 | human chr5p15.31 | chromosome location | human chr5p15.31 | 23 | 1 | 26134 | 50 |
ADCY2 |
4.321e-02 | -3.14 | CARM1 (coactivator associated arginine methyltransferase 1) | protein interactions | 10498 | 304 | 3 | 19454 | 50 |
RORA,DTNA,CAMK2G |
4.366e-02 | -3.13 | channel activity | molecular function | GO:0015267 | 502 | 4 | 18094 | 48 |
SLC14A1,GPM6A,RYR3,TRPM3 |
4.379e-02 | -3.13 | regulation of transmembrane transport | biological process | GO:0034762 | 485 | 4 | 18204 | 50 |
ATP1A2,SLC1A2,DPP6,SORBS1 |
4.381e-02 | -3.13 | Integration of energy metabolism | REACTOME pathways | R-HSA-163685 | 111 | 2 | 10285 | 31 |
PLCB1,ADCY2 |
4.388e-02 | -3.13 | Z disc | cellular component | GO:0030018 | 130 | 2 | 19108 | 49 |
NEBL,RYR3 |
4.392e-02 | -3.13 | passive transmembrane transporter activity | molecular function | GO:0022803 | 503 | 4 | 18094 | 48 |
SLC14A1,GPM6A,TRPM3,RYR3 |
4.430e-02 | -3.12 | N-Glycan antennae elongation | REACTOME pathways | R-HSA-975577 | 15 | 1 | 10285 | 31 |
MGAT4C |
4.430e-02 | -3.12 | Inhibition of adenylate cyclase pathway | REACTOME pathways | R-HSA-997269 | 15 | 1 | 10285 | 31 |
ADCY2 |
4.430e-02 | -3.12 | ERBB2 Regulates Cell Motility | REACTOME pathways | R-HSA-6785631 | 15 | 1 | 10285 | 31 |
NRG3 |
4.430e-02 | -3.12 | Adenylate cyclase inhibitory pathway | REACTOME pathways | R-HSA-170670 | 15 | 1 | 10285 | 31 |
ADCY2 |
4.467e-02 | -3.11 | Formin, FH2 domain | gene3d domains | 1.20.58.2220 | 15 | 1 | 14470 | 44 |
FMN2 |
4.472e-02 | -3.11 | FCERI mediated MAPK activation | REACTOME pathways | R-HSA-2871796 | 265 | 3 | 10285 | 31 |
MAPK10,CAMK2G,NRG3 |
4.492e-02 | -3.10 | muscle cell differentiation | biological process | GO:0042692 | 289 | 3 | 18204 | 50 |
RORA,NEBL,SYNE1 |
4.493e-02 | -3.10 | ATP-NAD_kinase_N | interpro domains | IPR017438 | 17 | 1 | 18521 | 50 |
DGKG |
4.493e-02 | -3.10 | PLipase_C_PInositol-sp_X_dom | interpro domains | IPR000909 | 17 | 1 | 18521 | 50 |
PLCB1 |
4.493e-02 | -3.10 | NAD/diacylglycerol_kinase_sf | interpro domains | IPR016064 | 17 | 1 | 18521 | 50 |
DGKG |
4.493e-02 | -3.10 | A/G_cyclase_CS | interpro domains | IPR018297 | 17 | 1 | 18521 | 50 |
ADCY2 |
4.525e-02 | -3.10 | Chagas disease (American trypanosomiasis) | KEGG pathways | hsa05142 | 102 | 2 | 7161 | 24 |
PLCB1,MAPK10 |
4.525e-02 | -3.10 | Chagas disease (American trypanosomiasis) | KEGG pathways | ko05142 | 102 | 2 | 7161 | 24 |
PLCB1,MAPK10 |
4.529e-02 | -3.09 | Cnot2 (CCR4-NOT transcription complex, subunit 2) | protein interactions | 72068 | 18 | 1 | 19454 | 50 |
MACF1 |
4.529e-02 | -3.09 | DCDC1 (doublecortin domain containing 1) | protein interactions | 341019 | 18 | 1 | 19454 | 50 |
FAT3 |
4.529e-02 | -3.09 | ZNF224 (zinc finger protein 224) | protein interactions | 7767 | 18 | 1 | 19454 | 50 |
LRP1B |
4.529e-02 | -3.09 | OPCML (opioid binding protein/cell adhesion molecule like) | protein interactions | 4978 | 18 | 1 | 19454 | 50 |
NTM |
4.529e-02 | -3.09 | TTC29 (tetratricopeptide repeat domain 29) | protein interactions | 83894 | 18 | 1 | 19454 | 50 |
MACF1 |
4.529e-02 | -3.09 | ACAP1 (ArfGAP with coiled-coil, ankyrin repeat and PH domains 1) | protein interactions | 9744 | 18 | 1 | 19454 | 50 |
NEBL |
4.529e-02 | -3.09 | ADAT2 (adenosine deaminase tRNA specific 2) | protein interactions | 134637 | 18 | 1 | 19454 | 50 |
NAV2 |
4.529e-02 | -3.09 | DCANP1 (dendritic cell associated nuclear protein 1) | protein interactions | 140947 | 18 | 1 | 19454 | 50 |
FAT3 |
4.529e-02 | -3.09 | NECTIN1 (nectin cell adhesion molecule 1) | protein interactions | 5818 | 18 | 1 | 19454 | 50 |
PARD3 |
4.530e-02 | -3.09 | STRN (striatin) | protein interactions | 6801 | 132 | 2 | 19454 | 50 |
CAMK2G,TNIK |
4.560e-02 | -3.09 | cardiocyte differentiation | biological process | GO:0035051 | 124 | 2 | 18204 | 50 |
NEBL,SYNE1 |
4.570e-02 | -3.09 | positive regulation of glycogen metabolic process | biological process | GO:0070875 | 17 | 1 | 18204 | 50 |
SORBS1 |
4.570e-02 | -3.09 | branch elongation of an epithelium | biological process | GO:0060602 | 17 | 1 | 18204 | 50 |
TNC |
4.570e-02 | -3.09 | regulation of fertilization | biological process | GO:0080154 | 17 | 1 | 18204 | 50 |
PLCB1 |
4.570e-02 | -3.09 | preganglionic parasympathetic fiber development | biological process | GO:0021783 | 17 | 1 | 18204 | 50 |
NAV2 |
4.570e-02 | -3.09 | retinal rod cell differentiation | biological process | GO:0060221 | 17 | 1 | 18204 | 50 |
NTRK2 |
4.570e-02 | -3.09 | protein trimerization | biological process | GO:0070206 | 17 | 1 | 18204 | 50 |
SLC1A2 |
4.570e-02 | -3.09 | cell migration in hindbrain | biological process | GO:0021535 | 17 | 1 | 18204 | 50 |
CTNNA2 |
4.570e-02 | -3.09 | cellular response to ATP | biological process | GO:0071318 | 17 | 1 | 18204 | 50 |
RYR3 |
4.570e-02 | -3.09 | positive regulation of meiotic nuclear division | biological process | GO:0045836 | 17 | 1 | 18204 | 50 |
PLCB1 |
4.570e-02 | -3.09 | microvillus assembly | biological process | GO:0030033 | 17 | 1 | 18204 | 50 |
TNIK |
4.570e-02 | -3.09 | cGMP metabolic process | biological process | GO:0046068 | 17 | 1 | 18204 | 50 |
RORA |
4.570e-02 | -3.09 | T-helper 17 type immune response | biological process | GO:0072538 | 17 | 1 | 18204 | 50 |
RORA |
4.570e-02 | -3.09 | cell communication by electrical coupling involved in cardiac conduction | biological process | GO:0086064 | 17 | 1 | 18204 | 50 |
ATP1A2 |
4.570e-02 | -3.09 | membrane depolarization during cardiac muscle cell action potential | biological process | GO:0086012 | 17 | 1 | 18204 | 50 |
ATP1A2 |
4.581e-02 | -3.08 | PI-PLC-X | pfam domains | PF00388 | 17 | 1 | 17795 | 49 |
PLCB1 |
4.581e-02 | -3.08 | ZZ | pfam domains | PF00569 | 17 | 1 | 17795 | 49 |
DTNA |
4.598e-02 | -3.08 | haematopoietic_and_lymphoid_tissue-abdomen-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-abdomen-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 120 | 2 | 16828 | 48 |
FMN2,CTNND2 |
4.626e-02 | -3.07 | actomyosin structure organization | biological process | GO:0031032 | 125 | 2 | 18204 | 50 |
SORBS1,NEBL |
4.626e-02 | -3.07 | cerebral cortex development | biological process | GO:0021987 | 125 | 2 | 18204 | 50 |
PLCB1,NTRK2 |
4.626e-02 | -3.07 | cellular component assembly involved in morphogenesis | biological process | GO:0010927 | 125 | 2 | 18204 | 50 |
NEBL,CNTN1 |
4.626e-02 | -3.07 | cellular anatomical entity morphogenesis | biological process | GO:0032989 | 125 | 2 | 18204 | 50 |
NEBL,CNTN1 |
4.653e-02 | -3.07 | MYO10 (myosin X) | protein interactions | 4651 | 134 | 2 | 19454 | 50 |
CAMK2G,DPP6 |
4.671e-02 | -3.06 | phosphatidylcholine transporter activity | molecular function | GO:0008525 | 18 | 1 | 18094 | 48 |
PITPNC1 |
4.671e-02 | -3.06 | acidic amino acid transmembrane transporter activity | molecular function | GO:0015172 | 18 | 1 | 18094 | 48 |
SLC1A2 |
4.671e-02 | -3.06 | lipoprotein particle receptor activity | molecular function | GO:0030228 | 18 | 1 | 18094 | 48 |
LRP1B |
4.671e-02 | -3.06 | intracellularly gated calcium channel activity | molecular function | GO:0015278 | 18 | 1 | 18094 | 48 |
RYR3 |
4.671e-02 | -3.06 | heparan sulfate proteoglycan binding | molecular function | GO:0043395 | 18 | 1 | 18094 | 48 |
HPSE2 |
4.671e-02 | -3.06 | transmembrane receptor protein tyrosine kinase activator activity | molecular function | GO:0030297 | 18 | 1 | 18094 | 48 |
NRG3 |
4.677e-02 | -3.06 | human chr20p12.3 | chromosome location | human chr20p12.3 | 25 | 1 | 26134 | 50 |
PLCB1 |
4.677e-02 | -3.06 | human chr7q31.1 | chromosome location | human chr7q31.1 | 25 | 1 | 26134 | 50 |
NRCAM |
4.693e-02 | -3.06 | limbic system development | biological process | GO:0021761 | 126 | 2 | 18204 | 50 |
ATP1A2,DCLK2 |
4.716e-02 | -3.05 | Myo1c (myosin IC) | protein interactions | 17913 | 135 | 2 | 19454 | 50 |
ABLIM1,CAMK2G |
4.718e-02 | -3.05 | PKA activation | REACTOME pathways | R-HSA-163615 | 16 | 1 | 10285 | 31 |
ADCY2 |
4.718e-02 | -3.05 | GRB2 events in ERBB2 signaling | REACTOME pathways | R-HSA-1963640 | 16 | 1 | 10285 | 31 |
NRG3 |
4.718e-02 | -3.05 | PI3K events in ERBB2 signaling | REACTOME pathways | R-HSA-1963642 | 16 | 1 | 10285 | 31 |
NRG3 |
4.750e-02 | -3.05 | anatomical structure formation involved in morphogenesis | biological process | GO:0048646 | 964 | 6 | 18204 | 50 |
NRG3,NEBL,NRCAM,CNTN1,FAT3,RORA |
4.752e-02 | -3.05 | A/G_cyclase | interpro domains | IPR001054 | 18 | 1 | 18521 | 50 |
ADCY2 |
4.752e-02 | -3.05 | Nucleotide_cyclase | interpro domains | IPR029787 | 18 | 1 | 18521 | 50 |
ADCY2 |
4.752e-02 | -3.05 | ATPase_P-typ_cation-transptr_N | interpro domains | IPR004014 | 18 | 1 | 18521 | 50 |
ATP1A2 |
4.760e-02 | -3.05 | response to amino acid | biological process | GO:0043200 | 127 | 2 | 18204 | 50 |
NTRK2,SLC1A2 |
4.764e-02 | -3.04 | astrocyte projection | cellular component | GO:0097449 | 19 | 1 | 19108 | 49 |
SLC1A2 |
4.764e-02 | -3.04 | postsynaptic specialization, intracellular component | cellular component | GO:0099091 | 19 | 1 | 19108 | 49 |
TNIK |
4.764e-02 | -3.04 | cation-transporting ATPase complex | cellular component | GO:0090533 | 19 | 1 | 19108 | 49 |
ATP1A2 |
4.764e-02 | -3.04 | cytosolic region | cellular component | GO:0099522 | 19 | 1 | 19108 | 49 |
PLCB1 |
4.764e-02 | -3.04 | parallel fiber to Purkinje cell synapse | cellular component | GO:0098688 | 19 | 1 | 19108 | 49 |
GPM6A |
4.764e-02 | -3.04 | positive regulation of nervous system development | biological process | GO:0051962 | 296 | 3 | 18204 | 50 |
NRXN1,NTRK2,MACF1 |
4.774e-02 | -3.04 | CNTNAP4 (contactin associated protein family member 4) | protein interactions | 85445 | 19 | 1 | 19454 | 50 |
MACF1 |
4.774e-02 | -3.04 | SYT7 (synaptotagmin 7) | protein interactions | 9066 | 19 | 1 | 19454 | 50 |
NRXN1 |
4.774e-02 | -3.04 | TNR (tenascin R) | protein interactions | 7143 | 19 | 1 | 19454 | 50 |
CNTN1 |
4.774e-02 | -3.04 | C3orf62 (chromosome 3 open reading frame 62) | protein interactions | 375341 | 19 | 1 | 19454 | 50 |
ATP1A2 |
4.774e-02 | -3.04 | EGFL6 (EGF like domain multiple 6) | protein interactions | 25975 | 19 | 1 | 19454 | 50 |
LRP1B |
4.774e-02 | -3.04 | RIT2 (Ras like without CAAX 2) | protein interactions | 6014 | 19 | 1 | 19454 | 50 |
DTNA |
4.774e-02 | -3.04 | OSM (oncostatin M) | protein interactions | 5008 | 19 | 1 | 19454 | 50 |
TRPM3 |
4.774e-02 | -3.04 | RRAD (RRAD, Ras related glycolysis inhibitor and calcium channel regulator) | protein interactions | 6236 | 19 | 1 | 19454 | 50 |
CAMK2G |
4.774e-02 | -3.04 | PLCB2 (phospholipase C beta 2) | protein interactions | 5330 | 19 | 1 | 19454 | 50 |
PLCB1 |
4.774e-02 | -3.04 | PHYHIPL (phytanoyl-CoA 2-hydroxylase interacting protein like) | protein interactions | 84457 | 19 | 1 | 19454 | 50 |
GPM6A |
4.774e-02 | -3.04 | GCHFR (GTP cyclohydrolase I feedback regulator) | protein interactions | 2644 | 19 | 1 | 19454 | 50 |
NEBL |
4.774e-02 | -3.04 | Mtx1 (metaxin 1) | protein interactions | 17827 | 19 | 1 | 19454 | 50 |
CAMK2G |
4.774e-02 | -3.04 | LTC4S (leukotriene C4 synthase) | protein interactions | 4056 | 19 | 1 | 19454 | 50 |
CAMK2G |
4.774e-02 | -3.04 | NLGN1 (neuroligin 1) | protein interactions | 22871 | 19 | 1 | 19454 | 50 |
NRXN1 |
4.774e-02 | -3.04 | SPZ1 (spermatogenic leucine zipper 1) | protein interactions | 84654 | 19 | 1 | 19454 | 50 |
DTNA |
4.774e-02 | -3.04 | Trp53 (transformation related protein 53) | protein interactions | 22059 | 19 | 1 | 19454 | 50 |
MAPK10 |
4.775e-02 | -3.04 | PHPHLIPASEC | prints domains | PR00390 | 15 | 1 | 5227 | 17 |
PLCB1 |
4.802e-02 | -3.04 | ductal_carcinoma | COSMIC cancer mutations | ductal_carcinoma | 15798 | 48 | 16828 | 48 |
KALRN,SYNE1,RFX4,MSI2,DGKG,GPC5,MACF1,ADCY2,NAV3,FAT3,TNC,PLCB1,LRP1B,TNIK,SOX5,RBMS3,CAMK2G,GPM6A,NAV2,MGAT4C,LSAMP,RORA,NRCAM,NEBL,PITPNC1,NHSL1,SLC14A1,ABLIM1,NTM,FMN2,DTNA,NKAIN3,NRG3,RYR3,DPP6,CNTN1,DCLK2,NRXN1,HPSE2,PARD3,TRPM3,NTRK2,ATP1A2,CTNND2,SFXN5,SORBS1,SLC4A4,SLC1A2 |
4.804e-02 | -3.04 | carboxylic acid transport | biological process | GO:0046942 | 297 | 3 | 18204 | 50 |
NTRK2,SLC1A2,SFXN5 |
4.804e-02 | -3.04 | muscle system process | biological process | GO:0003012 | 297 | 3 | 18204 | 50 |
RYR3,ATP1A2,DTNA |
4.806e-02 | -3.04 | bone-humerus-chondrosarcoma | COSMIC cancer mutations | bone-humerus-chondrosarcoma | 123 | 2 | 16828 | 48 |
LRP1B,KALRN |
4.815e-02 | -3.03 | DAGK | prosite domains | PS50146 | 15 | 1 | 12186 | 40 |
DGKG |
4.815e-02 | -3.03 | FH2 | prosite domains | PS51444 | 15 | 1 | 12186 | 40 |
FMN2 |
4.815e-02 | -3.03 | PIPLC_Y_DOMAIN | prosite domains | PS50008 | 15 | 1 | 12186 | 40 |
PLCB1 |
4.815e-02 | -3.03 | CNH | prosite domains | PS50219 | 15 | 1 | 12186 | 40 |
TNIK |
4.831e-02 | -3.03 | regulation of signaling | biological process | GO:0023051 | 3534 | 15 | 18204 | 50 |
TNIK,NRXN1,RORA,GPC5,MACF1,DGKG,NRG3,KALRN,ATP1A2,CTNND2,NTRK2,PLCB1,SYNE1,RBMS3,SORBS1 |
4.832e-02 | -3.03 | regulation of acrosome reaction | biological process | GO:0060046 | 18 | 1 | 18204 | 50 |
PLCB1 |
4.832e-02 | -3.03 | cardiac myofibril assembly | biological process | GO:0055003 | 18 | 1 | 18204 | 50 |
NEBL |
4.832e-02 | -3.03 | regulation of endothelial cell development | biological process | GO:1901550 | 18 | 1 | 18204 | 50 |
PLCB1 |
4.832e-02 | -3.03 | positive regulation of circadian rhythm | biological process | GO:0042753 | 18 | 1 | 18204 | 50 |
RORA |
4.832e-02 | -3.03 | regulation of protein kinase C signaling | biological process | GO:0090036 | 18 | 1 | 18204 | 50 |
DGKG |
4.832e-02 | -3.03 | negative regulation of anoikis | biological process | GO:2000811 | 18 | 1 | 18204 | 50 |
NTRK2 |
4.832e-02 | -3.03 | regulation of establishment of endothelial barrier | biological process | GO:1903140 | 18 | 1 | 18204 | 50 |
PLCB1 |
4.832e-02 | -3.03 | dendritic spine morphogenesis | biological process | GO:0060997 | 18 | 1 | 18204 | 50 |
CTNND2 |
4.832e-02 | -3.03 | negative regulation of sodium ion transport | biological process | GO:0010766 | 18 | 1 | 18204 | 50 |
ATP1A2 |
4.832e-02 | -3.03 | positive regulation of myelination | biological process | GO:0031643 | 18 | 1 | 18204 | 50 |
PARD3 |
4.842e-02 | -3.03 | TBL1X (transducin beta like 1 X-linked) | protein interactions | 6907 | 137 | 2 | 19454 | 50 |
SOX5,DGKG |
4.843e-02 | -3.03 | organic acid transport | biological process | GO:0015849 | 298 | 3 | 18204 | 50 |
SLC1A2,SFXN5,NTRK2 |
4.844e-02 | -3.03 | Cation_ATPase_N | pfam domains | PF00690 | 18 | 1 | 17795 | 49 |
ATP1A2 |
4.844e-02 | -3.03 | Guanylate_cyc | pfam domains | PF00211 | 18 | 1 | 17795 | 49 |
ADCY2 |
4.859e-02 | -3.02 | human chr18q12.1 | chromosome location | human chr18q12.1 | 26 | 1 | 26134 | 50 |
DTNA |
4.892e-02 | -3.02 | protein phosphorylation | biological process | GO:0006468 | 503 | 4 | 18204 | 50 |
MAPK10,TNIK,NTRK2,KALRN |
4.905e-02 | -3.01 | regulation of cell communication | biological process | GO:0010646 | 3541 | 15 | 18204 | 50 |
NRG3,KALRN,DGKG,NRXN1,TNIK,GPC5,MACF1,RORA,PLCB1,SORBS1,SYNE1,RBMS3,ATP1A2,CTNND2,NTRK2 |
4.921e-02 | -3.01 | cellular response to hormone stimulus | biological process | GO:0032870 | 504 | 4 | 18204 | 50 |
ATP1A2,SORBS1,TNC,PLCB1 |
4.924e-02 | -3.01 | alkali metal ion binding | molecular function | GO:0031420 | 19 | 1 | 18094 | 48 |
ATP1A2 |
4.924e-02 | -3.01 | ankyrin binding | molecular function | GO:0030506 | 19 | 1 | 18094 | 48 |
NRCAM |
4.924e-02 | -3.01 | water transmembrane transporter activity | molecular function | GO:0005372 | 19 | 1 | 18094 | 48 |
SLC14A1 |
4.930e-02 | -3.01 | DAGKc | smart domains | SM00046 | 14 | 1 | 9717 | 35 |
DGKG |
4.930e-02 | -3.01 | CNH | smart domains | SM00036 | 14 | 1 | 9717 | 35 |
TNIK |
4.930e-02 | -3.01 | 4.1m | smart domains | SM00294 | 14 | 1 | 9717 | 35 |
NRXN1 |
4.930e-02 | -3.01 | LY | smart domains | SM00135 | 14 | 1 | 9717 | 35 |
LRP1B |
4.931e-02 | -3.01 | Th17 cell differentiation | KEGG pathways | ko04659 | 107 | 2 | 7161 | 24 |
RORA,MAPK10 |
4.931e-02 | -3.01 | Th17 cell differentiation | KEGG pathways | hsa04659 | 107 | 2 | 7161 | 24 |
MAPK10,RORA |
4.940e-02 | -3.01 | ACTA1 (actin alpha 1, skeletal muscle) | protein interactions | 58 | 321 | 3 | 19454 | 50 |
SORBS1,DTNA,MACF1 |
4.951e-02 | -3.01 | cellular response to organonitrogen compound | biological process | GO:0071417 | 505 | 4 | 18204 | 50 |
SLC1A2,SORBS1,RYR3,PLCB1 |
4.963e-02 | -3.00 | medullary_carcinoma | COSMIC cancer mutations | medullary_carcinoma | 290 | 3 | 16828 | 48 |
SLC1A2,NRG3,KALRN |
4.963e-02 | -3.00 | thyroid-carcinoma-medullary_carcinoma | COSMIC cancer mutations | thyroid-carcinoma-medullary_carcinoma | 290 | 3 | 16828 | 48 |
NRG3,SLC1A2,KALRN |
4.968e-02 | -3.00 | SPCS2 (signal peptidase complex subunit 2) | protein interactions | 9789 | 139 | 2 | 19454 | 50 |
GPC5,MGAT4C |
4.999e-02 | -3.00 | regulation of biological quality | biological process | GO:0065008 | 2936 | 13 | 18204 | 50 |
NRCAM,DGKG,GPM6A,CAMK2G,NAV2,NRXN1,SLC4A4,MACF1,CTNNA2,ATP1A2,NTRK2,PLCB1,SYNE1 |